{"id": 42382569, "time": "2024-12-09 00:17:06", "headline": "Elon Musk Asks 'Was It Ever Not A Lie' As OpenAI Plans To Drop AGI Clause In Microsoft Deal", "summary": "Elon Musk has accused OpenAI of betraying its founding mission and criticized discussions to potentially remove restrictions limiting Microsoft&#39;s access to its advanced AI technology, raising concerns about the organization&#39;s shift toward for-profit operations.", "symbols": ["MSFT"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/24/12/42382569/elon-musk-asks-was-it-ever-not-a-lie-as-he-accuses-openai-of-selling-out-to-microsoft-and-betraying-its-founding-mission", "tags": ["contract"]}
{"id": 42382635, "time": "2024-12-09 00:31:19", "headline": "Reported Earlier, Japan Adjusted Current Account For October 2.41T Vs. 2.28T Est.; 1.27T Prior", "summary": "", "symbols": ["BBJP", "DXJ", "EWJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42382635/reported-earlier-japan-adjusted-current-account-for-october-2-41t-vs-2-28t-est-1-", "tags": []}
{"id": 42382638, "time": "2024-12-09 00:31:51", "headline": "Reported Earlier, Japan Current Account n.s.a. For October 2.457T Vs. 2.318T Est.; 1.717T Prior", "summary": "", "symbols": ["BBJP", "DXJ", "EWJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42382638/reported-earlier-japan-current-account-n-s-a-for-october-2-457t-vs-2-318t-est-1-7", "tags": []}
{"id": 42382639, "time": "2024-12-09 00:32:27", "headline": "Reported Earlier, Japan Gross Domestic Product (QoQ) For Q3 0.3% Vs. 0.2% Est.; 0.5% (Revised) Prior", "summary": "", "symbols": ["BBJP", "DXJ", "EWJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42382639/reported-earlier-japan-gross-domestic-product-qoq-for-q3-0-3-vs-0-2-est-0-5-revis", "tags": []}
{"id": 42382640, "time": "2024-12-09 00:32:58", "headline": "Reported Earlier, Japan Gross Domestic Product (GDP) Annualized (QoQ) For Q3 1.2% Vs. 0.9% Est.; 2.9% Prior", "summary": "", "symbols": ["BBJP", "DXJ", "EWJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42382640/reported-earlier-japan-gross-domestic-product-gdp-annualized-qoq-for-q3-1-2-vs-0-", "tags": []}
{"id": 42382642, "time": "2024-12-09 00:33:24", "headline": "Reported Earlier, Japan Gross Domestic Product (GDP) Price Index (YoY) For Q3 2.4% Est.; 2.5% Est.; 3.2% Prior", "summary": "", "symbols": ["BBJP", "DXJ", "EWJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42382642/reported-earlier-japan-gross-domestic-product-gdp-price-index-yoy-for-q3-2-4-est-", "tags": []}
{"id": 42382644, "time": "2024-12-09 00:33:42", "headline": "Reported Earlier, Australia Building Approvals (MoM) For October 4.2% Vs. 4.2% Est.; 5.8% (Revised) Prior", "summary": "", "symbols": ["EWA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42382644/reported-earlier-australia-building-approvals-mom-for-october-4-2-vs-4-2-est-5-8-", "tags": []}
{"id": 42382645, "time": "2024-12-09 00:34:03", "headline": "Reported Earlier, China Consumer Price Index (MoM) For November -0.6% Vs. -0.4% Est.; -0.3% Prior", "summary": "", "symbols": ["FXI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42382645/reported-earlier-china-consumer-price-index-mom-for-november-0-6-vs-0-4-est-0-3-p", "tags": []}
{"id": 42382646, "time": "2024-12-09 00:34:20", "headline": "Reported Earlier, China Consumer Price Index (YoY) For November 0.2% Vs. 0.5% Est.; 0.3% Prior", "summary": "", "symbols": ["FXI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42382646/reported-earlier-china-consumer-price-index-yoy-for-november-0-2-vs-0-5-est-0-3-p", "tags": []}
{"id": 42382647, "time": "2024-12-09 00:34:43", "headline": "Reported Earlier, China Producer Price Index (YoY) For November -2.5% Vs. -2.8% Est.; -2.9% Prior", "summary": "", "symbols": ["FXI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42382647/reported-earlier-china-producer-price-index-yoy-for-november-2-5-vs-2-8-est-2-9-p", "tags": []}
{"id": 42382665, "time": "2024-12-09 00:43:23", "headline": "Tesla Stock Hits $400 In Overnight Trading On Robinhood Amid Analyst Upgrades And FSD Optimism", "summary": "Tesla Inc. shares surged past $400 in overnight trading, reaching $401.16 as of 12:11 am EST Monday in New York, approaching its all-time high of $407.36 set in November 2021. ", "symbols": ["TSLA"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/24/12/42382665/tesla-stock-hits-400-in-overnight-trading-nears-all-time-high-amid-analyst-upgrades-and-fsd-optimism", "tags": ["analyst_up"]}
{"id": 42382786, "time": "2024-12-09 01:10:17", "headline": "Morgan Stanley Narrows Down Winning And Losing Bets In The First 100 Days Of Trump Administration", "summary": "Morgan Stanley sees potential growth in technology, natural gas, and defense sectors under Trump&#39;s 2024 win but flags risks from trade, fiscal, and regulatory challenges.", "symbols": ["AMZN", "GOOG", "ITA", "IWD", "LMT", "MSFT", "NVDA", "RSP", "RTX", "SPXE", "VYM"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/markets/equities/24/12/42382786/morgan-stanley-narrows-down-winning-and-losing-bets-in-the-first-100-days-of-trump-administration", "tags": []}
{"id": 42382883, "time": "2024-12-09 01:20:50", "headline": "Ark Invest's Cathie Wood Hails Bitcoin's $100K Climb As A 'Big Deal,' Labels Apex Crypto As Gold Substitute And Emerging Reserve Currency", "summary": "Renowned stock picker and founder of asset management giant Ark Invest, Cathie Wood, deemed Bitcoin&#39;s (CRYPTO: BTC) breach of the $100,000 mark a &#34;big deal&#34; on Sunday, hailing the leading cryptocurrency&#39;s rising prominence in the world of finance and investing.", "symbols": ["ARKB", "BTCUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42382883/ark-invests-cathie-wood-hails-bitcoins-100k-climb-as-a-big-deal-labels-apex-crypto-as-gold-substitute-and-emerging-reserve-currency", "tags": ["contract"]}
{"id": 42382977, "time": "2024-12-09 01:46:09", "headline": "Reported Earlier, Apple Expands In Saudi Arabia: Flagship Stores, Developer Training, And Economic Growth", "summary": "", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42382977/reported-earlier-apple-expands-in-saudi-arabia-flagship-stores-developer-training-and-economic-growt", "tags": []}
{"id": 42383017, "time": "2024-12-09 01:53:50", "headline": "Lundin Mining Sells Neves-Corvo And Zinkgruvan Mines To Boliden AB For Up To $1.52B", "summary": "", "symbols": ["BDNNY", "LUNMF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42383017/lundin-mining-sells-neves-corvo-and-zinkgruvan-mines-to-boliden-ab-for-up-to-1-52b", "tags": []}
{"id": 42383060, "time": "2024-12-09 02:03:12", "headline": "Datopotamab Deruxtecan Receives FDA Breakthrough Therapy Designation for EGFR-Mutated Lung Cancer", "summary": "", "symbols": ["AZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/government/24/12/42383060/datopotamab-deruxtecan-receives-fda-breakthrough-therapy-designation-for-egfr-mutated-lung-cancer", "tags": ["fda"]}
{"id": 42383069, "time": "2024-12-09 02:07:27", "headline": "Innate Pharma's TELLOMAK Phase 2 Trial: Lacutamab Demonstrates Significant Symptom Relief and Quality-of-Life Improvements In Advanced CTCL, Presented At ASH 2024", "summary": "", "symbols": ["IPHA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383069/innate-pharmas-tellomak-phase-2-trial-lacutamab-demonstrates-significant-symptom-relief-and-quality", "tags": ["fda"]}
{"id": 42383071, "time": "2024-12-09 02:08:23", "headline": "MaxCyte expects FY24: Core Revenue Growth Of 6%-8% (Prior At Least 5%) YoY; Reiterated SPL Revenue ~$6M, To Let Go Of 21 Employees To Save $5.8M In Costs For 2025", "summary": "", "symbols": ["MXCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383071/maxcyte-expects-fy24-core-revenue-growth-of-6-8-prior-at-least-5-yoy-reiterated-spl-revenue-6m-to-le", "tags": ["earnings"]}
{"id": 42383073, "time": "2024-12-09 02:09:36", "headline": "HIVE Digital November 2024 Production Results: Bitcoin Holdings Values At $261M, Mining Capacity Reaches 5.3 EH/s", "summary": "", "symbols": ["HIVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42383073/hive-digital-november-2024-production-results-bitcoin-holdings-values-at-261m-mining-capac", "tags": []}
{"id": 42383106, "time": "2024-12-09 02:11:11", "headline": "PureTech Health Presents Promising Data on LYT-200 for Treating Relapsed Leukemia and Blood Disorders at 2024 ASH Annual Meeting", "summary": "", "symbols": ["PRTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383106/puretech-health-presents-promising-data-on-lyt-200-for-treating-relapsed-leukemia-and-blood-disorder", "tags": []}
{"id": 42383108, "time": "2024-12-09 02:14:22", "headline": "Reported Sunday, Arcellx Unveiled New Data From Immagine-1 Study In Relapsed/Refractory Multiple Myeloma At The 66th ASH Annual Meeting And Exposition", "summary": "", "symbols": ["ACLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383108/reported-sunday-arcellx-unveiled-new-data-from-immagine-1-study-in-relapsedrefractory-multiple-myelo", "tags": []}
{"id": 42383342, "time": "2024-12-09 02:22:03", "headline": "Reported Sunday, Disc Medicine Shares Phase 1b Results For DISC-0974 In Myelofibrosis Patients At ASH 2024, Starts Phase 2 Trial", "summary": "", "symbols": ["IRON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383342/reported-sunday-disc-medicine-shares-phase-1b-results-for-disc-0974-in-myelofibrosis-patients-at-ash", "tags": ["fda"]}
{"id": 42383343, "time": "2024-12-09 02:24:22", "headline": "Toll Brothers, Oracle And 3 Stocks To Watch Heading Into Monday", "summary": " ", "symbols": ["CASY", "MDB", "ORCL", "SMCI", "TOL"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42383343/toll-brothers-oracle-and-3-stocks-to-watch-heading-into-monday", "tags": []}
{"id": 42383354, "time": "2024-12-09 02:25:13", "headline": "Reported Sunday, AbbVie's Emotional Impact Report Reveals Mental Health Challenges Faced By Diverse CLL Patient Populations At ASH 2024", "summary": "", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383354/reported-sunday-abbvies-emotional-impact-report-reveals-mental-health-challenges-faced-by-diverse-cl", "tags": []}
{"id": 42383361, "time": "2024-12-09 02:30:03", "headline": "Reported Saturday, AbbVie Unveils Phase 1b/2 EPCORE NHL-2 Trial Results: Epcoritamab Plus R2 Achieves 96% Overall Response Rate In Relapsed/Refractory Follicular Lymphoma", "summary": "", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383361/reported-saturday-abbvie-unveils-phase-1b2-epcore-nhl-2-trial-results-epcoritamab-plus-r2-achieves-9", "tags": ["fda"]}
{"id": 42383365, "time": "2024-12-09 02:33:12", "headline": "Reported Sunday, Beam Therapeutics Showcases Proof-Of-Concept Non-Human Primate Data For ESCAPE, A Non-Genotoxic Antibody-Based Conditioning Strategy For Sickle Cell Disease, At ASH 2024", "summary": "", "symbols": ["BEAM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383365/reported-sunday-beam-therapeutics-showcases-proof-of-concept-non-human-primate-data-for-escape-a-non", "tags": []}
{"id": 42383387, "time": "2024-12-09 02:36:07", "headline": "Reported Sunday, Vertex Highlights Long-Term Benefits Of CASGEVY For Sickle Cell Disease And Beta Thalassemia At ASH 2024", "summary": "", "symbols": ["VRTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383387/reported-sunday-vertex-highlights-long-term-benefits-of-casgevy-for-sickle-cell-disease-and-beta-tha", "tags": []}
{"id": 42383393, "time": "2024-12-09 02:41:21", "headline": "Reported Sunday, Johnson & Johnson Highlights TECVAYLI's Role In Advancing Frontline Multiple Myeloma Care With 100% MRD-Negative Results At ASH 2024", "summary": "", "symbols": ["JNJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383393/reported-sunday-johnson-johnson-highlights-tecvaylis-role-in-advancing-frontline-multiple-myeloma-ca", "tags": []}
{"id": 42383396, "time": "2024-12-09 02:42:47", "headline": "S&P 500, Nasdaq Hit Record Close As November Jobs Data Beats Expectations: Fear & Greed Index In 'Neutral' Zone", "summary": " ", "symbols": ["ASAN", "CASY", "DOCU", "LULU", "ORCL", "TOL"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42383396/sp-500-nasdaq-hit-record-close-following-jobs-report-investor-sentiment-declines-fear-greed-index-in-neutral-zone", "tags": []}
{"id": 42383465, "time": "2024-12-09 02:48:45", "headline": "Reported Sunday, bluebird bio Highlights 9-Year Data For LYFGENIA Gene Therapy: Sustained Benefits In Sickle Cell Disease Patients At ASH 2024", "summary": "", "symbols": ["BLUE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383465/reported-sunday-bluebird-bio-highlights-9-year-data-for-lyfgenia-gene-therapy-sustained-benefits-in", "tags": []}
{"id": 42383505, "time": "2024-12-09 02:50:05", "headline": "Stocks And Crypto Ride Optimism, But November CPI Could Be The Ultimate Market Test, Investors Warn", "summary": "In anticipation of the year-end, investors are eyeing a potential rally in stocks and cryptocurrencies, driven by lower interest rates, decreasing inflation, and rising corporate profits.", "symbols": ["BTCUSD", "QQQ", "SPY"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42383505/stocks-and-crypto-ride-optimism-but-november-cpi-could-be-the-ultimate-market-test-investors-warn", "tags": []}
{"id": 42383533, "time": "2024-12-09 02:53:43", "headline": "Reported Sunday, Roche's Genentech Showcases Polivy's Transformative Impact On Frontline DLBCL Treatment: Five-Year POLARIX Trial Results Presented At ASH 2024", "summary": "", "symbols": ["RHHBF", "RHHBY", "RHHVF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383533/reported-sunday-roches-genentech-showcases-polivys-transformative-impact-on-frontline-dlbcl-treatmen", "tags": ["fda"]}
{"id": 42383580, "time": "2024-12-09 03:05:22", "headline": "Reported Sunday, Gilead's Kite Highlights New Data Showcasing Yescarta's Curative Potential In Relapsed/Refractory Large B-Cell Lymphoma At ASH 2024", "summary": "", "symbols": ["GILD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383580/reported-sunday-gileads-kite-highlights-new-data-showcasing-yescartas-curative-potential-in-relapsed", "tags": []}
{"id": 42383621, "time": "2024-12-09 03:12:10", "headline": "Reported Sunday, Molecular Partners Reports Initial Efficacy And Safety Data For MP0533 In Phase 1/2a Study And Preclinical Success Of MP0621 At ASH 2024", "summary": "", "symbols": ["MOLN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383621/reported-sunday-molecular-partners-reports-initial-efficacy-and-safety-data-for-mp0533-in-phase-12a", "tags": ["fda"]}
{"id": 42383657, "time": "2024-12-09 03:16:45", "headline": "Reported Sunday, Genmab Presents Phase 1b/2 Data For Epcoritamab Monotherapy In Relapsed/Refractory CLL, Highlights 39% Complete Response Rate And Manageable Safety Profile At ASH 2024", "summary": "", "symbols": ["GMAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383657/reported-sunday-genmab-presents-phase-1b2-data-for-epcoritamab-monotherapy-in-relapsedrefractory-cll", "tags": []}
{"id": 42383695, "time": "2024-12-09 03:19:51", "headline": "Hello Gr Q3 Adj EPADS $0.38 Beats $0.27 Estimate, Sales $381.14M Beat $366.41M Estimate", "summary": "", "symbols": ["MOMO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42383695/hello-gr-q3-adj-epads-0-38-beats-0-27-estimate-sales-381-14m-beat-366-41m-estimate", "tags": []}
{"id": 42383701, "time": "2024-12-09 03:21:53", "headline": "Hello Gr Expects Q4 Revenue Of RMB2.56B-RMB2.66B Vs RMB2.61B Est", "summary": "", "symbols": ["MOMO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383701/hello-gr-expects-q4-revenue-of-rmb2-56b-rmb2-66b-vs-rmb2-61b-est", "tags": ["earnings"]}
{"id": 42383702, "time": "2024-12-09 03:22:39", "headline": "Reported Sunday, Vision Marine And Armada Collaborate To Launch Electric Pontoon Boat For North America's Eco-Conscious Boaters", "summary": "", "symbols": ["VMAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383702/reported-sunday-vision-marine-and-armada-collaborate-to-launch-electric-pontoon-boat-for-north-ameri", "tags": []}
{"id": 42383710, "time": "2024-12-09 03:24:44", "headline": "In Q3, Hello Group Reported 12.0M Monthly Active Users on Tantan App Vs 15.7M YoY, Total Paying Users of 6.9M Vs 7.8M YoY for Momo App, Total Paying Users of 0.9M for Tantan Vs 1.4M YoY", "summary": "", "symbols": ["MOMO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42383710/in-q3-hello-group-reported-12-0m-monthly-active-users-on-tantan-app-vs-15-7m-yoy-total-paying-users", "tags": []}
{"id": 42383726, "time": "2024-12-09 03:31:59", "headline": "Reported Saturday, Adaptive Biotechnologies Presented New Data at ASH 2024 Showcasing clonoSEQ MRD Testing Advances And Its Role In Guiding Blood Cancer Treatment Decisions", "summary": "", "symbols": ["ADPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383726/reported-saturday-adaptive-biotechnologies-presented-new-data-at-ash-2024-showcasing-clonoseq-mrd-te", "tags": []}
{"id": 42383725, "time": "2024-12-09 03:32:03", "headline": "Trump's Deregulation Efforts To Benefit Energy, Oil And Gas Sectors, While AI Frenzy Will Boost FAANG Stocks And Nvidia, Says Fintech Insider", "summary": "President-elect Donald Trump&#39;s victory has fueled a rally in equities. This is likely to sustain as the administration plans on &#34;tax cuts and deregulation will lead to higher corporate earnings,&#34; said Yogesh Kansal.", "symbols": ["AMZN", "GOOG", "GOOGL", "IWD", "MSFT", "NVDA", "RSP", "SPXE", "VYM"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/markets/equities/24/11/42383725/trump-administrations-deregulation-efforts-to-lift-energy-oil-and-gas-sectors-ai-frenzy-to-aid-faang-stocks-and-nvidia-says-fintech-insider", "tags": ["earnings", "insider"]}
{"id": 42383727, "time": "2024-12-09 03:32:07", "headline": "Earnings Scheduled For December 9, 2024", "summary": " ", "symbols": ["AI", "ASYS", "BRZE", "CASY", "GNSS", "HQY", "MDB", "MOMO", "MTN", "ODC", "ORCL", "PHR", "PL", "RENT", "TOL", "VBNK", "YEXT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42383727/earnings-scheduled-for-december-9-2024", "tags": ["earnings"]}
{"id": 42383750, "time": "2024-12-09 03:35:13", "headline": "Elon Musk Mocks Tesla Shorts After Stock Hits $400 In Overnight Trading On Robinhood", "summary": "Tesla CEO Elon Musk mocked short sellers of the company on Sunday after the stock breached $400 on Robinhood&#39;s overnight trading service.", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/markets/equities/24/12/42383750/elon-musk-mocks-tesla-shorts-after-stock-hits-400-in-overnight-trading-on-robinhood", "tags": ["management"]}
{"id": 42383772, "time": "2024-12-09 03:38:14", "headline": "Reported Saturday, Syndax's Revuforj (revumenib) Achieves High Response Rates In Acute Leukemia Trials, Presents Compelling Data At ASH 2024", "summary": "", "symbols": ["SNDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383772/reported-saturday-syndaxs-revuforj-revumenib-achieves-high-response-rates-in-acute-leukemia-trials-p", "tags": []}
{"id": 42383778, "time": "2024-12-09 03:43:34", "headline": "Reported Saturday, Blueprint Medicines Showcases AYVAKIT'S Survival Benefits And Disease-Modifying Effects In Advanced Systemic Mastocytosis At ASH 2024", "summary": "", "symbols": ["BPMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383778/reported-saturday-blueprint-medicines-showcases-ayvakits-survival-benefits-and-disease-modifying-eff", "tags": []}
{"id": 42383831, "time": "2024-12-09 03:47:11", "headline": "Reported Saturday, JinkoSolar Files Patent Infringement Lawsuit Against VSUN Solar And Affiliates Over Proprietary N-Type TOPCon Technology", "summary": "", "symbols": ["JKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383831/reported-saturday-jinkosolar-files-patent-infringement-lawsuit-against-vsun-solar-and-affiliates-ove", "tags": ["legal"]}
{"id": 42383873, "time": "2024-12-09 03:51:49", "headline": "Reported Saturday, Merus Unveils Clinically Meaningful Activity For Petosemtamab In 2L+ R/M HNSCC And Expands Evaluation In mCRC", "summary": "", "symbols": ["MRUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383873/reported-saturday-merus-unveils-clinically-meaningful-activity-for-petosemtamab-in-2l-rm-hnscc-and-e", "tags": []}
{"id": 42383874, "time": "2024-12-09 03:52:21", "headline": "Expert Slams Trump's Tariff Policies As 'Completely And Utterly Wrong' But Says 'We Don't Think They Are Going To Do Anything...'", "summary": "He also predicted significant market volatility in the upcoming year due to the tariff discussions. ", "symbols": ["QQQ", "SPY"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42383874/expert-slams-trumps-tariff-policies-as-completely-and-utterly-wrong-but-says-we-dont-think-they-are-going-to-do-anything", "tags": []}
{"id": 42383907, "time": "2024-12-09 03:59:07", "headline": "Reported Friday, New Era Helium Finalizes Business Combination, Set To Begin Nasdaq Trading Under Ticker Symbols NEHC And NEHCW", "summary": "", "symbols": ["ROCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383907/reported-friday-new-era-helium-finalizes-business-combination-set-to-begin-nasdaq-trading-under-tick", "tags": []}
{"id": 42383926, "time": "2024-12-09 04:04:26", "headline": "The FDA Has Accepted For Review GSK's Nucala (Mepolizumab) As An Add-on Maintenance Treatment For Patients With Chronic Obstructive Pulmonary Disease With An Eosinophilic Phenotype, With Prescription Drug User Fee Act Date Is 7 May 2025", "summary": "", "symbols": ["GSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42383926/the-fda-has-accepted-for-review-gsks-nucala-mepolizumab-as-an-add-on-maintenance-treatment-for-pa", "tags": ["fda"]}
{"id": 42383949, "time": "2024-12-09 04:07:00", "headline": "Apple Expands Retail Footprint In Saudi Arabia With Online Store Launch, Plans Multiple Flagship Locations", "summary": "Apple announced ambitious expansion plans in Saudi Arabia, marking a significant step in its Middle East growth strategy. The tech giant will launch its first Arabic-language online store in the summer of 2025, followed by multiple flagship retail locations starting in 2026, according to a company announcement Sunday.", "symbols": ["AAPL"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/news/global/24/12/42383949/apple-expands-retail-footprint-in-saudi-arabia-with-online-store-launch-plans-multiple-flagship-locations", "tags": []}
{"id": 42383966, "time": "2024-12-09 04:13:26", "headline": "Apollo And Santander Collaborate Over $370M Infrastructure Portfolio Financing", "summary": "", "symbols": ["APO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42383966/apollo-and-santander-collaborate-over-370m-infrastructure-portfolio-financing", "tags": []}
{"id": 42384092, "time": "2024-12-09 04:20:08", "headline": "Morgan Stanley Upgrades Reddit to Overweight, Raises Price Target to $200", "summary": "", "symbols": ["RDDT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42384092/morgan-stanley-upgrades-reddit-to-overweight-raises-price-target-to-200", "tags": ["analyst_up", "price_target_up"]}
{"id": 42384114, "time": "2024-12-09 04:24:31", "headline": "Ascendiant Capital Maintains Buy on PAVmed, Lowers Price Target to $19", "summary": "", "symbols": ["PAVM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42384114/ascendiant-capital-maintains-buy-on-pavmed-lowers-price-target-to-19", "tags": ["analyst_other", "price_target_down"]}
{"id": 42384137, "time": "2024-12-09 04:31:00", "headline": "Ascendiant Capital Maintains Buy on Lucid Diagnostics, Lowers Price Target to $7", "summary": "", "symbols": ["LUCD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42384137/ascendiant-capital-maintains-buy-on-lucid-diagnostics-lowers-price-target-to-7", "tags": ["analyst_other", "price_target_down"]}
{"id": 42384143, "time": "2024-12-09 04:33:51", "headline": "On Saturday, Novartis Announced Longer-term Results From Phase 3 ASC4FIRST Trial Of Scemblix (Asciminib) Compared To Standard-Of-Care Tyrosine Kinase Inhibitors And Imatinib Alone In Adult Patients With Newly Diagnosed Chronic Myeloid Leukemia", "summary": "", "symbols": ["NVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42384143/on-saturday-novartis-announced-longer-term-results-from-phase-3-asc4first-trial-of-scemblix-ascim", "tags": ["fda"]}
{"id": 42384148, "time": "2024-12-09 04:35:44", "headline": "Litecoin, Dogecoin Record Hash Rate Gains After A Mining Company Reveals 3X Profit Over Bitcoin", "summary": "Litecoin (CRYPTO: LTC) and Dogecoin (CRYPTO: DOGE) recorded a sharp uptick in hash rate on Sunday after a mining company disclosed that the two coins yielded three times the profit as mining Bitcoin (CRYPTO: &lt;", "symbols": ["BTCM", "BTCUSD", "DOGEUSD", "LTC", "LTCUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/24/12/42384148/litecoin-and-dogecoin-witness-spike-in-hash-rate-as-mining-becomes-profitable", "tags": []}
{"id": 42384177, "time": "2024-12-09 04:39:25", "headline": "Ascendiant Capital Maintains Buy on Plus Therapeutics, Lowers Price Target to $19", "summary": "", "symbols": ["PSTV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42384177/ascendiant-capital-maintains-buy-on-plus-therapeutics-lowers-price-target-to-19", "tags": ["analyst_other", "price_target_down"]}
{"id": 42384408, "time": "2024-12-09 04:51:36", "headline": "Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $7", "summary": "", "symbols": ["ATOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42384408/ascendiant-capital-maintains-buy-on-atossa-therapeutics-raises-price-target-to-7", "tags": ["analyst_other", "price_target_up"]}
{"id": 42384513, "time": "2024-12-09 05:06:28", "headline": "Iran Plans To Regulate Crypto To 'Nullify Sanctions' Ahead Of Trump's White House Return", "summary": "Iran is moving to \u201corganize\u201d cryptocurrency through regulation rather than restriction, a strategic shift that coincides with President-elect Donald Trump\u2018s pro-crypto stance and Bitcoin\u2018s (CRYPTO: BTC) ", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/news/global/24/12/42384513/iran-plans-to-regulate-crypto-to-nullify-sanctions-as-trump-set-to-oversee-administration", "tags": []}
{"id": 42384514, "time": "2024-12-09 05:06:37", "headline": "Needham Reiterates Buy on Merus, Maintains $85 Price Target", "summary": "", "symbols": ["MRUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42384514/needham-reiterates-buy-on-merus-maintains-85-price-target", "tags": ["analyst_other"]}
{"id": 42384543, "time": "2024-12-09 05:08:55", "headline": "BMO Capital Initiates Coverage On Apple Hospitality REIT with Outperform Rating, Announces Price Target of $18", "summary": "", "symbols": ["APLE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42384543/bmo-capital-initiates-coverage-on-apple-hospitality-reit-with-outperform-rating-announces-price-targ", "tags": ["analyst_init"]}
{"id": 42384544, "time": "2024-12-09 05:10:30", "headline": "Needham Reiterates Buy on Cogent Biosciences, Maintains $15 Price Target", "summary": "", "symbols": ["COGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42384544/needham-reiterates-buy-on-cogent-biosciences-maintains-15-price-target", "tags": ["analyst_other"]}
{"id": 42384559, "time": "2024-12-09 05:10:52", "headline": "BMO Capital Initiates Coverage On Ryman Hospitality Props with Outperform Rating, Announces Price Target of $133", "summary": "", "symbols": ["RHP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42384559/bmo-capital-initiates-coverage-on-ryman-hospitality-props-with-outperform-rating-announces-price-tar", "tags": ["analyst_init"]}
{"id": 42384569, "time": "2024-12-09 05:15:32", "headline": "AI Robot Trader Goes All-In On Tesla, Betting Big On Elon Musk's Momentum Amid Trump Trade Plays", "summary": "The fintech firm, which manages approximately $50 million across three ETFs, utilizes AI-driven strategies to rebalance its portfolio monthly", "symbols": ["BX", "KKR", "TPL", "TSLA", "VST"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/markets/24/12/42384569/ai-robot-trader-goes-all-in-on-tesla-betting-big-on-elon-musks-momentum-amid-trump-trade-plays", "tags": []}
{"id": 42384578, "time": "2024-12-09 05:16:03", "headline": "Not All iPhone Charging Cables Are Safe: Here's How Hackers Turned Them Into Tools Of Espionage", "summary": "Hackers can exploit third-party USB-C cables, embedding hidden electronics like Wi-Fi antennas to spy on iPhone users, emphasizing the need to use official accessories and avoid public charging ports.", "symbols": [], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/24/12/42384578/iphone-charging-cables-arent-all-safe-how-hackers-turn-them-into-tools-of-espionage", "tags": []}
{"id": 42384719, "time": "2024-12-09 05:22:34", "headline": "Keefe, Bruyette & Woods Downgrades Payoneer Global to Market Perform, Maintains Price Target to $12", "summary": "", "symbols": ["PAYO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42384719/keefe-bruyette-woods-downgrades-payoneer-global-to-market-perform-maintains-price-target-to-12", "tags": ["analyst_down", "analyst_other"]}
{"id": 42384726, "time": "2024-12-09 05:25:22", "headline": "Keefe, Bruyette & Woods Downgrades SLM to Market Perform, Raises Price Target to $30", "summary": "", "symbols": ["SLM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42384726/keefe-bruyette-woods-downgrades-slm-to-market-perform-raises-price-target-to-30", "tags": ["analyst_down", "price_target_up"]}
{"id": 42384730, "time": "2024-12-09 05:26:43", "headline": "Tesla CEO Elon Musk Reveals Reason Behind Dropping Company Logo On Cybercab: 'If The Product Is Special Enough...'", "summary": "Tesla CEO Elon Musk explains decision to not include logo on Cybercab, saying if product is special enough, no logo is needed.", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/24/12/42384730/tesla-ceo-reveals-reason-behind-dropping-company-logo-on-cybercab", "tags": ["management"]}
{"id": 42384097, "time": "2024-12-09 04:21:13", "headline": "Elon Musk's SpaceX Gets Pentagon Contract To Extend Ukraine's Access To Starshield: Report", "summary": "Elon Musk&#39;s rocket manufacturing company SpaceX has reportedly bagged a Pentagon contract to expand Ukraine&#39;s access to Starshield.", "symbols": [], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/general/space/24/12/42384097/elon-musks-spacex-gets-pentagon-contract-to-extend-ukraines-access-to-starshield-report", "tags": ["contract"]}
{"id": 42384739, "time": "2024-12-09 05:28:01", "headline": "Keefe, Bruyette & Woods Downgrades Shift4 Payments to Market Perform, Maintains Price Target to $112", "summary": "", "symbols": ["FOUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42384739/keefe-bruyette-woods-downgrades-shift4-payments-to-market-perform-maintains-price-target-to-112", "tags": ["analyst_down", "analyst_other"]}
{"id": 42384763, "time": "2024-12-09 05:31:39", "headline": "Xinhua Reported Earlier From China's Politburo Meeting: China Will Implement More Proactive Fiscal Policy And Moderately Loose Monetary Policy", "summary": "", "symbols": ["FXI", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42384763/xinhua-reported-earlier-from-chinas-politburo-meeting-china-will-implement-more-p", "tags": []}
{"id": 42384771, "time": "2024-12-09 05:33:26", "headline": "China's Politburo Urged Expansion Of Domestic Demand And Consumption In All Directions To Boost Economy", "summary": "", "symbols": ["FXI", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42384771/chinas-politburo-urged-expansion-of-domestic-demand-and-consumption-in-all-direct", "tags": []}
{"id": 42384776, "time": "2024-12-09 05:36:27", "headline": "China's Politburo Said We Must Expand Opening Up To Outside World, Stabilize Foreign Trade, Foreign Investment", "summary": "", "symbols": ["FXI", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42384776/chinas-politburo-said-we-must-expand-opening-up-to-outside-world-stabilize-foreig", "tags": []}
{"id": 42384779, "time": "2024-12-09 05:37:51", "headline": "China's Politburo Said Will Stabilize Property, Stock Markets", "summary": "", "symbols": ["FXI", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42384779/chinas-politburo-said-will-stabilize-property-stock-markets", "tags": []}
{"id": 42384783, "time": "2024-12-09 05:39:05", "headline": "Needham Reiterates Buy on TTM Technologies, Raises Price Target to $30", "summary": "", "symbols": ["TTMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42384783/needham-reiterates-buy-on-ttm-technologies-raises-price-target-to-30", "tags": ["analyst_other", "price_target_up"]}
{"id": 42384829, "time": "2024-12-09 05:45:43", "headline": "Baird Upgrades VeriSign to Outperform, Raises Price Target to $250", "summary": "", "symbols": ["VRSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42384829/baird-upgrades-verisign-to-outperform-raises-price-target-to-250", "tags": ["analyst_up", "price_target_up"]}
{"id": 42384892, "time": "2024-12-09 05:47:43", "headline": "BMO Capital Upgrades Omega Healthcare Invts to Outperform, Maintains Price Target to $45", "summary": "", "symbols": ["OHI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42384892/bmo-capital-upgrades-omega-healthcare-invts-to-outperform-maintains-price-target-to-45", "tags": ["analyst_up", "analyst_other"]}
{"id": 42384894, "time": "2024-12-09 05:47:55", "headline": "Is Tesla Bringing Back Its Media Team? New Job Listing Suggests So, Years After Elon Musk Said Other Companies Spend Money On 'Manipulating Public Opinion'", "summary": "Tesla is looking to hire a vehicle communications manager at its factory in Fremont, California, in a possible move towards restoring a media team.", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/24/12/42384894/is-tesla-bringing-back-its-media-team-new-job-listing-suggests-so-years-after-elon-musk-said-other-companies-spend-money-on-manipulating-public-opinion", "tags": []}
{"id": 42384918, "time": "2024-12-09 05:49:51", "headline": "Needham Maintains Buy on Carvana, Raises Price Target to $330", "summary": "", "symbols": ["CVNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42384918/needham-maintains-buy-on-carvana-raises-price-target-to-330", "tags": ["analyst_other", "price_target_up"]}
{"id": 42384977, "time": "2024-12-09 05:50:06", "headline": "Roth MKM Initiates Coverage On Monogram Technologies with Buy Rating, Announces Price Target of $4", "summary": "", "symbols": ["MGRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42384977/roth-mkm-initiates-coverage-on-monogram-technologies-with-buy-rating-announces-price-target-of-4", "tags": ["analyst_init"]}
{"id": 42385013, "time": "2024-12-09 05:55:21", "headline": "Telsey Advisory Group Maintains Outperform on Tractor Supply, Maintains $335 Price Target", "summary": "", "symbols": ["TSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385013/telsey-advisory-group-maintains-outperform-on-tractor-supply-maintains-335-price-target", "tags": ["analyst_other"]}
{"id": 42385072, "time": "2024-12-09 06:02:04", "headline": "Telsey Advisory Group Maintains Market Perform on RH, Raises Price Target to $330", "summary": "", "symbols": ["RH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385072/telsey-advisory-group-maintains-market-perform-on-rh-raises-price-target-to-330", "tags": ["analyst_other", "price_target_up"]}
{"id": 42385075, "time": "2024-12-09 06:02:07", "headline": "The FDA Has Granted 510(k) Clearance For AngioDynamics' Nanoknife System For Prostate Tissue Ablation", "summary": "", "symbols": ["ANGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385075/the-fda-has-granted-510-k-clearance-for-angiodynamics-nanoknife-system-for-prostate-tissue-ablation", "tags": ["fda"]}
{"id": 42385127, "time": "2024-12-09 06:03:44", "headline": "Needham Reiterates Buy on Arcellx, Maintains $105 Price Target", "summary": "", "symbols": ["ACLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385127/needham-reiterates-buy-on-arcellx-maintains-105-price-target", "tags": ["analyst_other"]}
{"id": 42385134, "time": "2024-12-09 06:05:09", "headline": "Arthur J. Gallagher Signs Definitive Deal To Acquire AssuredPartners For Gross Consideration Of $13.45B", "summary": "", "symbols": ["AJG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42385134/arthur-j-gallagher-signs-definitive-deal-to-acquire-assuredpartners-for-gross-consideration-of-13-45", "tags": ["merger", "contract"]}
{"id": 42385137, "time": "2024-12-09 06:05:54", "headline": "Benchmark Maintains Buy on MaxLinear, Raises Price Target to $28", "summary": "", "symbols": ["MXL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385137/benchmark-maintains-buy-on-maxlinear-raises-price-target-to-28", "tags": ["analyst_other", "price_target_up"]}
{"id": 42385139, "time": "2024-12-09 06:06:19", "headline": "CareTrust REIT Acquires 46-facility, 3,820-Bed/Unit Skilled Nursing And Seniors Housing Portfolio In The Midwest For Total Investment Amount Of $97M", "summary": "", "symbols": ["CTRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42385139/caretrust-reit-acquires-46-facility-3-820-bedunit-skilled-nursing-and-seniors-housing-portfolio-in-t", "tags": ["merger"]}
{"id": 42385140, "time": "2024-12-09 06:06:26", "headline": "Macquarie Asset Management Acquires 40% Stake in Dow's US Gulf Coast Infrastructure", "summary": "", "symbols": ["DOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42385140/macquarie-asset-management-acquires-40-stake-in-dows-us-gulf-coast-infrastructure", "tags": ["merger"]}
{"id": 42385141, "time": "2024-12-09 06:06:46", "headline": "HC Wainwright & Co. Reiterates Buy on BitFuFu, Maintains $7 Price Target", "summary": "", "symbols": ["FUFU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385141/hc-wainwright-co-reiterates-buy-on-bitfufu-maintains-7-price-target", "tags": ["analyst_other"]}
{"id": 42385146, "time": "2024-12-09 06:08:07", "headline": "IDEAYA Biosciences Unveils IDE892, A Promising PRMT5 Inhibitor With Potential To Revolutionize MTAP-Deleted Tumor Treatment", "summary": "", "symbols": ["IDYA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385146/ideaya-biosciences-unveils-ide892-a-promising-prmt5-inhibitor-with-potential-to-revolutionize-mtap-d", "tags": []}
{"id": 42385153, "time": "2024-12-09 06:08:52", "headline": "Stephens & Co. Reiterates Overweight on One Group Hospitality, Maintains $6 Price Target", "summary": "", "symbols": ["STKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385153/stephens-co-reiterates-overweight-on-one-group-hospitality-maintains-6-price-target", "tags": ["analyst_other"]}
{"id": 42385154, "time": "2024-12-09 06:09:13", "headline": "Jeffs' Brands Secures Exclusive Deal to Sell Advanced Drone Safety Systems on Amazon", "summary": "", "symbols": ["AMZN", "JFBR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385154/jeffs-brands-secures-exclusive-deal-to-sell-advanced-drone-safety-systems-on-amazon", "tags": ["contract"]}
{"id": 42385163, "time": "2024-12-09 06:09:20", "headline": "Telsey Advisory Group Maintains Market Perform on Signet Jewelers, Maintains $87 Price Target", "summary": "", "symbols": ["SIG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385163/telsey-advisory-group-maintains-market-perform-on-signet-jewelers-maintains-87-price-target", "tags": ["analyst_other"]}
{"id": 42385220, "time": "2024-12-09 06:11:41", "headline": "Why Interpublic Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket", "summary": " ", "symbols": ["ADD", "ALBT", "AUMN", "BIOA", "DUO", "ESSA", "GXAI", "HCTI", "IPG", "LEV", "MRM", "OMC", "ORIS", "RENT", "RIME", "SATL", "SBET", "SPCB", "SXTC", "ZBAO", "ZEO"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42385220/why-interpublic-shares-are-trading-higher-by-around-14-here-are-20-stocks-moving-premarket", "tags": ["why_moving"]}
{"id": 42385290, "time": "2024-12-09 06:15:02", "headline": "HC Wainwright & Co. Reiterates Buy on Xtract One Technologies, Lowers Price Target to C$1", "summary": "", "symbols": ["TSX:XTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385290/hc-wainwright-co-reiterates-buy-on-xtract-one-technologies-lowers-price-target-to-c-1", "tags": ["analyst_other", "price_target_down"]}
{"id": 42385349, "time": "2024-12-09 06:16:30", "headline": "Chinese Social Media Company Hello Group Gains After Q3 Print, CEO Flags Overseas Growth", "summary": "Hello Group Inc reported a 12.1% decline in Q3 net revenue to $381.14M, beating analyst estimate. Momo app&#39;s paying users and MAU decreased.", "symbols": ["MOMO"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/24/12/42385349/chinese-social-media-company-hello-group-gains-after-q3-print-ceo-flags-overseas-growth", "tags": ["earnings", "management"]}
{"id": 42385367, "time": "2024-12-09 06:18:18", "headline": "HC Wainwright & Co. Maintains Buy on Uranium Energy, Raises Price Target to $11", "summary": "", "symbols": ["UEC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385367/hc-wainwright-co-maintains-buy-on-uranium-energy-raises-price-target-to-11", "tags": ["analyst_other", "price_target_up"]}
{"id": 42385369, "time": "2024-12-09 06:18:33", "headline": "Brera Holdings to Invest in 52% Stake in Italian Football Club SS Juve Stabia", "summary": "", "symbols": ["BREA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42385369/brera-holdings-to-invest-in-52-stake-in-italian-football-club-ss-juve-stabia", "tags": []}
{"id": 42385380, "time": "2024-12-09 06:19:26", "headline": "Jefferies Upgrades Tenaris to Buy, Raises Price Target to $47", "summary": "", "symbols": ["TS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385380/jefferies-upgrades-tenaris-to-buy-raises-price-target-to-47", "tags": ["analyst_up", "price_target_up"]}
{"id": 42385449, "time": "2024-12-09 06:20:50", "headline": "HC Wainwright & Co. Initiates Coverage On GRI Bio with Buy Rating, Announces Price Target of $10", "summary": "", "symbols": ["GRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385449/hc-wainwright-co-initiates-coverage-on-gri-bio-with-buy-rating-announces-price-target-of-10", "tags": ["analyst_init"]}
{"id": 42385509, "time": "2024-12-09 06:22:31", "headline": "Jefferies Initiates Coverage On Scotts Miracle Gro with Hold Rating, Announces Price Target of $72", "summary": "", "symbols": ["SMG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385509/jefferies-initiates-coverage-on-scotts-miracle-gro-with-hold-rating-announces-price-target-of-72", "tags": ["analyst_init"]}
{"id": 42385510, "time": "2024-12-09 06:22:47", "headline": "Loar Holdings Filed For Offering Of Up To 4.75M Shares Of Common Stock", "summary": "", "symbols": ["LOAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/12/42385510/loar-holdings-filed-for-offering-of-up-to-4-75m-shares-of-common-stock", "tags": ["offering"]}
{"id": 42385511, "time": "2024-12-09 06:23:20", "headline": "Needham Reiterates Buy on CoStar Gr, Maintains $100 Price Target", "summary": "", "symbols": ["CSGP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385511/needham-reiterates-buy-on-costar-gr-maintains-100-price-target", "tags": ["analyst_other"]}
{"id": 42385513, "time": "2024-12-09 06:24:08", "headline": "Jefferies Upgrades Vertex Pharmaceuticals to Buy, Raises Price Target to $550", "summary": "", "symbols": ["VRTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385513/jefferies-upgrades-vertex-pharmaceuticals-to-buy-raises-price-target-to-550", "tags": ["analyst_up", "price_target_up"]}
{"id": 42385516, "time": "2024-12-09 06:25:58", "headline": "Jefferies Downgrades Bioage Labs to Hold, Lowers Price Target to $7", "summary": "", "symbols": ["BIOA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385516/jefferies-downgrades-bioage-labs-to-hold-lowers-price-target-to-7", "tags": ["analyst_down", "price_target_down"]}
{"id": 42385519, "time": "2024-12-09 06:26:36", "headline": "Larger Fonts, Bigger Impact: iQIYI Makes Entertainment More Accessible", "summary": "iQIYI introduces &#39;Extra Large Font&#39; feature to enhance accessibility for senior and visually impaired users. ", "symbols": ["IQ"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/12/42385519/larger-fonts-bigger-impact-iqiyi-makes-entertainment-more-accessible", "tags": []}
{"id": 42385531, "time": "2024-12-09 06:27:19", "headline": "The Wall Street Journal Reported Activist Investor Barington Capital Has Built A Position In Macy's, Plans To Push For Changes To Boost Its Slumping Stock", "summary": "", "symbols": ["M"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385531/the-wall-street-journal-reported-activist-investor-barington-capital-has-built-a-position-in-macys-p", "tags": []}
{"id": 42385555, "time": "2024-12-09 06:30:08", "headline": "HC Wainwright & Co. Reiterates Buy on Innate Pharma, Maintains $11.5 Price Target", "summary": "", "symbols": ["IPHA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385555/hc-wainwright-co-reiterates-buy-on-innate-pharma-maintains-11-5-price-target", "tags": ["analyst_other"]}
{"id": 42385559, "time": "2024-12-09 06:30:17", "headline": "Asia And Europe Markets Mixed; Crude Gains Amid China Policy Shift - Global Markets Today While US Slept", "summary": "US markets mixed, Nasdaq and S&amp;P 500 hit record highs on strong forecasts and jobs data, Dow down due to health insurance stocks. Asian markets mostly up.", "symbols": ["ADIV", "AGOV", "ASHR", "BBEU", "BOIL", "CQQQ", "DBC", "EEM", "EEMA", "EWU", "EZU", "FLAX", "FXA", "FXB", "FXC", "FXE", "FXI", "GLD", "GSG", "GXC", "IEMG", "IEUR", "IEV", "KDIV", "SPEM", "SPY", "UNG", "USDU", "USO", "UUP", "VGK", "VWO"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/markets/forex/24/12/42385559/asia-and-europe-markets-mixed-crude-gains-amid-china-policy-shift-global-markets-today-while-us-slept", "tags": []}
{"id": 42385600, "time": "2024-12-09 06:32:01", "headline": "Jefferies Initiates Coverage On Pharming with Buy Rating, Announces Price Target of $14", "summary": "", "symbols": ["PHAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385600/jefferies-initiates-coverage-on-pharming-with-buy-rating-announces-price-target-of-14", "tags": ["analyst_init"]}
{"id": 42385602, "time": "2024-12-09 06:32:09", "headline": "Trane Technologies Board Approved Up To $5B Share Buyback Program", "summary": "", "symbols": ["TT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385602/trane-technologies-board-approved-up-to-5b-share-buyback-program", "tags": ["buyback"]}
{"id": 42385615, "time": "2024-12-09 06:32:29", "headline": "Loar Holdings Launches Public Offering Of 4.75M Shares Of Its Common Stock, Including 1.58M Shares Offered By Certain Stockholders And 3.16M Shares Offered By Company", "summary": "", "symbols": ["LOAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385615/loar-holdings-launches-public-offering-of-4-75m-shares-of-its-common-stock-including-1-58m-shares-of", "tags": ["offering"]}
{"id": 42385617, "time": "2024-12-09 06:32:59", "headline": "HC Wainwright & Co. Reiterates Buy on Disc Medicine, Maintains $118 Price Target", "summary": "", "symbols": ["IRON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385617/hc-wainwright-co-reiterates-buy-on-disc-medicine-maintains-118-price-target", "tags": ["analyst_other"]}
{"id": 42385618, "time": "2024-12-09 06:33:03", "headline": "Needham Maintains Buy on CS Disco, Maintains $8 Price Target", "summary": "", "symbols": ["LAW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385618/needham-maintains-buy-on-cs-disco-maintains-8-price-target", "tags": ["analyst_other"]}
{"id": 42385621, "time": "2024-12-09 06:33:30", "headline": "Jefferies Upgrades McCormick & Co to Buy, Raises Price Target to $91", "summary": "", "symbols": ["MKC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385621/jefferies-upgrades-mccormick-co-to-buy-raises-price-target-to-91", "tags": ["analyst_up", "price_target_up"]}
{"id": 42385623, "time": "2024-12-09 06:33:42", "headline": "Enanta Pharmaceuticals Announced Topline Results From The First-in-pediatrics Phase 2 Study Evaluating Zelicapavir Children Aged 28 Days To 36 Months With Respiratory Syncytial Virus, Showing Antiviral Effect For The Primary And Secondary Virology Endpoints In The Overall Pooled Efficacy Population", "summary": "", "symbols": ["ENTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42385623/enanta-pharmaceuticals-announced-topline-results-from-the-first-in-pediatrics-phase-2-study-evalu", "tags": ["fda"]}
{"id": 42385627, "time": "2024-12-09 06:35:17", "headline": "Jefferies Upgrades Enhabit to Buy, Raises Price Target to $9.5", "summary": "", "symbols": ["EHAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385627/jefferies-upgrades-enhabit-to-buy-raises-price-target-to-9-5", "tags": ["analyst_up", "price_target_up"]}
{"id": 42385628, "time": "2024-12-09 06:35:26", "headline": "Healthcare Realty Trust Tapped Tom Bohjalian As Board Chair", "summary": "", "symbols": ["HR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385628/healthcare-realty-trust-tapped-tom-bohjalian-as-board-chair", "tags": []}
{"id": 42385639, "time": "2024-12-09 06:35:48", "headline": "Needham Reiterates Buy on Robinhood Markets, Raises Price Target to $52", "summary": "", "symbols": ["HOOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385639/needham-reiterates-buy-on-robinhood-markets-raises-price-target-to-52", "tags": ["analyst_other", "price_target_up"]}
{"id": 42385640, "time": "2024-12-09 06:35:57", "headline": "Hyperscale Data Provides Business Update; Reports Current Discussions With Potential Partners", "summary": "", "symbols": ["GPUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385640/hyperscale-data-provides-business-update-reports-current-discussions-with-potential-partners", "tags": []}
{"id": 42385641, "time": "2024-12-09 06:37:09", "headline": "Parsons Bags $53M, Three-year Contract From The Royal Commission For Riyadh City In Saudi Arabia For PMO Services On Its Main And Ring Roads Program", "summary": "", "symbols": ["PSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385641/parsons-bags-53m-three-year-contract-from-the-royal-commission-for-riyadh-city-in-saudi-arabia-for-p", "tags": ["contract"]}
{"id": 42385642, "time": "2024-12-09 06:37:18", "headline": "Healthcare Realty Trust Named Interim CFO  Austen Helfrich As Permanent Finance Chief", "summary": "", "symbols": ["HR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385642/healthcare-realty-trust-named-interim-cfo-austen-helfrich-as-permanent-finance-chief", "tags": ["management"]}
{"id": 42385653, "time": "2024-12-09 06:39:04", "headline": "TXNM Energy To Affirm 2024 Ongoing EPS Guidance Of $2.70 - $2.75 (Est $2.73) During Meetings With Investors", "summary": "", "symbols": ["TXNM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385653/txnm-energy-to-affirm-2024-ongoing-eps-guidance-of-2-70-2-75-est-2-73-during-meetings-with-investors", "tags": ["earnings", "guidance"]}
{"id": 42385654, "time": "2024-12-09 06:39:23", "headline": "Needham Reiterates Buy on BigCommerce Holdings, Maintains $10 Price Target", "summary": "", "symbols": ["BIGC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385654/needham-reiterates-buy-on-bigcommerce-holdings-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 42385657, "time": "2024-12-09 06:39:47", "headline": "Jefferies Initiates Coverage On Six Flags Entertainment with Buy Rating, Announces Price Target of $59", "summary": "", "symbols": ["FUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385657/jefferies-initiates-coverage-on-six-flags-entertainment-with-buy-rating-announces-price-target-of-59", "tags": ["analyst_init"]}
{"id": 42385710, "time": "2024-12-09 06:41:14", "headline": "MEDIROM Subsidiary Receives Orders For Over 25,000 MOTHER Bracelet Units, Including Orders From Japanese Companies Such As NFES Technologies", "summary": "", "symbols": ["MRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385710/medirom-subsidiary-receives-orders-for-over-25-000-mother-bracelet-units-including-orders-from-japan", "tags": []}
{"id": 42385711, "time": "2024-12-09 06:41:16", "headline": "Affimed to Review Clinical Data from Lung Cancer Trial on December 17", "summary": "", "symbols": ["AFMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385711/affimed-to-review-clinical-data-from-lung-cancer-trial-on-december-17", "tags": ["fda"]}
{"id": 42385712, "time": "2024-12-09 06:42:06", "headline": "Jefferies Downgrades Biogen to Hold, Lowers Price Target to $180", "summary": "", "symbols": ["BIIB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385712/jefferies-downgrades-biogen-to-hold-lowers-price-target-to-180", "tags": ["analyst_down", "price_target_down"]}
{"id": 42385713, "time": "2024-12-09 06:42:12", "headline": "Stephens & Co. Reiterates Equal-Weight on Darden Restaurants, Maintains $164 Price Target", "summary": "", "symbols": ["DRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385713/stephens-co-reiterates-equal-weight-on-darden-restaurants-maintains-164-price-target", "tags": ["analyst_other"]}
{"id": 42385723, "time": "2024-12-09 06:44:02", "headline": "B of A Securities Downgrades Advanced Micro Devices to Neutral, Lowers Price Target to $155", "summary": "", "symbols": ["AMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385723/b-of-a-securities-downgrades-advanced-micro-devices-to-neutral-lowers-price-target-to-155", "tags": ["analyst_down", "price_target_down"]}
{"id": 42385732, "time": "2024-12-09 06:44:21", "headline": "Tesla Shares Surge In Pre-Market On Monday, Hovering Near $400: What's Going On?", "summary": "This increase follows Tesla&#39;s announcement of a new, affordable vehicle model\u00a0during an investor meeting with\u00a0Deutsche Bank.", "symbols": ["TSLA"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/markets/equities/24/12/42385732/tesla-shares-surge-in-pre-market-on-monday-hovering-near-400-whats-going-on", "tags": ["why_moving"]}
{"id": 42385735, "time": "2024-12-09 06:44:38", "headline": "Needham Maintains Buy on Coinbase Glb, Raises Price Target to $420", "summary": "", "symbols": ["COIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385735/needham-maintains-buy-on-coinbase-glb-raises-price-target-to-420", "tags": ["analyst_other", "price_target_up"]}
{"id": 42385745, "time": "2024-12-09 06:45:17", "headline": "Jefferies Upgrades Kodiak Sciences to Buy, Announces $20 Price Target", "summary": "", "symbols": ["KOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385745/jefferies-upgrades-kodiak-sciences-to-buy-announces-20-price-target", "tags": ["analyst_up"]}
{"id": 42385747, "time": "2024-12-09 06:45:22", "headline": "Arthur J. Gallagher & Co Launches $8.5B Common Stock Offering To Fund Acquisition Of Dolphin TopCo", "summary": "", "symbols": ["AJG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42385747/arthur-j-gallagher-co-launches-8-5b-common-stock-offering-to-fund-acquisition-of-dolphin-topco", "tags": ["offering"]}
{"id": 42385849, "time": "2024-12-09 06:46:50", "headline": "US Stocks On Edge As Investors Await November Inflation Data: Super Micro, Palantir Among Stocks In Focus", "summary": "US indices slightly down in premarket trading on Mon amid mixed global trade. Key economic indicators &amp; inflation data in focus this week. Tech stocks surged, while energy &amp; healthcare lagged. Strong jobs report boosted market sentiment.", "symbols": ["AI", "ASAN", "CASY", "DOCU", "JFBR", "ORCL", "PLTR", "QQQ", "RGTI", "SMCI", "SPY", "TOL", "ZBAO"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/24/12/42385849/us-stocks-could-open-lower-as-markets-await-november-inflation-data-this-week-global-cues-weigh-in-super-micro-planatir-stocks-in-focus", "tags": []}
{"id": 42385850, "time": "2024-12-09 06:47:24", "headline": "Chiesi Global Rare Diseases, A Business Unit Of The Chiesi And Protalix Biotherapeutics Announced That The European Medicines Agency Has Validated The Variation Submission For Pegunigalsidase Alfa To Label A Less Frequent Dosing Regimen", "summary": "", "symbols": ["PLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42385850/chiesi-global-rare-diseases-a-business-unit-of-the-chiesi-and-protalix-biotherapeutics-announced-", "tags": []}
{"id": 42385859, "time": "2024-12-09 06:48:16", "headline": "Lundin Exits Europe For $1.5 Billion, Turns Focus To South America", "summary": "Lundin Mining sells European mines to Boliden for up to $1.52B, focuses on South America. Neves-Corvo and Zinkgruvan boost Boliden&#39;s zinc production.", "symbols": ["BLIDF", "LUNMF"], "source": "benzinga", "author": "Stjepan Kalinic", "url": "https://www.benzinga.com/24/12/42385859/lundin-exits-europe-for-15-billion-turns-focus-to-south-america", "tags": []}
{"id": 42385860, "time": "2024-12-09 06:48:23", "headline": "B of A Securities Upgrades YPF to Buy, Raises Price Target to $55", "summary": "", "symbols": ["YPF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42385860/b-of-a-securities-upgrades-ypf-to-buy-raises-price-target-to-55", "tags": ["analyst_up", "price_target_up"]}
{"id": 42385870, "time": "2024-12-09 06:49:05", "headline": "Reuters Reported  China's Market Regulator Has Opened An Investigation Into Nvidia Over Suspected Violation Of China's Antimonopoly Law", "summary": "", "symbols": ["FXI", "NVDA", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/fintech/24/12/42385870/reuters-reported-chinas-market-regulator-has-opened-an-investigation-into-nvidia-over-suspected-viol", "tags": ["legal"]}
{"id": 42385871, "time": "2024-12-09 06:49:27", "headline": "Merck's Phase 3 KEYLYNK-001 Trial Of Keytruda (Pembrolizumab) Plus Chemotherapy Followed By Maintenance With Lynparza (Olaparib), With Or Without Bevacizumab, As A First-line Treatment For BRCA Non-mutated Advanced Epithelial Ovarian Cancer Met Its Primary Endpoint Of Progression-free Survival, The Study Did Not Reach Its Secondary Endpoint Of Overall Survival", "summary": "", "symbols": ["MRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42385871/mercks-phase-3-keylynk-001-trial-of-keytruda-pembrolizumab-plus-chemotherapy-followed-by-maintena", "tags": ["fda"]}
{"id": 42385874, "time": "2024-12-09 06:49:47", "headline": "Tesla Reduces Supercharging Prices To Accelerate EV Adoption Amid Slowing Demand", "summary": "EV giant Tesla Inc has been reducing the price for charging at its supercharger network in a bid to accelerate electric vehicle adoption, company executive Max de Zegher said on Saturday.", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/24/12/42385874/tesla-reduces-supercharging-prices-to-accelerate-ev-adoption-amid-slowing-demand", "tags": []}
{"id": 42386019, "time": "2024-12-09 06:51:23", "headline": "B of A Securities Downgrades SoFi Techs to Underperform, Maintains Price Target to $12", "summary": "", "symbols": ["SOFI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386019/b-of-a-securities-downgrades-sofi-techs-to-underperform-maintains-price-target-to-12", "tags": ["analyst_down", "analyst_other"]}
{"id": 42386031, "time": "2024-12-09 06:52:51", "headline": "B of A Securities Downgrades Capital One Finl to Neutral, Lowers Price Target to $200", "summary": "", "symbols": ["COF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386031/b-of-a-securities-downgrades-capital-one-finl-to-neutral-lowers-price-target-to-200", "tags": ["analyst_down", "price_target_down"]}
{"id": 42386042, "time": "2024-12-09 06:54:47", "headline": "U Power Partners with Thai Investor to Expand Battery-Swapping Technology in Southeast Asia", "summary": "", "symbols": ["UCAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386042/u-power-partners-with-thai-investor-to-expand-battery-swapping-technology-in-southeast-asia", "tags": ["contract"]}
{"id": 42386056, "time": "2024-12-09 06:58:01", "headline": "JP Morgan Upgrades Equinor to Overweight", "summary": "", "symbols": ["EQNR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386056/jp-morgan-upgrades-equinor-to-overweight", "tags": ["analyst_up"]}
{"id": 42386059, "time": "2024-12-09 06:58:27", "headline": "Devon Energy To Retire As CEO And Director, Effective March 1, Giving Away The Position To COO Clay Gaspar", "summary": "", "symbols": ["DVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386059/devon-energy-to-retire-as-ceo-and-director-effective-march-1-giving-away-the-position-to-coo-clay-ga", "tags": ["management"]}
{"id": 42386113, "time": "2024-12-09 07:00:06", "headline": "JP Morgan Upgrades Nokia to Overweight, Raises Price Target to $6.35", "summary": "", "symbols": ["NOK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386113/jp-morgan-upgrades-nokia-to-overweight-raises-price-target-to-6-35", "tags": ["analyst_up", "price_target_up"]}
{"id": 42386152, "time": "2024-12-09 07:00:22", "headline": "Critical Insights From Capital One Finl Analyst Ratings: What You Need To Know", "summary": " ", "symbols": ["COF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42386152/critical-insights-from-capital-one-finl-analyst-ratings-what-you-need-to-know", "tags": []}
{"id": 42386154, "time": "2024-12-09 07:00:27", "headline": "Palantir Expands Contract with US Special Operations Command for $36.8M", "summary": "", "symbols": ["PLTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/government/24/12/42386154/palantir-expands-contract-with-us-special-operations-command-for-36-8m", "tags": ["contract"]}
{"id": 42386158, "time": "2024-12-09 07:00:29", "headline": "Deep Dive Into Ryman Hospitality Props Stock: Analyst Perspectives (4 Ratings)", "summary": " ", "symbols": ["RHP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42386158/deep-dive-into-ryman-hospitality-props-stock-analyst-perspectives-4-ratings", "tags": []}
{"id": 42386169, "time": "2024-12-09 07:00:38", "headline": "Peeling Back The Layers: Exploring Reddit Through Analyst Insights", "summary": " ", "symbols": ["RDDT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42386169/peeling-back-the-layers-exploring-reddit-through-analyst-insights", "tags": []}
{"id": 42386189, "time": "2024-12-09 07:00:47", "headline": "Assessing Biogen: Insights From 19 Financial Analysts", "summary": " ", "symbols": ["BIIB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42386189/assessing-biogen-insights-from-19-financial-analysts", "tags": []}
{"id": 42386192, "time": "2024-12-09 07:00:57", "headline": "Critical Insights From Pharming Analyst Ratings: What You Need To Know", "summary": " ", "symbols": ["PHAR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42386192/critical-insights-from-pharming-analyst-ratings-what-you-need-to-know", "tags": []}
{"id": 42386219, "time": "2024-12-09 07:01:10", "headline": "16 Analysts Assess Coinbase Glb: What You Need To Know", "summary": " ", "symbols": ["COIN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42386219/16-analysts-assess-coinbase-glb-what-you-need-to-know", "tags": []}
{"id": 42386223, "time": "2024-12-09 07:01:17", "headline": "B of A Securities Upgrades PayPal Holdings to Buy, Raises Price Target to $103", "summary": "", "symbols": ["PYPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386223/b-of-a-securities-upgrades-paypal-holdings-to-buy-raises-price-target-to-103", "tags": ["analyst_up", "price_target_up"]}
{"id": 42386224, "time": "2024-12-09 07:01:20", "headline": "Olema Says FDA Cleared IND Application For OP-3136, A Novel Small Molecule That Potently And Selectively Inhibits KAT6, A Validated Epigenetic Target That Is Dysregulated In Breast And Other Cancers", "summary": "", "symbols": ["OLMA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386224/olema-says-fda-cleared-ind-application-for-op-3136-a-novel-small-molecule-that-potently-and-selectiv", "tags": ["fda"]}
{"id": 42386231, "time": "2024-12-09 07:01:43", "headline": "InspireMD Enrolls First Patient in Clinical Trial for CGuard Carotid Stent System", "summary": "", "symbols": ["NSPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386231/inspiremd-enrolls-first-patient-in-clinical-trial-for-cguard-carotid-stent-system", "tags": ["fda"]}
{"id": 42386259, "time": "2024-12-09 07:02:27", "headline": "Lattice Semiconductor Plans To Repurchase Up To An Additional $100M Of Its Outstanding Common Stock Through End Of December 2025", "summary": "", "symbols": ["LSCC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386259/lattice-semiconductor-plans-to-repurchase-up-to-an-additional-100m-of-its-outstanding-common-stock-t", "tags": ["buyback"]}
{"id": 42386275, "time": "2024-12-09 07:02:48", "headline": "Cemtrex Wins $6.7M in Contracts for Wastewater Treatment Facility Upgrades", "summary": "", "symbols": ["CETX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386275/cemtrex-wins-6-7m-in-contracts-for-wastewater-treatment-facility-upgrades", "tags": ["analyst_up"]}
{"id": 42386296, "time": "2024-12-09 07:03:32", "headline": "Datadog Plans Proposed Private Offering Of $775M Of Convertible Senior Notes", "summary": "", "symbols": ["DDOG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386296/datadog-plans-proposed-private-offering-of-775m-of-convertible-senior-notes", "tags": ["offering"]}
{"id": 42386309, "time": "2024-12-09 07:03:57", "headline": "Seres Therapeutics' SER-155 Receives FDA Breakthrough Therapy Designation for Bloodstream Infection Reduction", "summary": "", "symbols": ["MCRB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/government/24/12/42386309/seres-therapeutics-ser-155-receives-fda-breakthrough-therapy-designation-for-bloodstream-infection-r", "tags": ["fda"]}
{"id": 42386314, "time": "2024-12-09 07:04:23", "headline": "Riot Platforms Intends To Offer $500M Of Its  Convertible Senior Notes Due 2030 In Private Offering", "summary": "", "symbols": ["RIOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386314/riot-platforms-intends-to-offer-500m-of-its-convertible-senior-notes-due-2030-in-private-offering", "tags": ["offering"]}
{"id": 42386338, "time": "2024-12-09 07:05:03", "headline": "Corbus Pharmaceuticals Has Dosed The First Patient In The Phase 1 Portion Of The Clinical Study Of CRB-601 For Advanced Solid Tumors", "summary": "", "symbols": ["CRBP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42386338/corbus-pharmaceuticals-has-dosed-the-first-patient-in-the-phase-1-portion-of-the-clinical-study-o", "tags": ["fda"]}
{"id": 42386340, "time": "2024-12-09 07:05:06", "headline": "Fractyl Health to Present New Preclinical Data on Gene Therapy for Obesity and Diabetes at 2024 World Congress", "summary": "", "symbols": ["GUTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386340/fractyl-health-to-present-new-preclinical-data-on-gene-therapy-for-obesity-and-diabetes-at-2024-worl", "tags": []}
{"id": 42386351, "time": "2024-12-09 07:05:42", "headline": "VersaBank Q4 2024 GAAP EPS C$0.20 Misses C$0.39 Estimate, Sales C$27.285M Beat C$26.543M Estimate", "summary": "", "symbols": ["VBNK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42386351/versabank-q4-2024-gaap-eps-c-0-20-misses-c-0-39-estimate-sales-c-27-285m-beat-c-26-543m-estimate", "tags": ["earnings"]}
{"id": 42386353, "time": "2024-12-09 07:06:25", "headline": "Cogent Biosciences Presents Data on Bezuclastinib for Mastocytosis at ASH 2024", "summary": "", "symbols": ["COGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386353/cogent-biosciences-presents-data-on-bezuclastinib-for-mastocytosis-at-ash-2024", "tags": []}
{"id": 42386355, "time": "2024-12-09 07:06:52", "headline": "JP Morgan Downgrades STMicroelectronics to Neutral", "summary": "", "symbols": ["STM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386355/jp-morgan-downgrades-stmicroelectronics-to-neutral", "tags": ["analyst_down"]}
{"id": 42386360, "time": "2024-12-09 07:07:04", "headline": "Universe Pharmaceuticals Enters Definitive Agreement With Several Investors For Purchase And Sale Of An Aggregate Of 18.75M Of Ordinary Shares; Expects Aggregate Gross Proceeds To Be $15M", "summary": "", "symbols": ["UPC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386360/universe-pharmaceuticals-enters-definitive-agreement-with-several-investors-for-purchase-and-sale-of", "tags": ["contract"]}
{"id": 42386366, "time": "2024-12-09 07:07:26", "headline": "Kura Oncology Provided Clinical Data From KOMET-007 Phase 1 Dose-escalation Trial Of Ziftomenib In Combination With Standards Of Care For NPM1-mutant And KMT2A-rearranged Acute Myeloid Leukemia", "summary": "", "symbols": ["KURA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42386366/kura-oncology-provided-clinical-data-from-komet-007-phase-1-dose-escalation-trial-of-ziftomenib-i", "tags": ["fda"]}
{"id": 42386368, "time": "2024-12-09 07:07:45", "headline": "Zuanic & Associates Maintains Overweight on Chicago Atlantic Realto Overweight", "summary": "", "symbols": ["REFI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386368/zuanic-associates-maintains-overweight-on-chicago-atlantic-realto-overweight", "tags": ["analyst_other"]}
{"id": 42386387, "time": "2024-12-09 07:08:32", "headline": "Perpetua Resources Partners with Sunshine Silver to Explore Antimony Processing in Idaho", "summary": "", "symbols": ["PPTA", "TSX:PPTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386387/perpetua-resources-partners-with-sunshine-silver-to-explore-antimony-processing-in-idaho", "tags": ["contract"]}
{"id": 42386393, "time": "2024-12-09 07:08:59", "headline": "Zuanic & Associates Maintains Overweight on NewLake Capital Partnersto Overweight", "summary": "", "symbols": ["NLCP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386393/zuanic-associates-maintains-overweight-on-newlake-capital-partnersto-overweight", "tags": ["analyst_other"]}
{"id": 42386395, "time": "2024-12-09 07:09:11", "headline": "Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target", "summary": "", "symbols": ["AUTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386395/needham-reiterates-buy-on-autolus-therapeutics-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 42386405, "time": "2024-12-09 07:09:32", "headline": "Barington Capital Says Macy's Shares Are Undervalued; Calls For Changes To Its Capital Allocation Plan To Improve Shareholder Value", "summary": "", "symbols": ["M"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386405/barington-capital-says-macys-shares-are-undervalued-calls-for-changes-to-its-capital-allocation-plan", "tags": []}
{"id": 42386408, "time": "2024-12-09 07:10:04", "headline": "JP Morgan Initiates Coverage On Bentley Systems with Neutral Rating, Announces Price Target of $52", "summary": "", "symbols": ["BSY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386408/jp-morgan-initiates-coverage-on-bentley-systems-with-neutral-rating-announces-price-target-of-52", "tags": ["analyst_init"]}
{"id": 42386411, "time": "2024-12-09 07:10:54", "headline": "CytoSorbents to Raise Funds Through Rights Offering, Unlocking Up to $10M in Liquidity", "summary": "", "symbols": ["CTSO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386411/cytosorbents-to-raise-funds-through-rights-offering-unlocking-up-to-10m-in-liquidity", "tags": ["offering"]}
{"id": 42386515, "time": "2024-12-09 07:12:31", "headline": "JP Morgan Upgrades Synchrony Finl to Overweight, Raises Price Target to $72", "summary": "", "symbols": ["SYF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386515/jp-morgan-upgrades-synchrony-finl-to-overweight-raises-price-target-to-72", "tags": ["analyst_up", "price_target_up"]}
{"id": 42386517, "time": "2024-12-09 07:12:38", "headline": "Barington Capital Says Macy's Needs To Form Separate Real Estate Subsidiary To Optimize Value Potential Of Its Real Estate Portfolio", "summary": "", "symbols": ["M"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386517/barington-capital-says-macys-needs-to-form-separate-real-estate-subsidiary-to-optimize-value-potenti", "tags": []}
{"id": 42386521, "time": "2024-12-09 07:13:46", "headline": "Barington Capital Says Macy's Needs To Significantly Reduce Capital Expenditures & Needs To Aggressively Repurchase Shares", "summary": "", "symbols": ["M"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386521/barington-capital-says-macys-needs-to-significantly-reduce-capital-expenditures-needs-to-aggressivel", "tags": ["buyback"]}
{"id": 42386524, "time": "2024-12-09 07:14:31", "headline": "JP Morgan Downgrades Redwood Trust to Neutral, Lowers Price Target to $7", "summary": "", "symbols": ["RWT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386524/jp-morgan-downgrades-redwood-trust-to-neutral-lowers-price-target-to-7", "tags": ["analyst_down", "price_target_down"]}
{"id": 42386532, "time": "2024-12-09 07:16:11", "headline": "Air Industries Secures $11M Follow-On Contract for US Navy E-2D Aircraft Landing Gear", "summary": "", "symbols": ["AIRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/government/24/12/42386532/air-industries-secures-11m-follow-on-contract-for-us-navy-e-2d-aircraft-landing-gear", "tags": ["contract"]}
{"id": 42386634, "time": "2024-12-09 07:17:01", "headline": "Baird Maintains Outperform on Amer Sports, Raises Price Target to $30", "summary": "", "symbols": ["AS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386634/baird-maintains-outperform-on-amer-sports-raises-price-target-to-30", "tags": ["analyst_other", "price_target_up"]}
{"id": 42386636, "time": "2024-12-09 07:17:54", "headline": "JP Morgan Upgrades Cummins to Neutral, Raises Price Target to $420", "summary": "", "symbols": ["CMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386636/jp-morgan-upgrades-cummins-to-neutral-raises-price-target-to-420", "tags": ["analyst_up", "price_target_up"]}
{"id": 42386651, "time": "2024-12-09 07:18:45", "headline": "NASDAQ Alerts SemiLEDS Corp for Failing to Meet Minimum Equity Requirements, 45-Day Compliance Period Given", "summary": "", "symbols": ["LEDS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/government/24/12/42386651/nasdaq-alerts-semileds-corp-for-failing-to-meet-minimum-equity-requirements-45-day-compliance-period", "tags": []}
{"id": 42386653, "time": "2024-12-09 07:19:30", "headline": "Bernstein Upgrades JD.com to Outperform, Raises Price Target to $46", "summary": "", "symbols": ["JD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386653/bernstein-upgrades-jd-com-to-outperform-raises-price-target-to-46", "tags": ["analyst_up", "price_target_up"]}
{"id": 42386815, "time": "2024-12-09 07:21:43", "headline": "JP Morgan Upgrades Victoria's Secret to Neutral, Raises Price Target to $45", "summary": "", "symbols": ["VSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386815/jp-morgan-upgrades-victorias-secret-to-neutral-raises-price-target-to-45", "tags": ["analyst_up", "price_target_up"]}
{"id": 42386818, "time": "2024-12-09 07:22:22", "headline": "Bernstein Downgrades Kanzhun to Market Perform, Lowers Price Target to $15", "summary": "", "symbols": ["BZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386818/bernstein-downgrades-kanzhun-to-market-perform-lowers-price-target-to-15", "tags": ["analyst_down", "price_target_down"]}
{"id": 42386822, "time": "2024-12-09 07:23:41", "headline": "B of A Securities Upgrades TaskUs to Buy, Maintains Price Target to $18", "summary": "", "symbols": ["TASK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386822/b-of-a-securities-upgrades-taskus-to-buy-maintains-price-target-to-18", "tags": ["analyst_up", "analyst_other"]}
{"id": 42386825, "time": "2024-12-09 07:24:29", "headline": "Barclays Downgrades Cboe Global Markets to Equal-Weight, Lowers Price Target to $220", "summary": "", "symbols": ["CBOE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386825/barclays-downgrades-cboe-global-markets-to-equal-weight-lowers-price-target-to-220", "tags": ["analyst_down", "price_target_down"]}
{"id": 42386834, "time": "2024-12-09 07:25:03", "headline": "Trading Halt: Halted at 7:25:00 a.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["RLMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/12/42386834/trading-halt-halted-at-7-25-00-a-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 42386835, "time": "2024-12-09 07:25:03", "headline": "Trading Halt: Halted at 7:25:00 a.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["EBTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/12/42386835/trading-halt-halted-at-7-25-00-a-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 42386836, "time": "2024-12-09 07:25:27", "headline": "White Oak Global Advisors, LLC On Friday, Reported A Stake Of 58.2% In Zeo Energy In A 13D Filing", "summary": "", "symbols": ["ZEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386836/white-oak-global-advisors-llc-on-friday-reported-a-stake-of-58-2-in-zeo-energy-in-a-13d-filing", "tags": []}
{"id": 42386857, "time": "2024-12-09 07:25:54", "headline": "Deutsche Bank Initiates Coverage On First Citizens BancShares with Buy Rating, Announces Price Target of $2600", "summary": "", "symbols": ["FCNCA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386857/deutsche-bank-initiates-coverage-on-first-citizens-bancshares-with-buy-rating-announces-price-target", "tags": ["analyst_init"]}
{"id": 42386899, "time": "2024-12-09 07:26:52", "headline": "Cantor Fitzgerald Initiates Coverage On Hut 8 with Overweight Rating, Announces Price Target of $35", "summary": "", "symbols": ["HUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386899/cantor-fitzgerald-initiates-coverage-on-hut-8-with-overweight-rating-announces-price-target-of-35", "tags": ["analyst_init"]}
{"id": 42386900, "time": "2024-12-09 07:27:12", "headline": "Stereotaxis and MicroPort EP Secure NMPA Approval for Magbot Ablation Catheter in China", "summary": "", "symbols": ["STXS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/government/24/12/42386900/stereotaxis-and-microport-ep-secure-nmpa-approval-for-magbot-ablation-catheter-in-china", "tags": []}
{"id": 42386901, "time": "2024-12-09 07:27:28", "headline": "Barclays Upgrades Robinhood Markets to Overweight, Raises Price Target to $49", "summary": "", "symbols": ["HOOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386901/barclays-upgrades-robinhood-markets-to-overweight-raises-price-target-to-49", "tags": ["analyst_up", "price_target_up"]}
{"id": 42386902, "time": "2024-12-09 07:27:44", "headline": "Deutsche Bank Initiates Coverage On Synovus Finl with Buy Rating, Announces Price Target of $64", "summary": "", "symbols": ["SNV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386902/deutsche-bank-initiates-coverage-on-synovus-finl-with-buy-rating-announces-price-target-of-64", "tags": ["analyst_init"]}
{"id": 42386980, "time": "2024-12-09 07:31:19", "headline": "AST SpaceMobile and Vodafone Partner for Global Broadband Connectivity Through 2034", "summary": "", "symbols": ["ASTS", "VOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386980/ast-spacemobile-and-vodafone-partner-for-global-broadband-connectivity-through-2034", "tags": []}
{"id": 42386990, "time": "2024-12-09 07:31:42", "headline": "LeddarTech, Texas Instruments Enter Strategic Collaboration Agreement And Software License Agreement", "summary": "", "symbols": ["LDTC", "TXN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386990/leddartech-texas-instruments-enter-strategic-collaboration-agreement-and-software-license-agreement", "tags": ["contract"]}
{"id": 42386998, "time": "2024-12-09 07:32:28", "headline": "Relmada Therapeutics Announced That In Light Of The Recent Data Monitoring Committee Evaluation Of The Full Dataset From The Reliance II Phase 3 Study Of Rel-1017 Program, The Company Will Discontinue The Reliance II And Relight Phase 3 Studies", "summary": "", "symbols": ["RLMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42386998/relmada-therapeutics-announced-that-in-light-of-the-recent-data-monitoring-committee-evaluation-o", "tags": ["fda"]}
{"id": 42386999, "time": "2024-12-09 07:32:31", "headline": "Barclays Upgrades Charles Schwab to Overweight, Raises Price Target to $95", "summary": "", "symbols": ["SCHW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42386999/barclays-upgrades-charles-schwab-to-overweight-raises-price-target-to-95", "tags": ["analyst_up", "price_target_up"]}
{"id": 42387006, "time": "2024-12-09 07:32:56", "headline": "IDEXX Laboratories Board Authorizes Increase In Its Ongoing Share Repurchase Program, Authorizing Repurchase Of Up To 5M Additional Shares", "summary": "", "symbols": ["IDXX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387006/idexx-laboratories-board-authorizes-increase-in-its-ongoing-share-repurchase-program-authorizing-rep", "tags": ["buyback"]}
{"id": 42387011, "time": "2024-12-09 07:33:24", "headline": "Leerink Partners Downgrades Myriad Genetics to Market Perform, Lowers Price Target to $21", "summary": "", "symbols": ["MYGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387011/leerink-partners-downgrades-myriad-genetics-to-market-perform-lowers-price-target-to-21", "tags": ["analyst_down", "price_target_down"]}
{"id": 42387009, "time": "2024-12-09 07:33:26", "headline": "Tesla Model Q Priced Below $30,000 After Subsidies To Reportedly Launch In First Half Of 2025", "summary": "Tesla will reportedly launch a new vehicle called Model Q in the first half of next year, priced below $30,000 after subsidies.", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/media/24/12/42387009/tesla-model-q-priced-below-30000-after-subsidies-to-reportedly-launch-in-first-half-of-2025", "tags": []}
{"id": 42387016, "time": "2024-12-09 07:33:39", "headline": "Vor Bio Presents Data on AML Therapy at ASH 2024 Annual Meeting", "summary": "", "symbols": ["VOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/government/24/12/42387016/vor-bio-presents-data-on-aml-therapy-at-ash-2024-annual-meeting", "tags": []}
{"id": 42387039, "time": "2024-12-09 07:34:05", "headline": "Independent Bank Corp. And Enterprise Bancorp Sign Definitive Merger Agreement Valued At ~$562M Or $45.06/Share; Agreement Provides That Enterprise Shareholders Will Receive 0.60 Shares Of Independent Stock And $2 In Cash For Each Share Of Enterprise Common Stock Held", "summary": "", "symbols": ["EBTC", "INDB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42387039/independent-bank-corp-and-enterprise-bancorp-sign-definitive-merger-agreement-valued-at-562m-or-45-0", "tags": ["merger", "contract"]}
{"id": 42387052, "time": "2024-12-09 07:34:35", "headline": "TD Cowen Upgrades Blackstone to Buy, Raises Price Target to $230", "summary": "", "symbols": ["BX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387052/td-cowen-upgrades-blackstone-to-buy-raises-price-target-to-230", "tags": ["analyst_up", "price_target_up"]}
{"id": 42387054, "time": "2024-12-09 07:35:12", "headline": "Syndax Announces Additional Data From AUGMENT-101 Trial Of Revuforj", "summary": "", "symbols": ["SNDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42387054/syndax-announces-additional-data-from-augment-101-trial-of-revuforj", "tags": ["fda"]}
{"id": 42387056, "time": "2024-12-09 07:35:17", "headline": "Anavex Shares Alzheimer's Treatment Data at 2025 JP Morgan Healthcare Conference", "summary": "", "symbols": ["AVXL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387056/anavex-shares-alzheimers-treatment-data-at-2025-jp-morgan-healthcare-conference", "tags": []}
{"id": 42387060, "time": "2024-12-09 07:35:55", "headline": "Market-Moving News for December 9th", "summary": "", "symbols": ["MRM", "NVDA", "ZEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42387060/market-moving-news-for-december-9th", "tags": []}
{"id": 42387062, "time": "2024-12-09 07:36:08", "headline": "Sunshine Biopharma Announces Development Of An Orally Active Protease Inhibitor With Dose-Dependent Antiviral Activity In Mice With SARS-CoV-2)", "summary": "", "symbols": ["SBFM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42387062/sunshine-biopharma-announces-development-of-an-orally-active-protease-inhibitor-with-dose-depende", "tags": []}
{"id": 42387065, "time": "2024-12-09 07:36:59", "headline": "Dogecoin Grinds Higher But 'Lower Prices Are To Be Expected,' Warns Technical Analyst", "summary": "Dogecoin&#39;s (CRYPTO: DOGE) strong gains in November point to overall bullish sentiment, but traders expect a pullback in the near term.", "symbols": ["BONKUSD", "DOGEUSD", "FLOKIUSD", "PEPEUSD", "SHIBUSD", "WIFUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42387065/dogecoin-grinds-higher-but-lower-prices-are-to-be-expected-warns-technical-analyst", "tags": []}
{"id": 42387066, "time": "2024-12-09 07:37:03", "headline": "Morgan Stanley Upgrades Jefferies Financial Gr to Overweight, Raises Price Target to $97", "summary": "", "symbols": ["JEF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387066/morgan-stanley-upgrades-jefferies-financial-gr-to-overweight-raises-price-target-to-97", "tags": ["analyst_up", "price_target_up"]}
{"id": 42387090, "time": "2024-12-09 07:37:28", "headline": "Guggenheim Initiates Coverage On Tempus AI with Buy Rating, Announces Price Target of $74", "summary": "", "symbols": ["TEM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387090/guggenheim-initiates-coverage-on-tempus-ai-with-buy-rating-announces-price-target-of-74", "tags": ["analyst_init"]}
{"id": 42387092, "time": "2024-12-09 07:37:32", "headline": "Citigroup Upgrades Timken to Buy, Raises Price Target to $90", "summary": "", "symbols": ["TKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387092/citigroup-upgrades-timken-to-buy-raises-price-target-to-90", "tags": ["analyst_up", "price_target_up"]}
{"id": 42387095, "time": "2024-12-09 07:37:46", "headline": "Theratechnologies Announces Preliminary Tolerability And Efficacy Data From Phase 1b, Dose-Ranging Trial Of Sudocetaxel Zendusortide In Advanced Ovarian Cancer; Says No No Dose-Limiting Toxicities Reported In Two Different Weekly Doses In Heavily Pre-Treated Patients", "summary": "", "symbols": ["THTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42387095/theratechnologies-announces-preliminary-tolerability-and-efficacy-data-from-phase-1b-dose-ranging", "tags": ["fda"]}
{"id": 42387102, "time": "2024-12-09 07:39:26", "headline": "Bitcoin Miner MARA Holdings Raises $850M In 0% Convertible Notes, Offering A 40% Premium Over Current Share Price", "summary": "Bitcoin miner MARA Holdings Inc (NASDAQ:MARA) recently completed its $850 million offering of 0% convertible senior notes due 2031.", "symbols": ["BTCUSD", "MARA", "MSTR"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/24/12/42387102/mara-holdings-raises-850-million-in-0-convertible-notes-offering-a-40-premium-over-current-share-price", "tags": ["offering"]}
{"id": 42387104, "time": "2024-12-09 07:39:32", "headline": "Morgan Stanley Upgrades Moelis to Overweight, Raises Price Target to $92", "summary": "", "symbols": ["MC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387104/morgan-stanley-upgrades-moelis-to-overweight-raises-price-target-to-92", "tags": ["analyst_up", "price_target_up"]}
{"id": 42387108, "time": "2024-12-09 07:39:37", "headline": "Citigroup Downgrades Bioage Labs to Neutral, Lowers Price Target to $7", "summary": "", "symbols": ["BIOA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387108/citigroup-downgrades-bioage-labs-to-neutral-lowers-price-target-to-7", "tags": ["analyst_down", "price_target_down"]}
{"id": 42387175, "time": "2024-12-09 07:41:22", "headline": "Just Two Months After IPO, BioAge Labs Stops Eli Lilly-Collaborated Obesity Trial On Safety Concerns", "summary": "BioAge Labs halts STRIDES Phase 2 trial of azelaprag after liver enzyme elevations, plans further analysis with updates expected in Q1 2025.", "symbols": ["BIOA", "LLY"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/12/42387175/just-two-months-after-ipo-bioage-labs-stops-eli-lilly-collaborated-obesity-trial-on-safety-concerns", "tags": ["fda"]}
{"id": 42387210, "time": "2024-12-09 07:42:37", "headline": "Morgan Stanley Downgrades Lazard to Equal-Weight, Raises Price Target to $63", "summary": "", "symbols": ["LAZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387210/morgan-stanley-downgrades-lazard-to-equal-weight-raises-price-target-to-63", "tags": ["analyst_down", "price_target_up"]}
{"id": 42387224, "time": "2024-12-09 07:45:28", "headline": "Northland Capital Markets Maintains Outperform on Gorilla Tech Gr, Raises Price Target to $13", "summary": "", "symbols": ["GRRR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387224/northland-capital-markets-maintains-outperform-on-gorilla-tech-gr-raises-price-target-to-13", "tags": ["analyst_other", "price_target_up"]}
{"id": 42387227, "time": "2024-12-09 07:46:30", "headline": "Trump's Tariff Threat Causes Tesla's South Korean Rivals To Rethink $54B Battery Plant Investment", "summary": "Korean firms are in talks with U.S. authorities to maintain tax credits, crucial for their operations amid declining EV demand and battery prices.", "symbols": ["GM", "HMC", "SONY"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/tech/24/12/42387227/trumps-tariff-threat-causes-teslas-south-korean-rivals-to-rethink-54b-battery-plant-investment", "tags": []}
{"id": 42387334, "time": "2024-12-09 07:47:28", "headline": "Morgan Stanley Downgrades Houlihan Lokey to Underweight, Raises Price Target to $200", "summary": "", "symbols": ["HLI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387334/morgan-stanley-downgrades-houlihan-lokey-to-underweight-raises-price-target-to-200", "tags": ["analyst_down", "price_target_up"]}
{"id": 42387336, "time": "2024-12-09 07:47:46", "headline": "UBS Initiates Coverage On Elanco Animal Health with Buy Rating, Announces Price Target of $18", "summary": "", "symbols": ["ELAN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387336/ubs-initiates-coverage-on-elanco-animal-health-with-buy-rating-announces-price-target-of-18", "tags": ["analyst_init"]}
{"id": 42387366, "time": "2024-12-09 07:50:04", "headline": "Bitcoin Seller's Delight: Bhutan Transfers $40M In BTC To QCP Capital", "summary": "The Royal Government of Bhutan has transferred 406.074 BTC, valued at approximately $40 million, to QCP Capital, according to data from Onchain Lens.", "symbols": ["BTCUSD", "ETHUSD", "SANDUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42387366/bitcoin-sellers-delight-bhutan-transfers-40m-in-btc-to-qcp-capital", "tags": []}
{"id": 42387369, "time": "2024-12-09 07:50:13", "headline": "Arcellx's Cancer Cell Therapy Shows Deep, Durable Responses With Manageable Safety Profile In Heavily Pretreated Blood Cancer Patients", "summary": "Arcellx&#39;s Phase 2 trial of anito-cel in relapsed multiple myeloma reveals high response rates and manageable safety, with durable patient outcomes.", "symbols": ["ACLX", "GILD"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/24/12/42387369/arcellxs-cancer-cell-therapy-shows-deep-durable-responses-with-manageable-safety-profile-in-heavily-pretreated-blood-cancer-patients", "tags": ["fda"]}
{"id": 42387553, "time": "2024-12-09 07:51:39", "headline": "Morgan Stanley Upgrades Bank of New York Mellon to Overweight, Raises Price Target to $94", "summary": "", "symbols": ["BK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387553/morgan-stanley-upgrades-bank-of-new-york-mellon-to-overweight-raises-price-target-to-94", "tags": ["analyst_up", "price_target_up"]}
{"id": 42387554, "time": "2024-12-09 07:51:47", "headline": "Wells Fargo Upgrades C.H. Robinson Worldwide to Overweight, Raises Price Target to $130", "summary": "", "symbols": ["CHRW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387554/wells-fargo-upgrades-c-h-robinson-worldwide-to-overweight-raises-price-target-to-130", "tags": ["analyst_up", "price_target_up"]}
{"id": 42387555, "time": "2024-12-09 07:51:53", "headline": "Omnicom And Interpublic Group of Companies Boards Approve Agreement Pursuant To Which Omnicom Will Acquire Interpublic; Under Terms, Interpublic Shareholders will Receive 0.344 Omnicom Shares For Each Share Of Interpublic They Own", "summary": "", "symbols": ["IPG", "OMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42387555/omnicom-and-interpublic-group-of-companies-boards-approve-agreement-pursuant-to-which-omnicom-will-a", "tags": ["merger", "contract"]}
{"id": 42387568, "time": "2024-12-09 07:53:08", "headline": "Morgan Stanley Upgrades State Street to Overweight, Raises Price Target to $139", "summary": "", "symbols": ["STT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387568/morgan-stanley-upgrades-state-street-to-overweight-raises-price-target-to-139", "tags": ["analyst_up", "price_target_up"]}
{"id": 42387581, "time": "2024-12-09 07:54:21", "headline": "Bitcoin, Ethereum, Dogecoin Reverse After Advances; Trump's Deregulation Efforts Are Expected To Benefit Energy Sectors; Tesla Cuts Supercharging Prices To Drive EV Adoption - Top Headlines Today While US Slept", "summary": " ", "symbols": ["BTCUSD", "ETHUSD", "SPY"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/24/12/42387581/litecoin-and-dogecoin-saw-hash-rate-gains-after-a-mining-firm-reported-triple-bitcoins-profits-trumps-deregulation-efforts-are-expected-to-benefit-energy-sectors-tesla-cuts-supercharging-prices-to-drive-ev-adoption-top-headlines-today-while-us-slept", "tags": []}
{"id": 42387586, "time": "2024-12-09 07:54:42", "headline": "Wells Fargo Upgrades RealReal to Overweight, Raises Price Target to $15", "summary": "", "symbols": ["REAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387586/wells-fargo-upgrades-realreal-to-overweight-raises-price-target-to-15", "tags": ["analyst_up", "price_target_up"]}
{"id": 42387588, "time": "2024-12-09 07:55:04", "headline": "Trading Halt: Halt status updated at 7:55:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["EBTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/12/42387588/trading-halt-halt-status-updated-at-7-55-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 42387591, "time": "2024-12-09 07:55:06", "headline": "Trading Halt: Halted at 7:55:00 a.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["PTVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/12/42387591/trading-halt-halted-at-7-55-00-a-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 42387622, "time": "2024-12-09 07:57:19", "headline": "Morgan Stanley Upgrades Northern Trust to Equal-Weight, Raises Price Target to $127", "summary": "", "symbols": ["NTRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387622/morgan-stanley-upgrades-northern-trust-to-equal-weight-raises-price-target-to-127", "tags": ["analyst_up", "price_target_up"]}
{"id": 42387631, "time": "2024-12-09 07:58:04", "headline": "Wells Fargo Downgrades Victoria's Secret to Equal-Weight, Raises Price Target to $45", "summary": "", "symbols": ["VSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387631/wells-fargo-downgrades-victorias-secret-to-equal-weight-raises-price-target-to-45", "tags": ["analyst_down", "price_target_up"]}
{"id": 42387719, "time": "2024-12-09 08:00:11", "headline": "Morgan Stanley Downgrades Bank of America to Equal-Weight, Raises Price Target to $55", "summary": "", "symbols": ["BAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387719/morgan-stanley-downgrades-bank-of-america-to-equal-weight-raises-price-target-to-55", "tags": ["analyst_down", "price_target_up"]}
{"id": 42387785, "time": "2024-12-09 08:00:26", "headline": "Analyst Ratings For Houlihan Lokey", "summary": " ", "symbols": ["HLI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42387785/analyst-ratings-for-houlihan-lokey", "tags": []}
{"id": 42387856, "time": "2024-12-09 08:00:44", "headline": "A Closer Look at 16 Analyst Recommendations For Charles Schwab", "summary": " ", "symbols": ["SCHW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42387856/a-closer-look-at-16-analyst-recommendations-for-charles-schwab", "tags": []}
{"id": 42387890, "time": "2024-12-09 08:00:59", "headline": "Wells Fargo Downgrades HF Sinclair to Equal-Weight, Lowers Price Target to $45", "summary": "", "symbols": ["DINO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387890/wells-fargo-downgrades-hf-sinclair-to-equal-weight-lowers-price-target-to-45", "tags": ["analyst_down", "price_target_down"]}
{"id": 42387911, "time": "2024-12-09 08:01:08", "headline": "In-Depth Examination Of 4 Analyst Recommendations For BigCommerce Holdings", "summary": " ", "symbols": ["BIGC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42387911/in-depth-examination-of-4-analyst-recommendations-for-bigcommerce-holdings", "tags": []}
{"id": 42387920, "time": "2024-12-09 08:01:22", "headline": "Cracking The Code: Understanding Analyst Reviews For Amer Sports", "summary": " ", "symbols": ["AS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42387920/cracking-the-code-understanding-analyst-reviews-for-amer-sports", "tags": []}
{"id": 42387951, "time": "2024-12-09 08:01:43", "headline": "A Glimpse Into The Expert Outlook On SoFi Techs Through 7 Analysts", "summary": " ", "symbols": ["SOFI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42387951/a-glimpse-into-the-expert-outlook-on-sofi-techs-through-7-analysts", "tags": ["guidance"]}
{"id": 42387952, "time": "2024-12-09 08:01:47", "headline": "MeiraGTx Announces FDA FDA Regenerative Medicine Advanced Therapy Designation For AAV2-hAQP1 In Treatment Of Grade 2/3 Radiation-Induced Xerostomia", "summary": "", "symbols": ["MGTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387952/meiragtx-announces-fda-fda-regenerative-medicine-advanced-therapy-designation-for-aav2-haqp1-in-trea", "tags": ["fda"]}
{"id": 42387958, "time": "2024-12-09 08:01:54", "headline": "The Latest Analyst Ratings For SLM", "summary": " ", "symbols": ["SLM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42387958/the-latest-analyst-ratings-for-slm", "tags": []}
{"id": 42387961, "time": "2024-12-09 08:02:01", "headline": "AbbVie Announces Topline Results For The Phase 3 TEMPO-2 Trial Evaluating Tavapadon As A Monotherapy For Parkinson's Disease; Tavapadon Met The Primary Endpoint And Also Met Its Key Secondary Endpoint", "summary": "", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42387961/abbvie-announces-topline-results-for-the-phase-3-tempo-2-trial-evaluating-tavapadon-as-a-monother", "tags": ["fda"]}
{"id": 42387962, "time": "2024-12-09 08:02:06", "headline": "Palantir Jumps After Securing USSOCOM Contract Boost - What's Going On?", "summary": "Palantir expands contract with USSOCOM for advanced AI and software integration, marking first deployment of Mission Manager to SOF Units.", "symbols": ["AIPI", "DAT", "PLTR"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/12/42387962/palantir-scores-368-million-deal-with-ussocom-to-lead-ai-powered-mission-command", "tags": ["why_moving", "contract"]}
{"id": 42387978, "time": "2024-12-09 08:02:54", "headline": "Morgan Stanley Downgrades Regions Finl to Equal-Weight, Raises Price Target to $32", "summary": "", "symbols": ["RF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387978/morgan-stanley-downgrades-regions-finl-to-equal-weight-raises-price-target-to-32", "tags": ["analyst_down", "price_target_up"]}
{"id": 42387987, "time": "2024-12-09 08:02:56", "headline": "Crinetics Announces FDA Acceptance Of Its New Drug Application For Paltusotine In Adult Patients With Acromegaly", "summary": "", "symbols": ["CRNX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42387987/crinetics-announces-fda-acceptance-of-its-new-drug-application-for-paltusotine-in-adult-patients-wit", "tags": ["fda"]}
{"id": 42388001, "time": "2024-12-09 08:03:17", "headline": "First Hawaiian Completes Investment Portfolio Restructuring; Company Executed The Sale Of $293M Of Its Lower-Yielding Available-For-Sale Debt Securities For An Estimated After-Tax Loss Of $19.7M", "summary": "", "symbols": ["FHB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388001/first-hawaiian-completes-investment-portfolio-restructuring-company-executed-the-sale-of-293m-of-its", "tags": []}
{"id": 42388009, "time": "2024-12-09 08:03:37", "headline": "NV5 Acquires Southport Engineering Associates, Terms Not Disclosed", "summary": "", "symbols": ["NVEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42388009/nv5-acquires-southport-engineering-associates-terms-not-disclosed", "tags": ["merger"]}
{"id": 42388012, "time": "2024-12-09 08:03:46", "headline": "Wells Fargo Downgrades PBF Energy to Equal-Weight, Lowers Price Target to $34", "summary": "", "symbols": ["PBF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388012/wells-fargo-downgrades-pbf-energy-to-equal-weight-lowers-price-target-to-34", "tags": ["analyst_down", "price_target_down"]}
{"id": 42388028, "time": "2024-12-09 08:04:24", "headline": "Rent the Runway Q3 2024 GAAP EPS $(4.94) Beats $(4.99) Estimate, Sales $75.900M Miss $76.050M Estimate", "summary": "", "symbols": ["RENT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42388028/rent-the-runway-q3-2024-gaap-eps-4-94-beats-4-99-estimate-sales-75-900m-miss-76-050m-estimate", "tags": ["earnings"]}
{"id": 42388041, "time": "2024-12-09 08:04:31", "headline": "Novolex And Pactiv Evergreen To Combine, Establishing A Leading Manufacturer In Food And Beverage Packaging; Pactiv Evergreen Shareholders To Receive $18.00 Per Share In Cash", "summary": "", "symbols": ["PTVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42388041/novolex-and-pactiv-evergreen-to-combine-establishing-a-leading-manufacturer-in-food-and-beverage-pac", "tags": []}
{"id": 42388056, "time": "2024-12-09 08:04:46", "headline": "This Robinhood Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday", "summary": " ", "symbols": ["HOOD", "JD", "JEF", "MKC", "PYPL"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42388056/this-robinhood-analyst-turns-bullish-here-are-top-5-upgrades-for-monday-3", "tags": ["analyst_up"]}
{"id": 42388061, "time": "2024-12-09 08:05:01", "headline": "Windtree Files New Istaroxime PCT Patent Application Titled 'Istaroxime Derivatives Thereof For Preventing Or Reducing The Risk Of Acute Myocardial Arrhythmia'", "summary": "", "symbols": ["WINT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388061/windtree-files-new-istaroxime-pct-patent-application-titled-istaroxime-derivatives-thereof-for-preve", "tags": []}
{"id": 42388075, "time": "2024-12-09 08:05:09", "headline": "Top 3 Energy Stocks That May Plunge This Quarter", "summary": " ", "symbols": ["GLNG", "NFE", "PFIE"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42388075/top-3-energy-stocks-that-may-plunge-this-quarter", "tags": []}
{"id": 42388096, "time": "2024-12-09 08:05:38", "headline": "Oracle Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts", "summary": " ", "symbols": ["ORCL", "VOD"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/price-target/24/12/42388096/oracle-gears-up-for-q2-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts", "tags": ["guidance"]}
{"id": 42388116, "time": "2024-12-09 08:06:21", "headline": "Wells Fargo Upgrades Hess to Overweight, Raises Price Target to $193", "summary": "", "symbols": ["HES"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388116/wells-fargo-upgrades-hess-to-overweight-raises-price-target-to-193", "tags": ["analyst_up", "price_target_up"]}
{"id": 42388135, "time": "2024-12-09 08:07:10", "headline": "Foresight Autonomous Holdings Signs Commercial Cooperation Agreement With Automotive Supplier KONEC In South Korea, Aiming To Integrate 3D Perception Solutions Into Vehicles Of KONEC's Customers And Partners", "summary": "", "symbols": ["FRSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388135/foresight-autonomous-holdings-signs-commercial-cooperation-agreement-with-automotive-supplier-konec", "tags": ["contract"]}
{"id": 42388148, "time": "2024-12-09 08:07:41", "headline": "Sercomm And Harmonic Announce Strategic Collaboration On DOCSIS 4.0 Unified Technology", "summary": "", "symbols": ["HLIT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388148/sercomm-and-harmonic-announce-strategic-collaboration-on-docsis-4-0-unified-technology", "tags": []}
{"id": 42388162, "time": "2024-12-09 08:08:24", "headline": "Rent the Runway Q4 Outlook: Expects Revenue Of $74.4M-$80.3M Vs. $78.20M Est.; For FY24 Expects Revenue Growth Of 2%-4% YoY", "summary": "", "symbols": ["RENT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42388162/rent-the-runway-q4-outlook-expects-revenue-of-74-4m-80-3m-vs-78-20m-est-for-fy24-expects-revenue-gr", "tags": ["earnings", "guidance"]}
{"id": 42388173, "time": "2024-12-09 08:08:57", "headline": "Enphase Energy Announces Collaboration With NextEnergy In The Netherlands", "summary": "", "symbols": ["ENPH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388173/enphase-energy-announces-collaboration-with-nextenergy-in-the-netherlands", "tags": []}
{"id": 42388189, "time": "2024-12-09 08:10:06", "headline": "Leading And Lagging Sectors For December 9, 2024", "summary": " ", "symbols": ["XLE", "XLF", "XLI", "XLK", "XLP", "XLU", "XLV", "XLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/sector-etfs/24/12/42388189/leading-and-lagging-sectors-for-december-9-2024", "tags": []}
{"id": 42388199, "time": "2024-12-09 08:10:07", "headline": "Myriad Genetics Announces NCCN Prostate Cancer Guidelines Reinforcing Status Of Myriad Genetics' Prolaris Test As An 'Advanced Tool' Recommended For Prognostic Assessment", "summary": "", "symbols": ["MYGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42388199/myriad-genetics-announces-nccn-prostate-cancer-guidelines-reinforcing-status-of-myriad-genetics-p", "tags": []}
{"id": 42388210, "time": "2024-12-09 08:10:42", "headline": "Acurx Says Is Preparing To Advance To International Phase 3 Clinical Trials To Treat Patients With C. Difficile Infection, Says Is Also In The Process Of Discussing The Pediatric Development Plans For Ibezapolstat In C. Difficile Infection With FDA And EU Health Authorities, Per Regulatory Requirements", "summary": "", "symbols": ["ACXP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42388210/acurx-says-is-preparing-to-advance-to-international-phase-3-clinical-trials-to-treat-patients-wit", "tags": ["fda"]}
{"id": 42388213, "time": "2024-12-09 08:11:24", "headline": "Senseonics Holdings Remains On-target To Achieve Annual Growth Of ~50% In Patient Installed Base At The End Of 2024 As Compared With 2023; Reiterates FY24 Global Net Revenue Guidance Of ~$22M", "summary": "", "symbols": ["SENS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388213/senseonics-holdings-remains-on-target-to-achieve-annual-growth-of-50-in-patient-installed-base-at-th", "tags": ["analyst_other", "earnings", "guidance"]}
{"id": 42388267, "time": "2024-12-09 08:11:34", "headline": "Natera Announces Launch Of iPRS For Breast Cancer Risk Assessment", "summary": "", "symbols": ["NTRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388267/natera-announces-launch-of-iprs-for-breast-cancer-risk-assessment", "tags": []}
{"id": 42388364, "time": "2024-12-09 08:11:55", "headline": "aTyr Pharma To Present Preclinical Research Demonstrating Anti-Fibrotic Effects Of ATYR0101 In Lung and Kidney Fibrosis At Keystone Symposia On Fibrosis", "summary": "", "symbols": ["ATYR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42388364/atyr-pharma-to-present-preclinical-research-demonstrating-anti-fibrotic-effects-of-atyr0101-in-lu", "tags": []}
{"id": 42388377, "time": "2024-12-09 08:13:04", "headline": "Osisko Announces Renewal of Normal Course Issuer Bid For Up To 9,331,275 Of Its Common Shares", "summary": "", "symbols": ["OR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388377/osisko-announces-renewal-of-normal-course-issuer-bid-for-up-to-9-331-275-of-its-common-shares", "tags": []}
{"id": 42388382, "time": "2024-12-09 08:13:40", "headline": "Bionomics Publishes The Results From The Phase 2 ATTUNE Study Of BNC210 In Patients With Post-Traumatic Stress Disorder In NEJM Evidence", "summary": "", "symbols": ["BNOX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42388382/bionomics-publishes-the-results-from-the-phase-2-attune-study-of-bnc210-in-patients-with-post-tra", "tags": ["fda"]}
{"id": 42388383, "time": "2024-12-09 08:13:45", "headline": "Super Micro Surges 10% On Monday Pre-Market After Company Gets Nasdaq Extension To File Annual Report", "summary": "The delay was initially announced in August when\u00a0Super Micro\u00a0postponed its annual report\u00a0to evaluate internal controls over\u00a0financial reporting. ", "symbols": ["SMCI"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/markets/24/12/42388383/super-micro-surges-10-on-monday-pre-market-after-nasdaq-extension", "tags": []}
{"id": 42388384, "time": "2024-12-09 08:13:56", "headline": "Barclays Maintains Equal-Weight on AllianceBernstein Holding, Lowers Price Target to $36", "summary": "", "symbols": ["AB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388384/barclays-maintains-equal-weight-on-alliancebernstein-holding-lowers-price-target-to-36", "tags": ["analyst_other", "price_target_down"]}
{"id": 42388393, "time": "2024-12-09 08:14:34", "headline": "Cognyte Announced A $20M+ Agreement With A Longstanding National Security Customer In The Europe-Middle East-Africa Region", "summary": "", "symbols": ["CGNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388393/cognyte-announced-a-20m-agreement-with-a-longstanding-national-security-customer-in-the-europe-middl", "tags": ["contract"]}
{"id": 42388395, "time": "2024-12-09 08:14:41", "headline": "Elevai Biosciences Announces Next Steps In Regulatory Strategy For EL-22, Prepareing For Pre-IND Meeting With FDA Anticipated In First Quarter Of 2025", "summary": "", "symbols": ["ELAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388395/elevai-biosciences-announces-next-steps-in-regulatory-strategy-for-el-22-prepareing-for-pre-ind-meet", "tags": ["fda"]}
{"id": 42388421, "time": "2024-12-09 08:15:20", "headline": "This Six Flags Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday", "summary": " ", "symbols": ["BSY", "ELAN", "FUN", "HUT", "SNV"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42388421/this-six-flags-entertainment-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday", "tags": ["analyst_init"]}
{"id": 42388422, "time": "2024-12-09 08:15:30", "headline": "LM Funding America Enters Into Warrant Exercise Transaction For Gross Proceeds Of $5.1M", "summary": "", "symbols": ["LMFA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388422/lm-funding-america-enters-into-warrant-exercise-transaction-for-gross-proceeds-of-5-1m", "tags": []}
{"id": 42388431, "time": "2024-12-09 08:16:00", "headline": "Barclays Maintains Overweight on Apollo Global Management, Raises Price Target to $200", "summary": "", "symbols": ["APO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388431/barclays-maintains-overweight-on-apollo-global-management-raises-price-target-to-200", "tags": ["analyst_other", "price_target_up"]}
{"id": 42388432, "time": "2024-12-09 08:16:04", "headline": "SatixFy Reports Total Revenues Of $8.5M For Nine-Month Period Ended Sept. 30, Down 4% YoY, EPS $(0.41) vs $(0.74) YoY; Sees FY24 Revenues $17M-$19M", "summary": "", "symbols": ["SATX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42388432/satixfy-reports-total-revenues-of-8-5m-for-nine-month-period-ended-sept-30-down-4-yoy-eps-0-41-vs-0", "tags": ["earnings"]}
{"id": 42388538, "time": "2024-12-09 08:17:05", "headline": "Guardant Health To Share New Research Demonstrating Value Of Liquid Biopsy Tests, Real-world Data And AI Analytics In Tailoring Treatment Approaches For Breast Cancer At 2024 San Antonio Breast Cancer Symposium", "summary": "", "symbols": ["GH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42388538/guardant-health-to-share-new-research-demonstrating-value-of-liquid-biopsy-tests-real-world-data-", "tags": []}
{"id": 42388539, "time": "2024-12-09 08:17:14", "headline": "Barclays Maintains Overweight on BlackRock, Raises Price Target to $1220", "summary": "", "symbols": ["BLK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388539/barclays-maintains-overweight-on-blackrock-raises-price-target-to-1220", "tags": ["analyst_other", "price_target_up"]}
{"id": 42388555, "time": "2024-12-09 08:18:43", "headline": "StoneX's Current CEO Sean O'Connor, Will Become Executive VC Of The Board Of Directors; Philip Smith, Will Become Group CEO; And Charles Lyon, Will Become Group President", "summary": "", "symbols": ["SNEX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388555/stonexs-current-ceo-sean-oconnor-will-become-executive-vc-of-the-board-of-directors-philip-smith-wil", "tags": ["management"]}
{"id": 42388571, "time": "2024-12-09 08:19:22", "headline": "Why Is Private Equity Giant Apollo Global Management Stock Shooting Higher Today?", "summary": "Apollo and Santander partner on $370M infrastructure portfolio financing. APO aims for $50B in clean energy investments by 2027.", "symbols": ["APO", "FDFF", "LBO", "SAN", "TTE"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/12/42388571/apollos-370-million-infrastructure-bet-fueling-the-future-of-clean-energy", "tags": ["why_moving"]}
{"id": 42388579, "time": "2024-12-09 08:19:40", "headline": "Barclays Maintains Equal-Weight on Blackstone, Raises Price Target to $199", "summary": "", "symbols": ["BX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388579/barclays-maintains-equal-weight-on-blackstone-raises-price-target-to-199", "tags": ["analyst_other", "price_target_up"]}
{"id": 42388583, "time": "2024-12-09 08:19:41", "headline": "D-Wave Quantum Entered Sales Agreement With Needham, Roth Capital, And Craig-Hallum Pursuant To Which Co. May Sell From Time To Time Shares; Co. May Offer And Sell Shares Having Aggregate Offering Price Of Up To $75M", "summary": "", "symbols": ["QBTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388583/d-wave-quantum-entered-sales-agreement-with-needham-roth-capital-and-craig-hallum-pursuant-to-which", "tags": ["offering", "contract"]}
{"id": 42388597, "time": "2024-12-09 08:19:58", "headline": "Ocean Power Technologies Secures $3M In Purchase Order Commitments For WAM-V USV's In Latin America", "summary": "", "symbols": ["OPTT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388597/ocean-power-technologies-secures-3m-in-purchase-order-commitments-for-wam-v-usvs-in-latin-america", "tags": []}
{"id": 42388600, "time": "2024-12-09 08:20:19", "headline": "Syntec Optics Secures $2.1M In New Orders For Space Optics", "summary": "", "symbols": ["OPTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388600/syntec-optics-secures-2-1m-in-new-orders-for-space-optics", "tags": []}
{"id": 42388601, "time": "2024-12-09 08:20:20", "headline": "BioAge Labs, Riot Platforms And Other Big Stocks Moving Lower In Monday's Pre-Market Session", "summary": " ", "symbols": ["APP", "BCAX", "BELFB", "BIOA", "HTBK", "PSBD", "RIOT", "ZIMV", "ZJK"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/markets/24/12/42388601/bioage-labs-riot-platforms-and-other-big-stocks-moving-lower-in-mondays-pre-market-session", "tags": ["why_moving"]}
{"id": 42388720, "time": "2024-12-09 08:20:49", "headline": "Satellogic Announces $10M Private Placement With Single Institutional Investor, Issuing 3.57M Class A Shares At $2.80 Each; Proceeds To Support General Corporate Purposes With Closing Expected By December 10, 2024", "summary": "", "symbols": ["SATL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388720/satellogic-announces-10m-private-placement-with-single-institutional-investor-issuing-3-57m-class-a", "tags": ["offering"]}
{"id": 42388726, "time": "2024-12-09 08:20:59", "headline": "Amentum Awarded $105M Research, Development, Test And Evaluation Contract To Enhance Electronic Warfare Systems", "summary": "", "symbols": ["AMTM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388726/amentum-awarded-105m-research-development-test-and-evaluation-contract-to-enhance-electronic-warfare", "tags": ["contract"]}
{"id": 42388727, "time": "2024-12-09 08:21:00", "headline": "Barclays Maintains Overweight on Brown-Forman, Raises Price Target to $51", "summary": "", "symbols": ["BF", "BF/B"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388727/barclays-maintains-overweight-on-brown-forman-raises-price-target-to-51", "tags": ["analyst_other", "price_target_up"]}
{"id": 42388732, "time": "2024-12-09 08:21:34", "headline": "Atossa Therapeutics Presents Data From Study Investigating Anti-Cancer Activity Of (Z)-Endoxifen-Related Compounds At AACR Special Conference In Cancer Research", "summary": "", "symbols": ["ATOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42388732/atossa-therapeutics-presents-data-from-study-investigating-anti-cancer-activity-of-z-endoxifen-re", "tags": []}
{"id": 42388821, "time": "2024-12-09 08:22:59", "headline": "Lantern Pharma Enrolls First Patient In Taiwan For Phase 2 HARMONIC Trial Of LP-300 Targeting Never-Smoker NSCLC Patients, Highlighting Taiwan Expansion Where Over 50% Of Lung Cancer Cases Occur In Never-Smokers, With Active Screening At Multiple Sites", "summary": "", "symbols": ["LTRN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42388821/lantern-pharma-enrolls-first-patient-in-taiwan-for-phase-2-harmonic-trial-of-lp-300-targeting-nev", "tags": ["fda"]}
{"id": 42388822, "time": "2024-12-09 08:23:06", "headline": "Barclays Maintains Equal-Weight on CME Gr, Raises Price Target to $257", "summary": "", "symbols": ["CME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388822/barclays-maintains-equal-weight-on-cme-gr-raises-price-target-to-257", "tags": ["analyst_other", "price_target_up"]}
{"id": 42388827, "time": "2024-12-09 08:23:55", "headline": "This AMD Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday", "summary": " ", "symbols": ["AMD", "BAC", "BIIB", "MYGN", "STM"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42388827/this-amd-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-monday", "tags": ["analyst_down"]}
{"id": 42388869, "time": "2024-12-09 08:25:04", "headline": "Barclays Maintains Equal-Weight on Coinbase Glb, Raises Price Target to $355", "summary": "", "symbols": ["COIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388869/barclays-maintains-equal-weight-on-coinbase-glb-raises-price-target-to-355", "tags": ["analyst_other", "price_target_up"]}
{"id": 42388870, "time": "2024-12-09 08:25:05", "headline": "Trading Halt: Halt status updated at 8:25:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["PTVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/12/42388870/trading-halt-halt-status-updated-at-8-25-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 42388872, "time": "2024-12-09 08:25:09", "headline": "Greenwave Technology Solutions Awarded Contract Valued At $15M-$35M Wth Core Tree Care For Hurricane Helene Recovery Services", "summary": "", "symbols": ["GWAV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388872/greenwave-technology-solutions-awarded-contract-valued-at-15m-35m-wth-core-tree-care-for-hurricane-h", "tags": ["contract"]}
{"id": 42388875, "time": "2024-12-09 08:26:41", "headline": "BMO Capital Downgrades CareTrust REIT to Market Perform, Lowers Price Target to $32", "summary": "", "symbols": ["CTRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388875/bmo-capital-downgrades-caretrust-reit-to-market-perform-lowers-price-target-to-32", "tags": ["analyst_down", "price_target_down"]}
{"id": 42388887, "time": "2024-12-09 08:27:41", "headline": "Barclays Maintains Underweight on Franklin Resources, Raises Price Target to $21", "summary": "", "symbols": ["BEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388887/barclays-maintains-underweight-on-franklin-resources-raises-price-target-to-21", "tags": ["analyst_other", "price_target_up"]}
{"id": 42388949, "time": "2024-12-09 08:30:17", "headline": "Forum Energy Technologies Announces $75M Share Repurchase Program Subject To Leverage Ratio Conditions And Completes $20M Sale-Leaseback Transactions For Texas Manufacturing Facilities, Retaining Long-Term Operational Use", "summary": "", "symbols": ["FET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388949/forum-energy-technologies-announces-75m-share-repurchase-program-subject-to-leverage-ratio-condition", "tags": ["buyback"]}
{"id": 42388955, "time": "2024-12-09 08:30:45", "headline": "ClearSign Technologies Regains Nasdaq Compliance", "summary": "", "symbols": ["CLIR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388955/clearsign-technologies-regains-nasdaq-compliance", "tags": []}
{"id": 42388970, "time": "2024-12-09 08:31:32", "headline": "Achieve Life Sciences Appoints Mark Oki As CFO, Effective Dec. 5", "summary": "", "symbols": ["ACHV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388970/achieve-life-sciences-appoints-mark-oki-as-cfo-effective-dec-5", "tags": ["management"]}
{"id": 42388995, "time": "2024-12-09 08:31:53", "headline": "Barclays Maintains Equal-Weight on GitLab, Raises Price Target to $70", "summary": "", "symbols": ["GTLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42388995/barclays-maintains-equal-weight-on-gitlab-raises-price-target-to-70", "tags": ["analyst_other", "price_target_up"]}
{"id": 42389010, "time": "2024-12-09 08:33:01", "headline": "Taoping Signs Non-binding Letter Of Intent To Acquire 100% Equity Of Yunti", "summary": "", "symbols": ["TAOP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42389010/taoping-signs-non-binding-letter-of-intent-to-acquire-100-equity-of-yunti", "tags": ["merger"]}
{"id": 42389015, "time": "2024-12-09 08:33:17", "headline": "Alexandria Real Estate Equities Announces $500M Common Stock Repurchase Program Through December 2025, To Be Funded On A Leverage-Neutral Basis Using Net Cash From Operations And Asset Sales", "summary": "", "symbols": ["ARE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389015/alexandria-real-estate-equities-announces-500m-common-stock-repurchase-program-through-december-2025", "tags": ["buyback"]}
{"id": 42389016, "time": "2024-12-09 08:33:23", "headline": "How To Earn $500 A Month From Designer Brands Stock Ahead Of Q3 Earnings", "summary": " ", "symbols": ["DBI"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42389016/how-to-earn-500-a-month-from-designer-brands-stock-ahead-of-q3-earnings", "tags": ["earnings"]}
{"id": 42389051, "time": "2024-12-09 08:34:37", "headline": "Barclays Maintains Overweight on Interactive Brokers Gr, Raises Price Target to $214", "summary": "", "symbols": ["IBKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389051/barclays-maintains-overweight-on-interactive-brokers-gr-raises-price-target-to-214", "tags": ["analyst_other", "price_target_up"]}
{"id": 42389052, "time": "2024-12-09 08:34:47", "headline": "Post Holdings Affirms FY25 Adj. EBITDA $1.410B-$1.460B", "summary": "", "symbols": ["POST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389052/post-holdings-affirms-fy25-adj-ebitda-1-410b-1-460b", "tags": []}
{"id": 42389056, "time": "2024-12-09 08:35:09", "headline": "Crown Laboratories And Revance Enter Amended And Restated Merger Agreement; Under Terms Of Amended And Restated Agreement, Crown Will Commence Tender Offer To Acquire All Outstanding Shares Of Revance's Common Stock For $3.10 Per Share In Cash", "summary": "", "symbols": ["RVNC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42389056/crown-laboratories-and-revance-enter-amended-and-restated-merger-agreement-under-terms-of-amended-an", "tags": ["merger", "contract"]}
{"id": 42389062, "time": "2024-12-09 08:36:14", "headline": "Post Holdings Reports Third Party Egg-Laying Flock, Michael Foods, Tested Positive For Avian Influenza.", "summary": "", "symbols": ["POST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389062/post-holdings-reports-third-party-egg-laying-flock-michael-foods-tested-positive-for-avian-influenza", "tags": []}
{"id": 42389094, "time": "2024-12-09 08:37:12", "headline": "Loop Capital Assumes Porch Group at Hold, Announces Price Target of $6", "summary": "", "symbols": ["PRCH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389094/loop-capital-assumes-porch-group-at-hold-announces-price-target-of-6", "tags": []}
{"id": 42389095, "time": "2024-12-09 08:37:18", "headline": "Carisma Therapeutics Announces Strategic Restructuring To Focus On In Vivo Macrophage Engineering Platform For Fibrosis, Oncology, And Autoimmune Therapies; Discontinues Development Of CT-0525 And Anti-HER2 Program, Reduces Workforce By 34%, And Projects $2.7M In Workforce Reduction Costs By Q1 2025", "summary": "", "symbols": ["CARM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389095/carisma-therapeutics-announces-strategic-restructuring-to-focus-on-in-vivo-macrophage-engineering-pl", "tags": []}
{"id": 42389096, "time": "2024-12-09 08:37:21", "headline": "Keybanc Maintains Overweight on Emerson Electric, Raises Price Target to $158", "summary": "", "symbols": ["EMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389096/keybanc-maintains-overweight-on-emerson-electric-raises-price-target-to-158", "tags": ["analyst_other", "price_target_up"]}
{"id": 42389098, "time": "2024-12-09 08:37:26", "headline": "Jeffs' Brands Pockets Drone System Distribution Deal On Amazon: Details", "summary": "Jeffs&#39; Brands gains premarket on securing exclusive distribution rights for drone safety systems developed by a leading company on Amazon.", "symbols": ["JFBR"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/12/42389098/jeffs-brands-drones-in-on-safety-with-exclusive-distribution-rights-via-amazon-global", "tags": ["contract"]}
{"id": 42389108, "time": "2024-12-09 08:37:53", "headline": "Barclays Maintains Overweight on Intercontinental Exchange, Raises Price Target to $187", "summary": "", "symbols": ["ICE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389108/barclays-maintains-overweight-on-intercontinental-exchange-raises-price-target-to-187", "tags": ["analyst_other", "price_target_up"]}
{"id": 42389113, "time": "2024-12-09 08:38:42", "headline": "Nvidia Hit With Antitrust Probe in China, Stock Slides", "summary": "Nvidia (NASDAQ: NVDA) drops in premarket as China investigates antitrust breach during Mellanox acquisition. US-China tensions escalate over chip sanctions.", "symbols": ["ARM", "INTC", "NVDA", "SHOC", "TSM", "USD"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/government/regulations/24/12/42389113/nvidia-hit-with-antitrust-probe-in-china-stock-slides", "tags": []}
{"id": 42389114, "time": "2024-12-09 08:38:44", "headline": "Loop Capital Maintains Hold on Hewlett Packard, Raises Price Target to $24", "summary": "", "symbols": ["HPE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389114/loop-capital-maintains-hold-on-hewlett-packard-raises-price-target-to-24", "tags": ["analyst_other", "price_target_up"]}
{"id": 42389127, "time": "2024-12-09 08:39:23", "headline": "Barclays Maintains Overweight on Kanzhun, Raises Price Target to $16", "summary": "", "symbols": ["BZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389127/barclays-maintains-overweight-on-kanzhun-raises-price-target-to-16", "tags": ["analyst_other", "price_target_up"]}
{"id": 42389138, "time": "2024-12-09 08:39:24", "headline": "Keybanc Upgrades Rockwell Automation to Overweight, Maintains Price Target to $345", "summary": "", "symbols": ["ROK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389138/keybanc-upgrades-rockwell-automation-to-overweight-maintains-price-target-to-345", "tags": ["analyst_up", "analyst_other"]}
{"id": 42389144, "time": "2024-12-09 08:40:14", "headline": "Loop Capital Maintains Hold on Roku, Raises Price Target to $80", "summary": "", "symbols": ["ROKU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389144/loop-capital-maintains-hold-on-roku-raises-price-target-to-80", "tags": ["analyst_other", "price_target_up"]}
{"id": 42389148, "time": "2024-12-09 08:40:31", "headline": "Barclays Maintains Overweight on KKR, Raises Price Target to $185", "summary": "", "symbols": ["KKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389148/barclays-maintains-overweight-on-kkr-raises-price-target-to-185", "tags": ["analyst_other", "price_target_up"]}
{"id": 42389149, "time": "2024-12-09 08:40:41", "headline": "Orion Energy Systems Partners With Leading Energy Management Service Provider; Orion Expects This Relationship To Generate Revenue Of $2M-$5M Per Year, With Initial Revenue Anticipated In Its Q4 2025 Ending March 31, 2025.", "summary": "", "symbols": ["OESX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389149/orion-energy-systems-partners-with-leading-energy-management-service-provider-orion-expects-this-rel", "tags": ["earnings", "contract"]}
{"id": 42389150, "time": "2024-12-09 08:41:04", "headline": "Keybanc Maintains Overweight on WESCO Intl, Raises Price Target to $245", "summary": "", "symbols": ["WCC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389150/keybanc-maintains-overweight-on-wesco-intl-raises-price-target-to-245", "tags": ["analyst_other", "price_target_up"]}
{"id": 42389153, "time": "2024-12-09 08:41:22", "headline": "Thai Airways Expands Agreement With Sabre By Adopting Advanced Fare Management Solutions", "summary": "", "symbols": ["SABR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389153/thai-airways-expands-agreement-with-sabre-by-adopting-advanced-fare-management-solutions", "tags": ["contract"]}
{"id": 42389155, "time": "2024-12-09 08:41:38", "headline": "Barclays Maintains Overweight on LPL Finl Hldgs, Raises Price Target to $378", "summary": "", "symbols": ["LPLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389155/barclays-maintains-overweight-on-lpl-finl-hldgs-raises-price-target-to-378", "tags": ["analyst_other", "price_target_up"]}
{"id": 42389207, "time": "2024-12-09 08:41:52", "headline": "BloomZ And Foom Form Strategic Business Alliance To Expand Into Webtoon Industry", "summary": "", "symbols": ["BLMZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389207/bloomz-and-foom-form-strategic-business-alliance-to-expand-into-webtoon-industry", "tags": []}
{"id": 42389209, "time": "2024-12-09 08:42:04", "headline": "Loop Capital Maintains Buy on News, Raises Price Target to $44", "summary": "", "symbols": ["NWSA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389209/loop-capital-maintains-buy-on-news-raises-price-target-to-44", "tags": ["analyst_other", "price_target_up"]}
{"id": 42389211, "time": "2024-12-09 08:42:40", "headline": "Virco Mfg Q3 EPS $0.52 Down From $0.62 YoY, Sales $82.62M Down From $84.25M YoY", "summary": "", "symbols": ["VIRC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42389211/virco-mfg-q3-eps-0-52-down-from-0-62-yoy-sales-82-62m-down-from-84-25m-yoy", "tags": ["earnings"]}
{"id": 42389217, "time": "2024-12-09 08:43:34", "headline": "Omnicell Announces OmniSphere, A Next-Generation, Cloud Native, Software Workflow Engine And Data Platform", "summary": "", "symbols": ["OMCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389217/omnicell-announces-omnisphere-a-next-generation-cloud-native-software-workflow-engine-and-data-platf", "tags": []}
{"id": 42389218, "time": "2024-12-09 08:43:35", "headline": "Barclays Maintains Overweight on Marex Group, Raises Price Target to $35", "summary": "", "symbols": ["MRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389218/barclays-maintains-overweight-on-marex-group-raises-price-target-to-35", "tags": ["analyst_other", "price_target_up"]}
{"id": 42389220, "time": "2024-12-09 08:43:38", "headline": "Loop Capital Maintains Buy on Ulta Beauty, Raises Price Target to $480", "summary": "", "symbols": ["ULTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389220/loop-capital-maintains-buy-on-ulta-beauty-raises-price-target-to-480", "tags": ["analyst_other", "price_target_up"]}
{"id": 42389222, "time": "2024-12-09 08:44:20", "headline": "Porch Group Reiterates $32M Q4'24 Adj EBITDA Guidance And Shares Investor Day Highlights", "summary": "", "symbols": ["PRCH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389222/porch-group-reiterates-32m-q424-adj-ebitda-guidance-and-shares-investor-day-highlights", "tags": ["analyst_other", "guidance"]}
{"id": 42389224, "time": "2024-12-09 08:44:35", "headline": "Keybanc Initiates Coverage On Talkspace with Overweight Rating, Announces Price Target of $4.5", "summary": "", "symbols": ["TALK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389224/keybanc-initiates-coverage-on-talkspace-with-overweight-rating-announces-price-target-of-4-5", "tags": ["analyst_init"]}
{"id": 42389228, "time": "2024-12-09 08:44:46", "headline": "Loop Capital Maintains Buy on Maplebear, Raises Price Target to $56", "summary": "", "symbols": ["CART"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389228/loop-capital-maintains-buy-on-maplebear-raises-price-target-to-56", "tags": ["analyst_other", "price_target_up"]}
{"id": 42389234, "time": "2024-12-09 08:45:02", "headline": "Safety Shot Announces Sure Shot, Is Now Available For Purchase On The Online Store Of A Leading E-Commerce Platform", "summary": "", "symbols": ["SHOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389234/safety-shot-announces-sure-shot-is-now-available-for-purchase-on-the-online-store-of-a-leading-e-com", "tags": []}
{"id": 42389240, "time": "2024-12-09 08:45:16", "headline": "EXCLUSIVE: Crown And 529 Capital To Co-Build and Co-Own Reverse Osmosis Plant in Mexico", "summary": "Crown Electrokinetics to Build Desalination Plant in Cabo San Lucas for Clean Water Supply\nCrown Electrokinetics (NASDAQ: CRKN) and 529 Capital are co-developing a reverse osmosis desalination plant in Cabo San Lucas to provide reliable clean water. The $40 million project will utilize Crown&#39;s proprietary slant wells to desalinate seawater, benefiting local resorts and communities. The plant aims to address the region&#39;s water shortage while generating recurring annual revenue for Crown E", "symbols": ["CRKN"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/24/12/42389240/exclusive-crown-and-529-capital-to-co-build-and-co-own-reverse-osmosis-plant-in-mexico", "tags": ["earnings"]}
{"id": 42389241, "time": "2024-12-09 08:45:19", "headline": "EXCLUSIVE: Crown Electrokinetics Tells Benzinga Co. Announces Plans To Build Co-Own Reverse Osmosis Plant In Mexico To Desalinate Water Collected From Slant Wells", "summary": "", "symbols": ["CRKN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389241/exclusive-crown-electrokinetics-tells-benzinga-co-announces-plans-to-build-co-own-reverse-osmosis-pl", "tags": []}
{"id": 42389252, "time": "2024-12-09 08:45:46", "headline": "HeartCore Announces A Series Of Strategic Initiatives Designed To Elevate The Customer Experience, Enhance The Value Offered To Current HeartCore CMS Clients, And Promote Cross-Selling Opportunities", "summary": "", "symbols": ["HTCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389252/heartcore-announces-a-series-of-strategic-initiatives-designed-to-elevate-the-customer-experience-en", "tags": []}
{"id": 42389281, "time": "2024-12-09 08:46:53", "headline": "Oracle Juggles GenAI Ambitions, Tight IT Budgets: What's Next For The Stock?", "summary": "Oracle faces challenges as it pursues GenAI and cloud growth with cautious IT budgets. Stock target of $140 by 2025 suggests tempered outlook.", "symbols": ["ORCL"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/24/12/42389281/oracles-genai-dreams-clash-with-budget-realities-whats-next-for-the-stock", "tags": ["guidance"]}
{"id": 42389373, "time": "2024-12-09 08:47:40", "headline": "SELLAS Announces Median Overall Survival Not Yet Reached, Now Exceeds 7.7. Months At Latest Follow-Up In The 30 mg BIW Cohort In Patients Relapsed Or Refractory To Venetoclax-Based Regimens;  Overall Response Rate Of 56% Achieved To Date In Patient With Acute Myeloid Leukemia With Myelodysplasia Related Changes Prospectively Enrolled In Two Expansion Cohorts; Exceeding Prespecified Target Response Rate Of 33%", "summary": "", "symbols": ["SLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42389373/sellas-announces-median-overall-survival-not-yet-reached-now-exceeds-7-7-months-at-latest-follow-", "tags": []}
{"id": 42389385, "time": "2024-12-09 08:48:21", "headline": "Northeast Bank Announces Commencement Of At-the-Market Offering Of $75M Voting Common Stock", "summary": "", "symbols": ["NBN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389385/northeast-bank-announces-commencement-of-at-the-market-offering-of-75m-voting-common-stock", "tags": ["offering"]}
{"id": 42389396, "time": "2024-12-09 08:49:18", "headline": "Sonnet BioTherapeutics Announces Results Of SON-1010 At Highest Dose Have Been Formally Evaluated By Safety Review Committee In Phase 1 SB101 Trial; Max Tolerated Dose Was Set At 1200 ng/kg", "summary": "", "symbols": ["SONN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42389396/sonnet-biotherapeutics-announces-results-of-son-1010-at-highest-dose-have-been-formally-evaluated", "tags": ["fda"]}
{"id": 42389242, "time": "2024-12-09 08:45:29", "headline": "EXCLUSIVE: Crown Electrokinetics Tells Benzinga 'Expected To Produce Up To An Estimated $40M In Reoccurring Annual Revenue'", "summary": "", "symbols": ["CRKN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389242/exclusive-crown-electrokinetics-tells-benzinga-expected-to-produce-up-to-an-estimated-40-in-reoccurr", "tags": ["earnings"]}
{"id": 42389402, "time": "2024-12-09 08:49:34", "headline": "RBC Capital Maintains Outperform on Bio-Rad Laboratories, Raises Price Target to $481", "summary": "", "symbols": ["BIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389402/rbc-capital-maintains-outperform-on-bio-rad-laboratories-raises-price-target-to-481", "tags": ["analyst_other", "price_target_up"]}
{"id": 42389384, "time": "2024-12-09 08:48:04", "headline": "Comcast and Warner Bros. Discovery Announce Multi-Year Distribution Agreements That Will Deliver WBD's Portfolio Of Content To Xfinity And Sky UK And Ireland Customers Using Comcast's Global Technology Platform Across Linear Television, Apps, And Streaming Services", "summary": "", "symbols": ["CMCSA", "WBD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389384/comcast-and-warner-bros-discovery-announce-multi-year-distribution-agreements", "tags": []}
{"id": 42389514, "time": "2024-12-09 08:51:47", "headline": "RBC Capital Maintains Outperform on Energy Transfer, Raises Price Target to $23", "summary": "", "symbols": ["ET"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389514/rbc-capital-maintains-outperform-on-energy-transfer-raises-price-target-to-23", "tags": ["analyst_other", "price_target_up"]}
{"id": 42389555, "time": "2024-12-09 08:52:20", "headline": "Macy's Reiterates Commitment To Shareholder Value Creation Amid Barington Capital Presentation, Highlights Confidence In Bold New Chapter Strategy And Ongoing Engagement With Shareholders Ahead Of Q3 Results And Outlook Updates", "summary": "", "symbols": ["M"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389555/macys-reiterates-commitment-to-shareholder-value-creation-amid-barington-capital-presentation-highli", "tags": ["analyst_other", "earnings", "guidance"]}
{"id": 42389562, "time": "2024-12-09 08:54:08", "headline": "MicroStrategy Sells 5.42M Shares For $2.13B Under $21B Sales Agreement, Acquires 21,550 Bitcoins For $2.1B At $98,783 Each, Increasing Total Holdings To 423,650 BTC At $25.6B Total Cost; Reports BTC Yields Of 43.2% For Q4 And 68.7% YTD 2024", "summary": "", "symbols": ["BTCUSD", "MSTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42389562/microstrategy-sells-5-42m-shares-for-2-13b-under-21b-sales-agreement-acquires-21-550-bitco", "tags": ["merger", "contract"]}
{"id": 42389585, "time": "2024-12-09 08:55:04", "headline": "Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["HUIZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/12/42389585/trading-halt-halt-status-updated-at-8-55-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 42389588, "time": "2024-12-09 08:55:16", "headline": "Wolfspeed Files For Common Stock Offering Of Up To $200M", "summary": "", "symbols": ["WOLF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389588/wolfspeed-files-for-common-stock-offering-of-up-to-200m", "tags": ["offering"]}
{"id": 42389594, "time": "2024-12-09 08:56:24", "headline": "RBC Capital Reiterates Outperform on Legend Biotech, Maintains $86 Price Target", "summary": "", "symbols": ["LEGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389594/rbc-capital-reiterates-outperform-on-legend-biotech-maintains-86-price-target", "tags": ["analyst_other"]}
{"id": 42389595, "time": "2024-12-09 08:56:42", "headline": "Shelter Insurance Selects Guidewire To Power The Co's Core Business, Simplify Its IT Operations And Help Deliver Additional Value To Agents, Policyholders And Employees", "summary": "", "symbols": ["GWRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389595/shelter-insurance-selects-guidewire-to-power-the-cos-core-business-simplify-its-it-operations-and-he", "tags": []}
{"id": 42389596, "time": "2024-12-09 08:56:50", "headline": "XRP Price Surges 328% In A Month, Outpaces Bitcoin, Ethereum: How High Can XRP Go?", "summary": "XRP (CRYPTO: XRP) has outperformed Bitcoin and Ethereum over the past month, following Ripple&#39;s favourable legal developments. ", "symbols": ["BTCUSD", "ETHUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42389596/xrp-price-surges-328-in-a-month-outpaces-bitcoin-ethereum-how-high-can-xrp-go", "tags": []}
{"id": 42389629, "time": "2024-12-09 08:58:11", "headline": "\"Apple Is Rumored To Equip Its In-House Developed 5G Modem Chip Into The New iPhone SE 4 Set To Launch In Early 2025, Sources From The Upstream Supply Chain Believe The Chip Is Unlikely To Catch Up With Competitors In Terms Of Performance Until 2026\" - DigiTimes Alert", "summary": "", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389629/apple-is-rumored-to-equip-its-in-house-developed-5g-modem-chip-into-the-new-iphone-se-4-set-to-launc", "tags": []}
{"id": 42389634, "time": "2024-12-09 08:59:03", "headline": "RBC Capital Reiterates Outperform on Match Group, Maintains $35 Price Target", "summary": "", "symbols": ["MTCH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389634/rbc-capital-reiterates-outperform-on-match-group-maintains-35-price-target", "tags": ["analyst_other"]}
{"id": 42389765, "time": "2024-12-09 09:00:25", "headline": "Critical Insights From Ulta Beauty Analyst Ratings: What You Need To Know", "summary": " ", "symbols": ["ULTA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42389765/critical-insights-from-ulta-beauty-analyst-ratings-what-you-need-to-know", "tags": []}
{"id": 42389767, "time": "2024-12-09 09:00:27", "headline": "An Overview of Ferguson's Earnings", "summary": " ", "symbols": ["FERG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42389767/an-overview-of-fergusons-earnings", "tags": ["earnings"]}
{"id": 42389770, "time": "2024-12-09 09:00:33", "headline": "A Glimpse Into The Expert Outlook On Energy Transfer Through 4 Analysts", "summary": " ", "symbols": ["ET"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42389770/a-glimpse-into-the-expert-outlook-on-energy-transfer-through-4-analysts", "tags": ["guidance"]}
{"id": 42389772, "time": "2024-12-09 09:00:37", "headline": "A Look Ahead: Stitch Fix's Earnings Forecast", "summary": " ", "symbols": ["SFIX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42389772/a-look-ahead-stitch-fixs-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 42389777, "time": "2024-12-09 09:00:39", "headline": "Nikola Corporation Enters $100M Equity Distribution Agreement For At-The-Market Offering Of Common Stock", "summary": "", "symbols": ["NKLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389777/nikola-corporation-enters-100m-equity-distribution-agreement-for-at-the-market-offering-of-common-st", "tags": ["offering", "contract"]}
{"id": 42389781, "time": "2024-12-09 09:00:41", "headline": "Peeling Back The Layers: Exploring STMicroelectronics Through Analyst Insights", "summary": " ", "symbols": ["STM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42389781/peeling-back-the-layers-exploring-stmicroelectronics-through-analyst-insights", "tags": []}
{"id": 42389788, "time": "2024-12-09 09:00:47", "headline": "Insights Ahead: Ollie's Bargain Outlet's Quarterly Earnings", "summary": " ", "symbols": ["OLLI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42389788/insights-ahead-ollies-bargain-outlets-quarterly-earnings", "tags": ["earnings"]}
{"id": 42389790, "time": "2024-12-09 09:00:51", "headline": "Analyst Expectations For Moelis's Future", "summary": " ", "symbols": ["MC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42389790/analyst-expectations-for-moeliss-future", "tags": []}
{"id": 42389792, "time": "2024-12-09 09:00:55", "headline": "Dave & Buster's Enter's Earnings Outlook", "summary": " ", "symbols": ["PLAY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42389792/dave-busters-enters-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 42389794, "time": "2024-12-09 09:00:58", "headline": "A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 19 Analysts", "summary": " ", "symbols": ["VRTX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42389794/a-glimpse-into-the-expert-outlook-on-vertex-pharmaceuticals-through-19-analysts", "tags": ["guidance"]}
{"id": 42389796, "time": "2024-12-09 09:01:03", "headline": "What's Next: Academy Sports's Earnings Preview", "summary": " ", "symbols": ["ASO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42389796/whats-next-academy-sportss-earnings-preview", "tags": ["earnings"]}
{"id": 42389799, "time": "2024-12-09 09:01:06", "headline": "Expert Ratings For PBF Energy", "summary": " ", "symbols": ["PBF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42389799/expert-ratings-for-pbf-energy", "tags": []}
{"id": 42389800, "time": "2024-12-09 09:01:06", "headline": "Genasys Announces Three-Year $3.35M Renewal Agreement For Indian Navy LRAD Systems Maintenance", "summary": "", "symbols": ["GNSS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389800/genasys-announces-three-year-3-35m-renewal-agreement-for-indian-navy-lrad-systems-maintenance", "tags": ["contract"]}
{"id": 42389805, "time": "2024-12-09 09:01:10", "headline": "AutoZone Earnings Preview", "summary": " ", "symbols": ["AZO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42389805/autozone-earnings-preview", "tags": ["earnings"]}
{"id": 42389809, "time": "2024-12-09 09:01:18", "headline": "A Peek at GameStop's Future Earnings", "summary": " ", "symbols": ["GME"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42389809/a-peek-at-gamestops-future-earnings", "tags": ["earnings"]}
{"id": 42389817, "time": "2024-12-09 09:01:25", "headline": "What's Next: United Natural Foods's Earnings Preview", "summary": " ", "symbols": ["UNFI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42389817/whats-next-united-natural-foodss-earnings-preview", "tags": ["earnings"]}
{"id": 42389818, "time": "2024-12-09 09:01:36", "headline": "Johnson Outdoors Earnings Preview", "summary": " ", "symbols": ["JOUT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42389818/johnson-outdoors-earnings-preview", "tags": ["earnings"]}
{"id": 42389819, "time": "2024-12-09 09:01:37", "headline": "GeoVax Receives Notice Of Allowance For Patent Application Titled 'Vaccinia Viral Vectors Encoding Chimeric Virus Like Particles.'", "summary": "", "symbols": ["GOVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42389819/geovax-receives-notice-of-allowance-for-patent-application-titled-vaccinia-viral-vectors-encoding", "tags": []}
{"id": 42389820, "time": "2024-12-09 09:01:44", "headline": "A Look at Energy Transfer's Upcoming Earnings Report", "summary": " ", "symbols": ["ET"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42389820/a-look-at-energy-transfers-upcoming-earnings-report", "tags": ["earnings"]}
{"id": 42389822, "time": "2024-12-09 09:01:48", "headline": "TNF Pharmaceuticals Reports Statistically Significant Phase 2a Results For Sarcopenia Treatment At International Conference, Plans Phase 2b Study In Early 2025; First Oral TNF-\u03b1 Inhibitor Targets $40B Market Potential", "summary": "", "symbols": ["TNFA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42389822/tnf-pharmaceuticals-reports-statistically-significant-phase-2a-results-for-sarcopenia-treatment-a", "tags": []}
{"id": 42389826, "time": "2024-12-09 09:01:52", "headline": "Preview: G-III Apparel Group's Earnings", "summary": " ", "symbols": ["GIII"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42389826/preview-g-iii-apparel-groups-earnings", "tags": ["earnings"]}
{"id": 42389852, "time": "2024-12-09 09:02:02", "headline": "Earnings Outlook For Designer Brands", "summary": " ", "symbols": ["DBI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42389852/earnings-outlook-for-designer-brands", "tags": ["earnings", "guidance"]}
{"id": 42389871, "time": "2024-12-09 09:02:42", "headline": "RBC Capital Maintains Sector Perform on NeueHealth, Lowers Price Target to $7", "summary": "", "symbols": ["NEUE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389871/rbc-capital-maintains-sector-perform-on-neuehealth-lowers-price-target-to-7", "tags": ["analyst_other", "price_target_down"]}
{"id": 42389872, "time": "2024-12-09 09:02:44", "headline": "Volato Group Withdraws S-1 Registration Statement", "summary": "", "symbols": ["SOAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389872/volato-group-withdraws-s-1-registration-statement", "tags": []}
{"id": 42389890, "time": "2024-12-09 09:03:08", "headline": "Volato Group Says On Track To Deliver Positive Net Income In Q4", "summary": "", "symbols": ["SOAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389890/volato-group-says-on-track-to-deliver-positive-net-income-in-q4", "tags": []}
{"id": 42389900, "time": "2024-12-09 09:03:31", "headline": "Perpetua Resources' Perpetua Resources Idaho, Has Agreed To Conduct Metallurgical Testing Of Antimony Concentrate Samples From Perpetua's Stibnite Gold Project With U.S. Antimony Corp", "summary": "", "symbols": ["PPTA", "TSX:PPTA", "UAMY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389900/perpetua-resources-perpetua-resources-idaho-has-agreed-to-conduct-metallurgical-testing-of-antimony", "tags": []}
{"id": 42389915, "time": "2024-12-09 09:04:07", "headline": "WidePoint Partners With 22Vets Technologies For Smart City IoT Program", "summary": "", "symbols": ["WYY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389915/widepoint-partners-with-22vets-technologies-for-smart-city-iot-program", "tags": ["contract"]}
{"id": 42389917, "time": "2024-12-09 09:04:12", "headline": "Reddit Launches Test Of AI-Powered Conversational Interface \"Reddit Answers,\" Allowing Users To Ask Questions And Receive Answers; Initial Rollout Limited To U.S. Users With Support In English Starting December 11, 2024", "summary": "", "symbols": ["RDDT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389917/reddit-launches-test-of-ai-powered-conversational-interface-reddit-answers-allowing-users-to-ask-que", "tags": []}
{"id": 42389924, "time": "2024-12-09 09:04:32", "headline": "Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields", "summary": " ", "symbols": ["APLE", "OUT", "PK"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42389924/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-delivering-high-dividend-yields", "tags": ["dividend"]}
{"id": 42389942, "time": "2024-12-09 09:04:44", "headline": "Newmark Arranges $1.75B Refinancing For Two Of Fontainebleau Development's Florida Resorts", "summary": "", "symbols": ["NMRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389942/newmark-arranges-1-75b-refinancing-for-two-of-fontainebleau-developments-florida-resorts", "tags": []}
{"id": 42389952, "time": "2024-12-09 09:05:07", "headline": "Top 3 Materials Stocks That May Rocket Higher In December", "summary": " ", "symbols": ["BAK", "CE", "DOW"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/12/42389952/top-3-materials-stocks-that-may-rocket-higher-in-december", "tags": []}
{"id": 42389959, "time": "2024-12-09 09:05:22", "headline": "Carbon TerraVault And Net Power Sign MOU To Develop Low Carbon, Reliable Power Solutions In California", "summary": "", "symbols": ["CRC", "NPWR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389959/carbon-terravault-and-net-power-sign-mou-to-develop-low-carbon-reliable-power-solutions-in-californi", "tags": []}
{"id": 42389985, "time": "2024-12-09 09:06:53", "headline": "Freight Technologies Selected By Nestl\u00e9 Mexico To Provide Domestic Logistics Services With Fr8App", "summary": "", "symbols": ["FRGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42389985/freight-technologies-selected-by-nestl-mexico-to-provide-domestic-logistics-services-with-fr8app", "tags": []}
{"id": 42389986, "time": "2024-12-09 09:06:55", "headline": "T2 Biosystems To License Proprietary Technology For Direct-From-Whole-Blood Sepsis Pathogen Detection, Aiming To Generate Non-Dilutive Capital, Create Royalty Revenue Streams, And Broaden Adoption Of FDA-Cleared Diagnostics Powered By T2MR Detection And Adaptable Sample Processing Technology", "summary": "", "symbols": ["CAH", "TTOO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42389986/t2-biosystems-to-license-proprietary-technology-for-direct-from-whole-blood-sepsis-pathogen-detec", "tags": ["earnings", "offering", "fda"]}
{"id": 42390013, "time": "2024-12-09 09:07:33", "headline": "Verizon CEO Says \"Our Ambition Is To Have More Than 50% Of Our Customers On MyPlan Offering\"", "summary": "", "symbols": ["VZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390013/verizon-ceo-says-our-ambition-is-to-have-more-than-50-of-our-customers-on-myplan-offering", "tags": ["offering", "management"]}
{"id": 42390064, "time": "2024-12-09 09:09:34", "headline": "Decentralization Takes Center Stage: 1iO CEO Stresses The Need For User Control In Digital Assets", "summary": "Markus Kuhnert, CEO of 1iO, stressed that Web3&#39;s primary goal is to give users control over their data.", "symbols": [], "source": "benzinga", "author": "Abbey Higginbotham", "url": "https://www.benzinga.com/news/events/24/12/42390064/decentralization-takes-center-stage-1io-ceo-stresses-the-need-for-user-control-in-digital-assets", "tags": ["management"]}
{"id": 42390079, "time": "2024-12-09 09:09:39", "headline": "Bytedance, TikTok Seek Emergency Injunction To Block Law That Would Force Sale Or Ban Tiktok", "summary": "", "symbols": ["FXI", "GOOG", "GOOGL", "META", "PINS", "SNAP", "SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390079/bytedance-tiktok-seek-emergency-injunction-to-block-law-that-would-force-sale-or-ban-tiktok", "tags": []}
{"id": 42390275, "time": "2024-12-09 09:13:10", "headline": "Lexaria Bioscience Says Liraglutide Processed With DehydraTECH To Be Studied In Human GLP-1 Study #5", "summary": "", "symbols": ["LEXX", "LEXXW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42390275/lexaria-bioscience-says-liraglutide-processed-with-dehydratech-to-be-studied-in-human-glp-1-study", "tags": []}
{"id": 42390276, "time": "2024-12-09 09:13:20", "headline": "This Analyst With 86% Accuracy Rate Sees Around 21% Upside In Chewy - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts", "summary": " ", "symbols": ["AXON", "CHWY", "DOCU", "MIR", "WTW"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42390276/this-analyst-with-86-accuracy-rate-sees-around-21-upside-in-chewy-here-are-5-stock-picks-for-last-week-from-wall-streets-most-accurate-analysts", "tags": []}
{"id": 42390294, "time": "2024-12-09 09:14:44", "headline": "Barnes & Noble Education Q2 EPS $(1.87) Up From $(9.11) YoY, Sales $602.12M Down From $610.38M YoY", "summary": "", "symbols": ["BNED"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42390294/barnes-noble-education-q2-eps-1-87-up-from-9-11-yoy-sales-602-12m-down-from-610-38m-yoy", "tags": ["earnings"]}
{"id": 42390311, "time": "2024-12-09 09:15:10", "headline": "Oppenheimer Initiates Coverage On Carlyle Credit Income with Perform Rating, Announces Price Target of $8", "summary": "", "symbols": ["CCIF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390311/oppenheimer-initiates-coverage-on-carlyle-credit-income-with-perform-rating-announces-price-target-o", "tags": ["analyst_init"]}
{"id": 42390331, "time": "2024-12-09 09:16:01", "headline": "Mullen Subsidiary Bollinger Motors Partners With Broadway Ford Truck Center To Expand Dealer Network And Strengthen Midwest Presence, Supporting Demand For Bollinger B4 All-Electric Class 4 Trucks Among Commercial Fleet Operators", "summary": "", "symbols": ["MULN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390331/mullen-subsidiary-bollinger-motors-partners-with-broadway-ford-truck-center-to-expand-dealer-network", "tags": ["contract"]}
{"id": 42390334, "time": "2024-12-09 09:16:20", "headline": "LTC Appoints Wendy Simpson Executive Chairman Of The Board; Promotes Pam Kessler And Clint Malin To Co-Chief Executive Officers, And Cece Chikhale To Chief Financial Officer, Effective December 31, 2024", "summary": "", "symbols": ["LTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390334/ltc-appoints-wendy-simpson-executive-chairman-of-the-board-promotes-pam-kessler-and-clint-malin-to-c", "tags": ["management"]}
{"id": 42390338, "time": "2024-12-09 09:16:55", "headline": "Artelo Biosciences Presents Phase 1 Data On ART27.13 For Cancer-Related Anorexia At International Conference, Highlighting Good Tolerability And Weight Stabilization Or Reversal In Two-Thirds Of Participants; Phase 2 Enrollment Ongoing In CAReS Trial", "summary": "", "symbols": ["ARTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42390338/artelo-biosciences-presents-phase-1-data-on-art27-13-for-cancer-related-anorexia-at-international", "tags": ["fda"]}
{"id": 42390340, "time": "2024-12-09 09:17:00", "headline": "Oppenheimer Maintains Outperform on Talen Energy, Raises Price Target to $250", "summary": "", "symbols": ["TLN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390340/oppenheimer-maintains-outperform-on-talen-energy-raises-price-target-to-250", "tags": ["analyst_other", "price_target_up"]}
{"id": 42390468, "time": "2024-12-09 09:17:18", "headline": "Top 10 Trending Stocks On WallStreetBets As Of December 9, 2024 (Via Swaggy Stocks)", "summary": "", "symbols": ["ACHR", "AI", "AMD", "ASTS", "MSTR", "NVDA", "PLTR", "RDDT", "SMCI", "TSLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390468/top-10-trending-stocks-on-wallstreetbets-as-of-december-9-2024-via-swaggy-stocks", "tags": []}
{"id": 42390515, "time": "2024-12-09 09:20:01", "headline": "NextPlat Raises 2024 Revenue Guidance To Over $63M, Reflecting 70% Growth YoY, Driven By Satellite Connectivity, Recurring Airtime Revenue, And Healthcare Contributions; Annual Report Expected By March 2025", "summary": "", "symbols": ["NXPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390515/nextplat-raises-2024-revenue-guidance-to-over-63m-reflecting-70-growth-yoy-driven-by-satellite-conne", "tags": ["earnings", "guidance"]}
{"id": 42390520, "time": "2024-12-09 09:20:09", "headline": "Oppenheimer Maintains Outperform on Porch Group, Raises Price Target to $7", "summary": "", "symbols": ["PRCH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390520/oppenheimer-maintains-outperform-on-porch-group-raises-price-target-to-7", "tags": ["analyst_other", "price_target_up"]}
{"id": 42390691, "time": "2024-12-09 09:22:25", "headline": "RBC Capital Maintains Outperform on Sunoco, Raises Price Target to $64", "summary": "", "symbols": ["SUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390691/rbc-capital-maintains-outperform-on-sunoco-raises-price-target-to-64", "tags": ["analyst_other", "price_target_up"]}
{"id": 42390725, "time": "2024-12-09 09:26:26", "headline": "BP, JERA Commit $5.8 Billion To Create Global Offshore Wind Giant", "summary": "BP shares are trading higher premarket on Monday. The company and JERA Co., Inc. agreed to merge their offshore wind businesses.", "symbols": ["BP", "NDIV"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/contracts/24/12/42390725/bp-jera-commit-5-8-billion-to-create-global-offshore-wind-giant", "tags": ["why_moving"]}
{"id": 42390726, "time": "2024-12-09 09:26:31", "headline": "AST SpaceMobile Secures Long-Term Vodafone Deal To Boost Global Coverage", "summary": "AST SpaceMobile shares up on Vodafone&#39;s long-term commercial agreement. Partnership aims to expand global broadband connectivity.", "symbols": ["ASTS", "UFO", "VOD"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/12/42390726/ast-spacemobile-secures-long-term-vodafone-deal-to-boost-global-coverage", "tags": ["contract"]}
{"id": 42390765, "time": "2024-12-09 09:29:11", "headline": "B of A Securities Maintains Underperform on Bloom Energy, Raises Price Target to $20", "summary": "", "symbols": ["BE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390765/b-of-a-securities-maintains-underperform-on-bloom-energy-raises-price-target-to-20", "tags": ["analyst_other", "price_target_up"]}
{"id": 42390813, "time": "2024-12-09 09:30:21", "headline": "How Is The Market Feeling About MPLX?", "summary": " ", "symbols": ["MPLX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42390813/how-is-the-market-feeling-about-mplx", "tags": []}
{"id": 42390816, "time": "2024-12-09 09:30:26", "headline": "(AMT) - Analyzing American Tower's Short Interest", "summary": " ", "symbols": ["AMT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42390816/amt-analyzing-american-towers-short-interest", "tags": []}
{"id": 42390817, "time": "2024-12-09 09:30:31", "headline": "Looking Into argenx's Recent Short Interest", "summary": " ", "symbols": ["ARGX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42390817/looking-into-argenxs-recent-short-interest", "tags": []}
{"id": 42390891, "time": "2024-12-09 09:32:17", "headline": "Princess Cruises Reports Record-Breaking Black Friday To Cyber Monday Bookings With 32% YoY Growth, 136% Surge On Cyber Monday, And 66% Increase In Demand For 2026 Sailings", "summary": "", "symbols": ["CCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390891/princess-cruises-reports-record-breaking-black-friday-to-cyber-monday-bookings-with-32-yoy-growth-13", "tags": []}
{"id": 42390904, "time": "2024-12-09 09:33:24", "headline": "RBC Capital Reiterates Sector Perform on Western Midstream, Maintains $41 Price Target", "summary": "", "symbols": ["WES"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390904/rbc-capital-reiterates-sector-perform-on-western-midstream-maintains-41-price-target", "tags": ["analyst_other"]}
{"id": 42390915, "time": "2024-12-09 09:34:49", "headline": "Watching CEL-SCI; Zacks Small-Cap Research Gives Stock $7 Price Valuation", "summary": "", "symbols": ["CVM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390915/watching-cel-sci-zacks-small-cap-research-gives-stock-7-price-valuation", "tags": []}
{"id": 42390919, "time": "2024-12-09 09:35:47", "headline": "Live On X, Dave Portnoy Hosts Michael Saylor On \"Davey Day Trader\"", "summary": "", "symbols": ["MSTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390919/live-on-x-dave-portnoy-hosts-michael-saylor-on-davey-day-trader", "tags": []}
{"id": 42390923, "time": "2024-12-09 09:36:06", "headline": "LeddarTech Holdings Shares Halted To The Downside; Stock Now Up 373.89%", "summary": "", "symbols": ["LDTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42390923/leddartech-holdings-shares-halted-to-the-downside-stock-now-up-373-89", "tags": ["halt"]}
{"id": 42390925, "time": "2024-12-09 09:36:41", "headline": "Craig-Hallum Initiates Coverage On Latham Group with Buy Rating, Announces Price Target of $10", "summary": "", "symbols": ["SWIM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390925/craig-hallum-initiates-coverage-on-latham-group-with-buy-rating-announces-price-target-of-10", "tags": ["analyst_init"]}
{"id": 42390928, "time": "2024-12-09 09:36:56", "headline": "Destiny Tech100 Shares Halted On Circuit Breaker To The Downside, Stock Now Down -4.62%", "summary": "", "symbols": ["DXYZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42390928/destiny-tech100-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down-4-62", "tags": ["halt"]}
{"id": 42390946, "time": "2024-12-09 09:38:39", "headline": "Deutsche Bank Maintains Hold on Lululemon Athletica, Raises Price Target to $396", "summary": "", "symbols": ["LULU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390946/deutsche-bank-maintains-hold-on-lululemon-athletica-raises-price-target-to-396", "tags": ["analyst_other", "price_target_up"]}
{"id": 42390953, "time": "2024-12-09 09:39:31", "headline": "Watching Quantum Computing; Iceberg Research Issues Update To Report Titled \"$QUBT is Already Running Behind with its New Chip Manufacturing Hype\"", "summary": "", "symbols": ["QUBT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390953/watching-quantum-computing-iceberg-research-issues-update-to-report-titled-qubt-is-already-running-b", "tags": []}
{"id": 42390990, "time": "2024-12-09 09:41:03", "headline": "Fangdd Network Group Shares Halted To The Upside; Stock Now Up 114.46%", "summary": "", "symbols": ["DUO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42390990/fangdd-network-group-shares-halted-to-the-upside-stock-now-up-114-46", "tags": ["halt"]}
{"id": 42390996, "time": "2024-12-09 09:41:21", "headline": "Deutsche Bank Maintains Buy on Tesla, Raises Price Target to $370", "summary": "", "symbols": ["TSLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42390996/deutsche-bank-maintains-buy-on-tesla-raises-price-target-to-370", "tags": ["analyst_other", "price_target_up"]}
{"id": 42390998, "time": "2024-12-09 09:41:37", "headline": "Rent the Runway Shares Resume Trade", "summary": "", "symbols": ["RENT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42390998/rent-the-runway-shares-resume-trade", "tags": []}
{"id": 42391068, "time": "2024-12-09 09:44:07", "headline": "Cantor Fitzgerald Reiterates Overweight on Legend Biotech, Maintains $83 Price Target", "summary": "", "symbols": ["LEGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391068/cantor-fitzgerald-reiterates-overweight-on-legend-biotech-maintains-83-price-target", "tags": ["analyst_other"]}
{"id": 42391069, "time": "2024-12-09 09:44:22", "headline": "Mizuho Maintains Neutral on Hershey, Lowers Price Target to $180", "summary": "", "symbols": ["HSY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391069/mizuho-maintains-neutral-on-hershey-lowers-price-target-to-180", "tags": ["analyst_other", "price_target_down"]}
{"id": 42391077, "time": "2024-12-09 09:45:26", "headline": "Price Over Earnings Overview: Air Products & Chemicals", "summary": " ", "symbols": ["APD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42391077/price-over-earnings-overview-air-products-chemicals", "tags": ["earnings"]}
{"id": 42391092, "time": "2024-12-09 09:46:08", "headline": "Mizuho Maintains Outperform on Simply Good Foods, Raises Price Target to $45", "summary": "", "symbols": ["SMPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391092/mizuho-maintains-outperform-on-simply-good-foods-raises-price-target-to-45", "tags": ["analyst_other", "price_target_up"]}
{"id": 42391096, "time": "2024-12-09 09:46:12", "headline": "Destiny Tech100 Shares Halted On Circuit Breaker To The Downside, Stock Now Down -20.6%", "summary": "", "symbols": ["DXYZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42391096/destiny-tech100-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down-20-6", "tags": ["halt"]}
{"id": 42391174, "time": "2024-12-09 09:47:13", "headline": "Fangdd Network Shares Resume Trade Then Halted On Circuit Breaker To The Downside, Stock Now Up 86.8%", "summary": "", "symbols": ["DUO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391174/fangdd-network-shares-resume-trade-then-halted-on-circuit-breaker-to-the-downside-stock-now-up-86-8", "tags": ["halt"]}
{"id": 42391210, "time": "2024-12-09 09:47:39", "headline": "Destiny Tech100 Shares Resume Trade", "summary": "", "symbols": ["DXYZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42391210/destiny-tech100-shares-resume-trade", "tags": []}
{"id": 42391224, "time": "2024-12-09 09:48:07", "headline": "Mizuho Maintains Outperform on General Motors, Raises Price Target to $62", "summary": "", "symbols": ["GM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391224/mizuho-maintains-outperform-on-general-motors-raises-price-target-to-62", "tags": ["analyst_other", "price_target_up"]}
{"id": 42391247, "time": "2024-12-09 09:49:56", "headline": "Mizuho Maintains Outperform on Veeva Systems, Raises Price Target to $280", "summary": "", "symbols": ["VEEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391247/mizuho-maintains-outperform-on-veeva-systems-raises-price-target-to-280", "tags": ["analyst_other", "price_target_up"]}
{"id": 42391254, "time": "2024-12-09 09:50:49", "headline": "US Listed Chinese Stocks Jump On China's Stimulus Measures, Looser Monetary Policy Assurances", "summary": "Chinese stocks rose ahead of China&#39;s key policy meeting this week. The government plans to discuss financial goals and stimulus measures to boost consumption.", "symbols": ["BABA", "BODI", "FXI", "JD", "KWEB"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/government/regulations/24/12/42391254/us-listed-chinese-stocks-jump-on-chinas-stimulus-measures-looser-monetary-policy-assurances", "tags": []}
{"id": 42391365, "time": "2024-12-09 09:51:30", "headline": "Mizuho Maintains Outperform on Rubrik, Raises Price Target to $68", "summary": "", "symbols": ["RBRK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391365/mizuho-maintains-outperform-on-rubrik-raises-price-target-to-68", "tags": ["analyst_other", "price_target_up"]}
{"id": 42391370, "time": "2024-12-09 09:51:56", "headline": "Fangdd Network Shares Resume Trade", "summary": "", "symbols": ["DUO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42391370/fangdd-network-shares-resume-trade", "tags": []}
{"id": 42391415, "time": "2024-12-09 09:52:30", "headline": "Wells Fargo Maintains Equal-Weight on Emera, Raises Price Target to C$56", "summary": "", "symbols": ["TSX:EMA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391415/wells-fargo-maintains-equal-weight-on-emera-raises-price-target-to-c-56", "tags": ["analyst_other", "price_target_up"]}
{"id": 42391416, "time": "2024-12-09 09:52:37", "headline": "Enphase Energy Teams With NextEnergy To Maximize Solar Savings In The Netherlands", "summary": "Enphase Energy partners with NextEnergy in Netherlands to offer solar and battery systems that maximize ROI and shorten payback period by participating in grid imbalance energy market.", "symbols": ["ENPH"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/markets/equities/24/12/42391416/enphase-energy-teams-with-nextenergy-to-maximize-solar-savings-in-the-netherlands", "tags": ["contract"]}
{"id": 42391427, "time": "2024-12-09 09:53:13", "headline": "Wells Fargo Maintains Underweight on Delek US Hldgs, Lowers Price Target to $16", "summary": "", "symbols": ["DK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391427/wells-fargo-maintains-underweight-on-delek-us-hldgs-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 42391429, "time": "2024-12-09 09:53:16", "headline": "Canopy Growth Wraps Up Acreage Acquisition Expanding US Cannabis Portfolio, What Investors Need To Know", "summary": "Canopy USA, LLC has wrapped up its acquisition of Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U) (OTCQX:\u00a0ACRHF, ACRDF), Canopy Growth Corporation&#39;s (TSX: WEED) (NASDAQ: CGC) U.S.-domiciled holding company said on Monday. Canopy USA, created in 2022 to streamline the Canadian cannabis giant&#39;s entry into the US market, now owns 100% of the issued and outstanding shares of Acreage. The $3.4 billion acquisition deal was first in 2019. Initially, the deal was to be undertaken should the U.S", "symbols": ["ACRDF", "CGC", "CSE:ACRG", "TSNDF", "TSX:TSND", "TSX:WEED", "WEED"], "source": "benzinga", "author": "Jelena Martinovic", "url": "https://www.benzinga.com/24/12/42391429/canopy-growth-closes-acreage-deal-expanding-us-cannabis-portfolio-heres-what-investors-need-to-know", "tags": ["contract"]}
{"id": 42391462, "time": "2024-12-09 09:55:16", "headline": "Cantor Fitzgerald Reiterates Overweight on KalVista Pharmato Overweight", "summary": "", "symbols": ["KALV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391462/cantor-fitzgerald-reiterates-overweight-on-kalvista-pharmato-overweight", "tags": ["analyst_other"]}
{"id": 42391472, "time": "2024-12-09 09:56:16", "headline": "Mizuho Maintains Outperform on GitLab, Raises Price Target to $80", "summary": "", "symbols": ["GTLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391472/mizuho-maintains-outperform-on-gitlab-raises-price-target-to-80", "tags": ["analyst_other", "price_target_up"]}
{"id": 42391474, "time": "2024-12-09 09:56:38", "headline": "2717 Partners Urges Logility Board To Explore Strategic Alternatives, Including A Take-Private Transaction, Citing Persistent Underperformance, Underappreciation In Public Markets, And Significant Value-Creation Potential Under Private Ownership", "summary": "", "symbols": ["LGTY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391474/2717-partners-urges-logility-board-to-explore-strategic-alternatives-including-a-take-private-transa", "tags": []}
{"id": 42391481, "time": "2024-12-09 09:57:17", "headline": "MicroStrategy Acquires $2.1B Worth of Bitcoin, Total Holdings Now Exceed 423,000 BTC", "summary": "MicroStrategy (NASDAQ:MSTR) disclosed that it acquired 21,550 Bitcoin (CRYPTO: BTC) for approximately $2.1 billion in the ", "symbols": ["BTCUSD", "MSTR", "RIOT"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42391481/microstrategy-acquires-21b-worth-of-bitcoin-total-holdings-now-exceed-423000-btc", "tags": ["merger"]}
{"id": 42391482, "time": "2024-12-09 09:57:20", "headline": "Wells Fargo Maintains Overweight on Marathon Petroleum, Raises Price Target to $186", "summary": "", "symbols": ["MPC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391482/wells-fargo-maintains-overweight-on-marathon-petroleum-raises-price-target-to-186", "tags": ["analyst_other", "price_target_up"]}
{"id": 42391513, "time": "2024-12-09 09:58:08", "headline": "Mizuho Maintains Neutral on Dow, Lowers Price Target to $46", "summary": "", "symbols": ["DOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391513/mizuho-maintains-neutral-on-dow-lowers-price-target-to-46", "tags": ["analyst_other", "price_target_down"]}
{"id": 42391526, "time": "2024-12-09 09:59:07", "headline": "Wells Fargo Maintains Overweight on Phillips 66, Lowers Price Target to $161", "summary": "", "symbols": ["PSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391526/wells-fargo-maintains-overweight-on-phillips-66-lowers-price-target-to-161", "tags": ["analyst_other", "price_target_down"]}
{"id": 42391529, "time": "2024-12-09 09:59:08", "headline": "Cantor Fitzgerald Reiterates Overweight on Kura Oncologyto Overweight", "summary": "", "symbols": ["KURA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391529/cantor-fitzgerald-reiterates-overweight-on-kura-oncologyto-overweight", "tags": ["analyst_other"]}
{"id": 42391591, "time": "2024-12-09 10:00:30", "headline": "Investigating NVIDIA's Standing In Semiconductors &amp; Semiconductor Equipment Industry Compared To Competitors", "summary": " ", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42391591/investigating-nvidias-standing-in-semiconductors-amp-semiconductor-equipment-industry-compared-to-c", "tags": []}
{"id": 42391594, "time": "2024-12-09 10:00:30", "headline": "Wells Fargo Maintains Overweight on Valero Energy, Lowers Price Target to $160", "summary": "", "symbols": ["VLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391594/wells-fargo-maintains-overweight-on-valero-energy-lowers-price-target-to-160", "tags": ["analyst_other", "price_target_down"]}
{"id": 42391596, "time": "2024-12-09 10:00:30", "headline": "Critical Insights From Lazard Analyst Ratings: What You Need To Know", "summary": " ", "symbols": ["LAZ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42391596/critical-insights-from-lazard-analyst-ratings-what-you-need-to-know", "tags": []}
{"id": 42391564, "time": "2024-12-09 10:00:31", "headline": "Fast Track Group IPOs Tomorrow, Here's What You Need To Know", "summary": " ", "symbols": ["FTRK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/ipos/24/12/42391564/fast-track-group-ipos-tomorrow-heres-what-you-need-to-know", "tags": []}
{"id": 42391600, "time": "2024-12-09 10:01:14", "headline": "In-Depth Analysis: Microsoft Versus Competitors In Software Industry", "summary": " ", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42391600/in-depth-analysis-microsoft-versus-competitors-in-software-industry", "tags": []}
{"id": 42391540, "time": "2024-12-09 10:01:20", "headline": "Mizuho Maintains Neutral on LyondellBasell Industries, Lowers Price Target to $85", "summary": "", "symbols": ["LYB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391540/mizuho-maintains-neutral-on-lyondellbasell-industries-lowers-price-target-to-85", "tags": ["analyst_other", "price_target_down"]}
{"id": 42391620, "time": "2024-12-09 10:01:52", "headline": "Understanding Apple's Position In Technology Hardware, Storage &amp; Peripherals Industry Compared To Competitors", "summary": " ", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42391620/understanding-apples-position-in-technology-hardware-storage-amp-peripherals-industry-compared-to-c", "tags": []}
{"id": 42391583, "time": "2024-12-09 10:00:31", "headline": "USA Wholesale Inventories (MoM) For October 0.2% Vs 0.2% Est.; -0.2% Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42391583/usa-wholesale-inventories-mom-for-october-0-2-vs-0-2-est-0-2-prior-unchanged", "tags": []}
{"id": 42391599, "time": "2024-12-09 10:02:06", "headline": "USA CB Employment Trends Index For November 108.25; 107.66 Prior", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42391599/usa-cb-employment-trends-index-for-november-108-25-107-66-prior", "tags": []}
{"id": 42391629, "time": "2024-12-09 10:02:10", "headline": "What the Options Market Tells Us About Axon Enterprise", "summary": " ", "symbols": ["AXON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42391629/what-the-options-market-tells-us-about-axon-enterprise", "tags": []}
{"id": 42391601, "time": "2024-12-09 10:02:16", "headline": "Uncovering Potential: Skillsoft's Earnings Preview", "summary": " ", "symbols": ["SKIL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42391601/uncovering-potential-skillsofts-earnings-preview", "tags": ["earnings"]}
{"id": 42391603, "time": "2024-12-09 10:02:28", "headline": "Synchrony Finl Stock: A Deep Dive Into Analyst Perspectives (15 Ratings)", "summary": " ", "symbols": ["SYF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42391603/synchrony-finl-stock-a-deep-dive-into-analyst-perspectives-15-ratings", "tags": []}
{"id": 42391647, "time": "2024-12-09 10:02:34", "headline": "Honeywell Cockpit Technologies And Mechanical Systems Selected By Avianca For New Airbus A320neo Fleet", "summary": "", "symbols": ["EADSY", "HON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391647/honeywell-cockpit-technologies-and-mechanical-systems-selected-by-avianca-for-new-airbus-a320neo-fle", "tags": []}
{"id": 42391666, "time": "2024-12-09 10:02:36", "headline": "Expert Ratings For Phillips 66", "summary": " ", "symbols": ["PSX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42391666/expert-ratings-for-phillips-66", "tags": []}
{"id": 42391614, "time": "2024-12-09 10:02:41", "headline": "Smart Money Is Betting Big In COIN Options", "summary": " ", "symbols": ["COIN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42391614/smart-money-is-betting-big-in-coin-options", "tags": []}
{"id": 42391625, "time": "2024-12-09 10:03:06", "headline": "Preview: Vince Holding's Earnings", "summary": " ", "symbols": ["VNCE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42391625/preview-vince-holdings-earnings", "tags": ["earnings"]}
{"id": 42391627, "time": "2024-12-09 10:03:18", "headline": "Expert Ratings For CareTrust REIT", "summary": " ", "symbols": ["CTRE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42391627/expert-ratings-for-caretrust-reit", "tags": []}
{"id": 42391662, "time": "2024-12-09 10:03:22", "headline": "Wells Fargo Maintains Equal-Weight on BP, Lowers Price Target to $31", "summary": "", "symbols": ["BP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391662/wells-fargo-maintains-equal-weight-on-bp-lowers-price-target-to-31", "tags": ["analyst_other", "price_target_down"]}
{"id": 42391631, "time": "2024-12-09 10:03:30", "headline": "Industry Comparison: Evaluating Meta Platforms Against Competitors In Interactive Media &amp; Services Industry", "summary": " ", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42391631/industry-comparison-evaluating-meta-platforms-against-competitors-in-interactive-media-amp-services", "tags": []}
{"id": 42391636, "time": "2024-12-09 10:03:30", "headline": "Amazon.com Unusual Options Activity For December 09", "summary": " ", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42391636/amazon-com-unusual-options-activity-for-december-09", "tags": []}
{"id": 42391695, "time": "2024-12-09 10:03:40", "headline": "Myriad Genetics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)", "summary": " ", "symbols": ["MYGN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42391695/myriad-genetics-stock-a-deep-dive-into-analyst-perspectives-4-ratings", "tags": []}
{"id": 42391663, "time": "2024-12-09 10:03:49", "headline": "Exploring MIND Technology's Earnings Expectations", "summary": " ", "symbols": ["MIND"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42391663/exploring-mind-technologys-earnings-expectations", "tags": ["earnings"]}
{"id": 42391670, "time": "2024-12-09 10:04:07", "headline": "14 Analysts Have This To Say About Arcellx", "summary": " ", "symbols": ["ACLX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42391670/14-analysts-have-this-to-say-about-arcellx", "tags": []}
{"id": 42391673, "time": "2024-12-09 10:04:07", "headline": "Evaluating Amazon.com Against Peers In Broadline Retail Industry", "summary": " ", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42391673/evaluating-amazon-com-against-peers-in-broadline-retail-industry", "tags": []}
{"id": 42391692, "time": "2024-12-09 10:04:07", "headline": "What to Expect from Mama's Creations's Earnings", "summary": " ", "symbols": ["MAMA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42391692/what-to-expect-from-mamas-creationss-earnings", "tags": ["earnings"]}
{"id": 42391708, "time": "2024-12-09 10:04:07", "headline": "Tesla To $370? Here Are 10 Top Analyst Forecasts For Monday", "summary": " ", "symbols": ["BIOA", "BK", "CART", "CVNA", "HES", "ICE", "LUCD", "RH", "TSLA", "VRSN"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42391708/tesla-to-370-here-are-10-top-analyst-forecasts-for-monday", "tags": []}
{"id": 42391705, "time": "2024-12-09 10:04:18", "headline": "Demystifying Marathon Petroleum: Insights From 13 Analyst Reviews", "summary": " ", "symbols": ["MPC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42391705/demystifying-marathon-petroleum-insights-from-13-analyst-reviews", "tags": []}
{"id": 42391723, "time": "2024-12-09 10:04:30", "headline": "Peeling Back The Layers: Exploring Delek US Hldgs Through Analyst Insights", "summary": " ", "symbols": ["DK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42391723/peeling-back-the-layers-exploring-delek-us-hldgs-through-analyst-insights", "tags": []}
{"id": 42391738, "time": "2024-12-09 10:04:50", "headline": "Benzinga Market Summary: China Reportedly Signals Monetary Policy Easing, Assad Ousted, Oil Prices Gain, Nvidia Stock Falls On China Antitrust Probe", "summary": "", "symbols": ["FXI", "NVDA", "SPY", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42391738/benzinga-market-summary-china-reportedly-signals-monetary-policy-easing-assad-ous", "tags": []}
{"id": 42391740, "time": "2024-12-09 10:04:58", "headline": "A Preview Of ImmunoPrecise Antibodies's Earnings", "summary": " ", "symbols": ["IPA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42391740/a-preview-of-immunoprecise-antibodiess-earnings", "tags": ["earnings"]}
{"id": 42391713, "time": "2024-12-09 10:05:07", "headline": "Earnings Outlook For Sportsman's Warehouse", "summary": " ", "symbols": ["SPWH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42391713/earnings-outlook-for-sportsmans-warehouse", "tags": ["earnings", "guidance"]}
{"id": 42391736, "time": "2024-12-09 10:05:09", "headline": "Expert Outlook: General Motors Through The Eyes Of 14 Analysts", "summary": " ", "symbols": ["GM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42391736/expert-outlook-general-motors-through-the-eyes-of-14-analysts", "tags": ["guidance"]}
{"id": 42391784, "time": "2024-12-09 10:06:52", "headline": "Comcast Cable CEO Says Competition Remains Intense In The Fourth Quarter; Q4 Hurricanes Will Impact Around 10,000 Broadband Losses", "summary": "", "symbols": ["CMCSA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391784/comcast-cable-ceo-says-competition-remains-intense-in-the-fourth-quarter-q4-hurricanes-will-impact-a", "tags": ["management"]}
{"id": 42391793, "time": "2024-12-09 10:06:56", "headline": "Wells Fargo Maintains Overweight on Chevron, Raises Price Target to $188", "summary": "", "symbols": ["CVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391793/wells-fargo-maintains-overweight-on-chevron-raises-price-target-to-188", "tags": ["analyst_other", "price_target_up"]}
{"id": 42391840, "time": "2024-12-09 10:08:05", "headline": "Wells Fargo Maintains Overweight on Shell, Lowers Price Target to $87", "summary": "", "symbols": ["SHEL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391840/wells-fargo-maintains-overweight-on-shell-lowers-price-target-to-87", "tags": ["analyst_other", "price_target_down"]}
{"id": 42391900, "time": "2024-12-09 10:10:25", "headline": "Wells Fargo Maintains Equal-Weight on Canadian Natural Res, Raises Price Target to C$50", "summary": "", "symbols": ["TSX:CNQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391900/wells-fargo-maintains-equal-weight-on-canadian-natural-res-raises-price-target-to-c-50", "tags": ["analyst_other", "price_target_up"]}
{"id": 42391918, "time": "2024-12-09 10:11:22", "headline": "'Mondelez Exploring Takeover Of U.S. Chocolate Maker Hershey; Chicago-Based Mondelez Has Made A Preliminary Approach; Mondelez Walked Away From Potential Hershey Deal In 2016' - Bloomberg News", "summary": "", "symbols": ["HSY", "MDLZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42391918/mondelez-exploring-takeover-of-u-s-chocolate-maker-hershey-chicago-based-mondelez-has-made-a-prelimi", "tags": ["merger", "contract"]}
{"id": 42391924, "time": "2024-12-09 10:11:53", "headline": "Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement With Theramex, Granting Exclusive Commercialization Rights For ELADYNOS In Mexico, Canada, South Africa, Israel, And Russia, Along With Additional Unpartnered Regions; Radius To Receive Upfront And Milestone Payments Plus Tiered Royalties", "summary": "", "symbols": ["RDUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42391924/radius-pharmaceuticals-expands-abaloparatide-licensing-agreement-with-theramex-granting-exclusive-co", "tags": ["contract"]}
{"id": 42391936, "time": "2024-12-09 10:12:22", "headline": "LeddarTech Rockets As Texas Instruments Backs AI-Driven ADAS Tech With Royalty Deal", "summary": "LeddarTech shares soar on collaboration with Texas Instruments for ADAS and AD markets, including software license agreement and industry-leading features.", "symbols": ["LDTC", "TXN"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/contracts/24/12/42391936/leddartech-rockets-as-texas-instruments-backs-ai-driven-adas-tech-with-royalty-deal", "tags": ["contract"]}
{"id": 42392016, "time": "2024-12-09 10:13:23", "headline": "Stephens & Co. Reiterates Overweight on Wingstop, Maintains $468 Price Target", "summary": "", "symbols": ["WING"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392016/stephens-co-reiterates-overweight-on-wingstop-maintains-468-price-target", "tags": ["analyst_other"]}
{"id": 42392014, "time": "2024-12-09 10:13:25", "headline": "What's Stalling Tokenized Securities? The Infrastructure Hurdle", "summary": "SPBD licenses are crucial for bridging blockchain and traditional finance. Prometheum&#39;s infrastructure supports tokenized securities, paving the way for adoption.", "symbols": [], "source": "benzinga", "author": "Abbey Higginbotham", "url": "https://www.benzinga.com/24/12/42392014/special-purpose-broker-dealer-licenses-reshape-digital-asset-securities-market", "tags": []}
{"id": 42392021, "time": "2024-12-09 10:13:32", "headline": "Wells Fargo Maintains Overweight on ConocoPhillips, Raises Price Target to $134", "summary": "", "symbols": ["COP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392021/wells-fargo-maintains-overweight-on-conocophillips-raises-price-target-to-134", "tags": ["analyst_other", "price_target_up"]}
{"id": 42392066, "time": "2024-12-09 10:15:14", "headline": "Looking Into Sunoco's Recent Short Interest", "summary": " ", "symbols": ["SUN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42392066/looking-into-sunocos-recent-short-interest", "tags": []}
{"id": 42392070, "time": "2024-12-09 10:15:20", "headline": "Peering Into ON Semiconductor's Recent Short Interest", "summary": " ", "symbols": ["ON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42392070/peering-into-on-semiconductors-recent-short-interest", "tags": []}
{"id": 42392073, "time": "2024-12-09 10:15:25", "headline": "(CMCSA) - Analyzing Comcast's Short Interest", "summary": " ", "symbols": ["CMCSA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42392073/cmcsa-analyzing-comcasts-short-interest", "tags": []}
{"id": 42392185, "time": "2024-12-09 10:17:26", "headline": "Wells Fargo Maintains Equal-Weight on Murphy Oil, Lowers Price Target to $35", "summary": "", "symbols": ["MUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392185/wells-fargo-maintains-equal-weight-on-murphy-oil-lowers-price-target-to-35", "tags": ["analyst_other", "price_target_down"]}
{"id": 42392235, "time": "2024-12-09 10:18:37", "headline": "Wells Fargo Maintains Equal-Weight on Occidental Petroleum, Lowers Price Target to $53", "summary": "", "symbols": ["OXY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392235/wells-fargo-maintains-equal-weight-on-occidental-petroleum-lowers-price-target-to-53", "tags": ["analyst_other", "price_target_down"]}
{"id": 42392275, "time": "2024-12-09 10:19:37", "headline": "Why Universe Pharmaceuticals (UPC) Stock Is Down 58%", "summary": "Universe Pharmaceuticals shares are trading lower by 58% during Monday&#39;s session. The company announced a registered direct offering.", "symbols": ["UPC"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/12/42392275/why-universe-pharmaceuticals-upc-stock-is-down-58", "tags": ["why_moving", "offering"]}
{"id": 42392283, "time": "2024-12-09 10:19:56", "headline": "Freight Technologies Secures 2-Year Deal With Nestl\u00e9 Mexico To Optimize Supply Chain: Details", "summary": "Fr8App selected by Nestl\u00e9 Mexico for domestic logistics, driving surge in Freight Technologies (FRGT) shares. Partnership showcases technology-driven solutions in supply chain sector.", "symbols": ["FRGT"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/24/12/42392283/fr8techs-fr8app-chosen-by-nestle-mexico-to-optimize-domestic-logistics-operations", "tags": ["contract"]}
{"id": 42392306, "time": "2024-12-09 10:20:37", "headline": "HC Wainwright & Co. Reiterates Buy on Artelo Biosciences, Maintains $5 Price Target", "summary": "", "symbols": ["ARTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392306/hc-wainwright-co-reiterates-buy-on-artelo-biosciences-maintains-5-price-target", "tags": ["analyst_other"]}
{"id": 42392320, "time": "2024-12-09 10:20:49", "headline": "Wells Fargo Maintains Overweight on Suncor Energy, Lowers Price Target to C$64", "summary": "", "symbols": ["TSX:SU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392320/wells-fargo-maintains-overweight-on-suncor-energy-lowers-price-target-to-c-64", "tags": ["analyst_other", "price_target_down"]}
{"id": 42392469, "time": "2024-12-09 10:22:36", "headline": "Wells Fargo Maintains Overweight on Agilent Technologies, Lowers Price Target to $155", "summary": "", "symbols": ["A"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392469/wells-fargo-maintains-overweight-on-agilent-technologies-lowers-price-target-to-155", "tags": ["analyst_other", "price_target_down"]}
{"id": 42392517, "time": "2024-12-09 10:23:44", "headline": "Plug Power Awaits Hydrogen Tax Credit Decision: What's At Stake", "summary": "Treasury&#39;s final guidance on 45V Production Tax Credit could lift overhang on PLUG&#39;s stock, but restrictive guidelines may hinder US growth.", "symbols": ["PLUG"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42392517/plug-power-awaits-hydrogen-tax-credit-decision-whats-at-stake", "tags": ["guidance"]}
{"id": 42392523, "time": "2024-12-09 10:23:59", "headline": "Wells Fargo Maintains Equal-Weight on Diamondrock Hospitality, Raises Price Target to $10.5", "summary": "", "symbols": ["DRH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392523/wells-fargo-maintains-equal-weight-on-diamondrock-hospitality-raises-price-target-to-10-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 42392555, "time": "2024-12-09 10:26:09", "headline": "Omnicom Inks $13 Billion Deal For Interpublic: Will It Topple WPP As Top Ad Company?", "summary": "Omnicom Group and Interpublic Group are nearing a $13\u2013$14 billion merger to create the largest advertising company, reshaping the industry amidst AI challenges and competition.", "symbols": ["IPG", "OMC", "PGPEF", "PUBGY", "WPP"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/news/large-cap/24/12/42392555/third-largest-ad-firm-omnicoms-interpublic-multi-billion-dollar-deal-could-topple-wpp-as-top-ad-company-but-regulatory-scrutiny-expected", "tags": ["merger", "contract"]}
{"id": 42392557, "time": "2024-12-09 10:26:28", "headline": "Stifel Maintains Buy on HubSpot, Raises Price Target to $880", "summary": "", "symbols": ["HUBS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392557/stifel-maintains-buy-on-hubspot-raises-price-target-to-880", "tags": ["analyst_other", "price_target_up"]}
{"id": 42392567, "time": "2024-12-09 10:26:59", "headline": "Wells Fargo Maintains Overweight on Host Hotels & Resorts, Raises Price Target to $22", "summary": "", "symbols": ["HST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392567/wells-fargo-maintains-overweight-on-host-hotels-resorts-raises-price-target-to-22", "tags": ["analyst_other", "price_target_up"]}
{"id": 42392606, "time": "2024-12-09 10:27:48", "headline": "Wells Fargo Maintains Equal-Weight on Park Hotels & Resorts, Raises Price Target to $17", "summary": "", "symbols": ["PK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392606/wells-fargo-maintains-equal-weight-on-park-hotels-resorts-raises-price-target-to-17", "tags": ["analyst_other", "price_target_up"]}
{"id": 42392611, "time": "2024-12-09 10:28:43", "headline": "Equinor Wraps Up $2 Billion Asset Sale, Streamlining Global Oil And Gas Portfolio", "summary": "Equinor exits Azerbaijan and Nigeria, realizing up to $2 billion and aligning with their strategy to optimize their portfolio and sustain production.", "symbols": ["EQNR", "KEAT"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/12/42392611/equinor-boosts-cash-flow-with-2-billion-exit-from-azerbaijan-and-nigeria", "tags": []}
{"id": 42392610, "time": "2024-12-09 10:28:44", "headline": "Peter Schiff: Bitcoin Is A Threat To The US And 'Public Enemy Number One'", "summary": "Renowned Bitcoin critic  Peter Schiff has labelled Bitcoin (CRYPTO: BTC) as a greater threat to the U.S.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42392610/peter-schiff-bitcoin-is-a-threat-to-the-us-and-public-enemy-number-one", "tags": []}
{"id": 42392612, "time": "2024-12-09 10:28:46", "headline": "Wells Fargo Maintains Equal-Weight on Pebblebrook Hotel, Raises Price Target to $16", "summary": "", "symbols": ["PEB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392612/wells-fargo-maintains-equal-weight-on-pebblebrook-hotel-raises-price-target-to-16", "tags": ["analyst_other", "price_target_up"]}
{"id": 42392614, "time": "2024-12-09 10:28:47", "headline": "Toll Brothers Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call", "summary": " ", "symbols": ["TOL"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42392614/toll-brothers-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call", "tags": ["earnings"]}
{"id": 42392667, "time": "2024-12-09 10:29:56", "headline": "Stifel Maintains Hold on Jack In The Box, Lowers Price Target to $52", "summary": "", "symbols": ["JACK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392667/stifel-maintains-hold-on-jack-in-the-box-lowers-price-target-to-52", "tags": ["analyst_other", "price_target_down"]}
{"id": 42392668, "time": "2024-12-09 10:29:58", "headline": "'OpenAI's Sora Could Be Here This Week' - The Information", "summary": "", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392668/openais-sora-could-be-here-this-week-the-information", "tags": []}
{"id": 42392683, "time": "2024-12-09 10:30:14", "headline": "Wells Fargo Maintains Underweight on RLJ Lodging, Raises Price Target to $10.5", "summary": "", "symbols": ["RLJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392683/wells-fargo-maintains-underweight-on-rlj-lodging-raises-price-target-to-10-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 42392699, "time": "2024-12-09 10:31:10", "headline": "A Closer Look at Tesla's Options Market Dynamics", "summary": " ", "symbols": ["TSLA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42392699/a-closer-look-at-teslas-options-market-dynamics", "tags": []}
{"id": 42392700, "time": "2024-12-09 10:31:11", "headline": "Wells Fargo Maintains Overweight on Ryman Hospitality Props, Raises Price Target to $130", "summary": "", "symbols": ["RHP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392700/wells-fargo-maintains-overweight-on-ryman-hospitality-props-raises-price-target-to-130", "tags": ["analyst_other", "price_target_up"]}
{"id": 42392702, "time": "2024-12-09 10:31:16", "headline": "Unpacking the Latest Options Trading Trends in CrowdStrike Holdings", "summary": " ", "symbols": ["CRWD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42392702/unpacking-the-latest-options-trading-trends-in-crowdstrike-holdings", "tags": []}
{"id": 42392703, "time": "2024-12-09 10:31:16", "headline": "'SAP To Cut Around 3,500 Of Its 25,000 Jobs In Germany Via Early Retirement And Redundancies' - Handelsblatt", "summary": "", "symbols": ["SAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392703/sap-to-cut-around-3-500-of-its-25-000-jobs-in-germany-via-early-retirement-and-redundancies-handelsb", "tags": []}
{"id": 42392736, "time": "2024-12-09 10:32:05", "headline": "Wells Fargo Maintains Underweight on Service Properties Trust, Lowers Price Target to $2.75", "summary": "", "symbols": ["SVC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392736/wells-fargo-maintains-underweight-on-service-properties-trust-lowers-price-target-to-2-75", "tags": ["analyst_other", "price_target_down"]}
{"id": 42392804, "time": "2024-12-09 10:33:30", "headline": "Wells Fargo Maintains Equal-Weight on Sunstone Hotel Invts, Raises Price Target to $13", "summary": "", "symbols": ["SHO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392804/wells-fargo-maintains-equal-weight-on-sunstone-hotel-invts-raises-price-target-to-13", "tags": ["analyst_other", "price_target_up"]}
{"id": 42392809, "time": "2024-12-09 10:33:43", "headline": "Oracle, Vertiv And A Health Care Stock On CNBC's 'Final Trades'", "summary": "On CNBC&#39;s &#34;Halftime Report Final Trades,&#34; Jason Snipe of Odyssey Capital Advisors said Oracle is going to report a strong quarter.", "symbols": ["GSK", "ORCL", "VRT"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42392809/oracle-vertiv-and-a-health-care-stock-on-cnbcs-final-trades", "tags": []}
{"id": 42392846, "time": "2024-12-09 10:34:39", "headline": "Wells Fargo Maintains Overweight on Xenia Hotels & Resorts, Raises Price Target to $18", "summary": "", "symbols": ["XHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392846/wells-fargo-maintains-overweight-on-xenia-hotels-resorts-raises-price-target-to-18", "tags": ["analyst_other", "price_target_up"]}
{"id": 42392879, "time": "2024-12-09 10:36:28", "headline": "Stifel Maintains Buy on MongoDB, Raises Price Target to $360", "summary": "", "symbols": ["MDB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392879/stifel-maintains-buy-on-mongodb-raises-price-target-to-360", "tags": ["analyst_other", "price_target_up"]}
{"id": 42392882, "time": "2024-12-09 10:36:45", "headline": "Wells Fargo Maintains Overweight on Workday, Raises Price Target to $330", "summary": "", "symbols": ["WDAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392882/wells-fargo-maintains-overweight-on-workday-raises-price-target-to-330", "tags": ["analyst_other", "price_target_up"]}
{"id": 42392936, "time": "2024-12-09 10:39:43", "headline": "Stifel Reiterates Buy on RH, Raises Price Target to $420", "summary": "", "symbols": ["RH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392936/stifel-reiterates-buy-on-rh-raises-price-target-to-420", "tags": ["analyst_other", "price_target_up"]}
{"id": 42392942, "time": "2024-12-09 10:40:40", "headline": "Jim Cramer: Exxon Is 'Overvalued' Versus Rival Oil Giant, Avoid Lumen Technologies", "summary": "On CNBC&#39;s &#34;Mad Money Lightning Round,&#34; Jim Cramer said Exxon Mobil Corporation is &#34;overvalued&#34; versus Chevron.", "symbols": ["AIT", "APLD", "BLK", "CVX", "LUMN", "LYB", "ON", "XOM"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42392942/jim-cramer-this-oil-giant-is-overvalued-versus-chevron-recommends-avoiding-lumen-technologies", "tags": []}
{"id": 42392953, "time": "2024-12-09 10:41:40", "headline": "Dow Partners With Macquarie In Gulf Coast Infrastructure Play, Retains Strategic Control", "summary": "Dow to sell 40% stake in U.S. Gulf Coast infrastructure assets to Macquarie Asset Management. Partnership aims for profitable growth through specialized infrastructure provider.", "symbols": ["DOGG", "DOW", "XLB"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/12/42392953/dow-sells-40-stake-in-gulf-coast-assets-eyes-up-to-3b-in-proceeds", "tags": ["contract"]}
{"id": 42392963, "time": "2024-12-09 10:42:01", "headline": "Scotiabank Maintains Sector Outperform on Agios Pharmaceuticals, Raises Price Target to $75", "summary": "", "symbols": ["AGIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42392963/scotiabank-maintains-sector-outperform-on-agios-pharmaceuticals-raises-price-target-to-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 42393008, "time": "2024-12-09 10:44:45", "headline": "Volato Group Files FormRW; The Registrant Confirms That The Registration Statement Has Not Been Declared Effective And That No Securities Have Been Sold Thereunder.", "summary": "", "symbols": ["SOAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393008/volato-group-files-formrw-the-registrant-confirms-that-the-registration-statement-has-not-been-decla", "tags": []}
{"id": 42393009, "time": "2024-12-09 10:44:55", "headline": "Scotiabank Maintains Sector Perform on BRP, Lowers Price Target to C$86", "summary": "", "symbols": ["TSX:DOO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393009/scotiabank-maintains-sector-perform-on-brp-lowers-price-target-to-c-86", "tags": ["analyst_other", "price_target_down"]}
{"id": 42393038, "time": "2024-12-09 10:47:19", "headline": "Scotiabank Maintains Sector Perform on Laurentian Bank of Canada, Raises Price Target to C$33", "summary": "", "symbols": ["TSX:LB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393038/scotiabank-maintains-sector-perform-on-laurentian-bank-of-canada-raises-price-target-to-c-33", "tags": ["analyst_other", "price_target_up"]}
{"id": 42388581, "time": "2024-12-09 08:19:40", "headline": "Arcellx shares are trading higher after the company announced its cancer cell therapy showed a deep durable response with the management safety profile in heavily pretreated blood cancer patients.", "summary": "", "symbols": ["ACLX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/12/42388581/arcellx-shares-are-trading-higher-after-the-company-announced-its-cancer-cell-therapy-showed-a-deep", "tags": ["why_moving"]}
{"id": 42388184, "time": "2024-12-09 08:10:02", "headline": "Olema Pharmaceuticals shares are trading higher after the company announced the FDA cleared the investigational new drug (IND) application for OP-3136.", "summary": "", "symbols": ["OLMA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/12/42388184/olema-pharmaceuticals-shares-are-trading-higher-after-the-company-announced-the-fda-cleared-the-inve", "tags": ["why_moving", "fda"]}
{"id": 42387621, "time": "2024-12-09 07:57:16", "headline": "Reddit shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $70 to $200.", "summary": "", "symbols": ["RDDT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/12/42387621/reddit-shares-are-trading-higher-after-morgan-stanley-upgraded-the-stock-from-equal-weight-to-overwe", "tags": ["analyst_up", "why_moving"]}
{"id": 42387610, "time": "2024-12-09 07:56:23", "headline": "MEDIROM shares are trading higher after its subsidiary announced it received over 25,000 MOTHER bracelet unit orders.", "summary": "", "symbols": ["MRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/12/42387610/medirom-shares-are-trading-higher-after-its-subsidiary-announced-it-received-over-25-000-mother-brac", "tags": ["why_moving"]}
{"id": 42386876, "time": "2024-12-09 07:26:29", "headline": "Palantir shares are trading higher after the company announced an expanded $36.8 million contract with the U.S. Special Operations Command.", "summary": "", "symbols": ["PLTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/12/42386876/palantir-shares-are-trading-higher-after-the-company-announced-an-expanded-36-8-million-contract-wit", "tags": ["why_moving", "contract"]}
{"id": 42393103, "time": "2024-12-09 10:49:32", "headline": "Scotiabank Maintains Sector Outperform on Snowflake, Raises Price Target to $220", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393103/scotiabank-maintains-sector-outperform-on-snowflake-raises-price-target-to-220", "tags": ["analyst_other", "price_target_up"]}
{"id": 42393128, "time": "2024-12-09 10:50:51", "headline": "Merck Reveals Mixed Data From Keytruda/Lynparza Regime In Ovarian Cancer", "summary": "Merck&#39;s ovarian cancer trial met its primary endpoint, while lymphoma trial data set the Phase 3 dose for zilovertamab vedotin at 1.75 mg/kg.", "symbols": ["MRK"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/24/12/42393128/merck-reveals-mixed-data-from-keytrudalynparza-regime-in-ovarian-cancer", "tags": ["fda"]}
{"id": 42393124, "time": "2024-12-09 10:50:54", "headline": "Talkspace Transitions To Payor Network, Bolsters Revenue: Analyst", "summary": "Talkspace is expected to generate revenue growth and margin expansion. Analyst rates TALK as Overweight with $4.50 target.", "symbols": ["AMZN", "TALK"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/24/12/42393124/talkspaces-transition-to-payor-network-supports-revenue-growth-margin-expansion-says-bullish-analyst", "tags": ["earnings"]}
{"id": 42393207, "time": "2024-12-09 10:51:55", "headline": "Truist Securities Maintains Hold on GMS, Raises Price Target to $97", "summary": "", "symbols": ["GMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393207/truist-securities-maintains-hold-on-gms-raises-price-target-to-97", "tags": ["analyst_other", "price_target_up"]}
{"id": 42393302, "time": "2024-12-09 10:53:37", "headline": "Scotiabank Maintains Sector Outperform on WEC Energy Group, Raises Price Target to $110", "summary": "", "symbols": ["WEC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393302/scotiabank-maintains-sector-outperform-on-wec-energy-group-raises-price-target-to-110", "tags": ["analyst_other", "price_target_up"]}
{"id": 42393317, "time": "2024-12-09 10:55:00", "headline": "Truist Securities Maintains Buy on REX American Resources, Lowers Price Target to $55", "summary": "", "symbols": ["REX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393317/truist-securities-maintains-buy-on-rex-american-resources-lowers-price-target-to-55", "tags": ["analyst_other", "price_target_down"]}
{"id": 42393319, "time": "2024-12-09 10:55:18", "headline": "Asset Entities Shares Halted To The Upside; Stock Now Up 115.26%", "summary": "", "symbols": ["ASST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42393319/asset-entities-shares-halted-to-the-upside-stock-now-up-115-26", "tags": ["halt"]}
{"id": 42393331, "time": "2024-12-09 10:56:05", "headline": "Stock Of The Day: Is Amazon's Run Setting Up For A Cooldown?", "summary": "Shares of Amazon.com (AMZN) been an important contributor to the market&#39;s recent strength. But now they are overbought and may reverse.", "symbols": ["AMZN", "TSLA"], "source": "benzinga", "author": "Mark Putrino", "url": "https://www.benzinga.com/24/12/42393331/stock-of-the-day-will-amazon-take-the-market-lower", "tags": []}
{"id": 42393396, "time": "2024-12-09 10:57:52", "headline": "Record Week: Bitcoin ETFs Net $2.5 Billion In Inflows, Ethereum ETFs Took In $1.2 Billion", "summary": "Digital asset investment products saw their highest-ever weekly inflows last week, totaling $3.85 billion, smashing the prior record set just weeks ago.", "symbols": ["BTCUSD", "ETHUSD", "SOLUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42393396/record-week-bitcoin-etfs-net-25-billion-in-inflows-ethereum-etfs-took-in-12-billion", "tags": []}
{"id": 42393451, "time": "2024-12-09 11:00:34", "headline": "In-Depth Examination Of 6 Analyst Recommendations For Redwood Trust", "summary": " ", "symbols": ["RWT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42393451/in-depth-examination-of-6-analyst-recommendations-for-redwood-trust", "tags": []}
{"id": 42393452, "time": "2024-12-09 11:00:42", "headline": "Demystifying Lululemon Athletica: Insights From 20 Analyst Reviews", "summary": " ", "symbols": ["LULU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42393452/demystifying-lululemon-athletica-insights-from-20-analyst-reviews", "tags": []}
{"id": 42393458, "time": "2024-12-09 11:00:52", "headline": "The Latest Analyst Ratings For Pebblebrook Hotel", "summary": " ", "symbols": ["PEB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42393458/the-latest-analyst-ratings-for-pebblebrook-hotel", "tags": []}
{"id": 42393459, "time": "2024-12-09 11:00:53", "headline": "Reported Earlier: Tata-Owned Air India Confirms Order For 10 A350s And 90 A320 Aircraft, Expanding Total Airbus Orderbook To 344", "summary": "", "symbols": ["EADSY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393459/reported-earlier-tata-owned-air-india-confirms-order-for-10-a350s-and-90-a320-aircraft-expanding-tot", "tags": []}
{"id": 42393468, "time": "2024-12-09 11:01:01", "headline": "20 Analysts Have This To Say About Blackstone", "summary": " ", "symbols": ["BX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42393468/20-analysts-have-this-to-say-about-blackstone", "tags": []}
{"id": 42393487, "time": "2024-12-09 11:01:09", "headline": "In-Depth Examination Of 4 Analyst Recommendations For Apple Hospitality REIT", "summary": " ", "symbols": ["APLE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42393487/in-depth-examination-of-4-analyst-recommendations-for-apple-hospitality-reit", "tags": []}
{"id": 42393504, "time": "2024-12-09 11:01:17", "headline": "4 Analysts Assess Diamondrock Hospitality: What You Need To Know", "summary": " ", "symbols": ["DRH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42393504/4-analysts-assess-diamondrock-hospitality-what-you-need-to-know", "tags": []}
{"id": 42393514, "time": "2024-12-09 11:01:39", "headline": "JMP Securities Reiterates Market Perform on Ares Comml Real Estto Market Perform", "summary": "", "symbols": ["ACRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393514/jmp-securities-reiterates-market-perform-on-ares-comml-real-estto-market-perform", "tags": ["analyst_other"]}
{"id": 42393528, "time": "2024-12-09 11:02:20", "headline": "VEON Launches Initial $30M Phase Of $100M Share Buyback Program For American Depositary Shares", "summary": "", "symbols": ["VEON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393528/veon-launches-initial-30m-phase-of-100m-share-buyback-program-for-american-depositary-shares", "tags": ["buyback"]}
{"id": 42393610, "time": "2024-12-09 11:03:16", "headline": "New York Fed Survey Shows Year-Ahead Expected Inflation In November At 3% Vs 2.9% In October; November 3-Year Ahead Expected Inflation At 2.6% Vs 2.5% In October; November 5-Year Ahead Expected Inflation At 2.9% Vs 2.8% In October", "summary": "", "symbols": ["SPY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42393610/new-york-fed-survey-shows-year-ahead-expected-inflation-in-november-at-3-vs-2-9-i", "tags": []}
{"id": 42393639, "time": "2024-12-09 11:04:19", "headline": "JMP Securities Reiterates Market Outperform on Blueprint Medicines, Maintains $125 Price Target", "summary": "", "symbols": ["BPMC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393639/jmp-securities-reiterates-market-outperform-on-blueprint-medicines-maintains-125-price-target", "tags": ["analyst_other"]}
{"id": 42393683, "time": "2024-12-09 11:06:02", "headline": "Boeing To Layoff 396 Workers At Various Locations In Washington From Feb 21", "summary": "", "symbols": ["BA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393683/boeing-to-layoff-396-workers-at-various-locations-in-washington-from-feb-21", "tags": []}
{"id": 42393702, "time": "2024-12-09 11:07:35", "headline": "Chinese Antitrust Investigation Into Nvidia 'All Speculative': Tech Expert", "summary": "Tech experts seemed to downplay Chinese regulators&#39; investigation into\u00a0Nvidia over an alleged breach of antitrust regulations.", "symbols": ["NVDA"], "source": "benzinga", "author": "Hayden Buckfire", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42393702/chinese-antitrust-investigation-into-nvidia-all-speculative-tech-expert", "tags": ["legal"]}
{"id": 42393755, "time": "2024-12-09 11:10:25", "headline": "D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $6 Price Target", "summary": "", "symbols": ["ARTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393755/d-boral-capital-maintains-buy-on-artelo-biosciences-maintains-6-price-target", "tags": ["analyst_other"]}
{"id": 42393770, "time": "2024-12-09 11:10:56", "headline": "Beam Therapeutics Unveils New Safety, Efficacy Data From Sickle Cell Disease Candidate, Stock Gains", "summary": "Beam Therapeutics unveiled BEAM-101 trial data at ASH, showing improved outcomes in sickle cell patients and promising preclinical BEAM-103 results.", "symbols": ["BEAM"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/12/42393770/beam-therapeutics-unveils-new-safety-efficacy-data-from-sickle-cell-disease-candidate-stock-gains", "tags": ["fda"]}
{"id": 42393771, "time": "2024-12-09 11:11:00", "headline": "JMP Securities Reiterates Market Outperform on Charles Schwab, Raises Price Target to $94", "summary": "", "symbols": ["SCHW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393771/jmp-securities-reiterates-market-outperform-on-charles-schwab-raises-price-target-to-94", "tags": ["analyst_other", "price_target_up"]}
{"id": 42393827, "time": "2024-12-09 11:13:54", "headline": "85% Of Cannabis Companies Report Positive Earnings, But Not All Are Winning - See Who's Leading", "summary": "85% of the companies analyzed by Beacon Securities achieved positive adjusted EBITDA for the quarter, an increase from 81% in Q2.\u00a0", "symbols": ["GLASF", "GRUSF", "GTBIF", "PLNH", "TCNNF", "VEXTF"], "source": "benzinga", "author": "Nicol\u00e1s Jose Rodriguez", "url": "https://www.benzinga.com/general/market-summary/24/12/42393827/85-of-cannabis-companies-report-positive-earnings-but-not-all-are-winning-see-whos-leading", "tags": ["earnings"]}
{"id": 42393831, "time": "2024-12-09 11:14:18", "headline": "Keefe, Bruyette & Woods Upgrades Equitable Hldgs to Outperform, Raises Price Target to $58", "summary": "", "symbols": ["EQH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393831/keefe-bruyette-woods-upgrades-equitable-hldgs-to-outperform-raises-price-target-to-58", "tags": ["analyst_up", "price_target_up"]}
{"id": 42393834, "time": "2024-12-09 11:14:21", "headline": "JMP Securities Reiterates Market Outperform on Terreno Realty, Maintains $72 Price Target", "summary": "", "symbols": ["TRNO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393834/jmp-securities-reiterates-market-outperform-on-terreno-realty-maintains-72-price-target", "tags": ["analyst_other"]}
{"id": 42393859, "time": "2024-12-09 11:15:18", "headline": "Price Over Earnings Overview: Hormel Foods", "summary": " ", "symbols": ["HRL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42393859/price-over-earnings-overview-hormel-foods", "tags": ["earnings"]}
{"id": 42393880, "time": "2024-12-09 11:16:30", "headline": "Taylor Swift's Record-Breaking Eras Tour Wraps: A Look At The Numbers", "summary": "Taylor Swift&#39;s record-breaking Eras Tour came to an end Sunday night with its final show in Vancouver, Canada. Here&#39;s a look back at the most profitable concert tour in history.\u00a0", "symbols": ["LYFT", "TGT"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/general/entertainment/24/12/42393880/taylor-swifts-record-breaking-eras-tour-wraps-a-look-at-the-numbers", "tags": []}
{"id": 42393882, "time": "2024-12-09 11:16:39", "headline": "AbbVie's Early Parkinson's Candidate Hits Primary Goal In Pivotal Late-Stage Study", "summary": "AbbVie reports Phase 3 TEMPO-2 trial success for tavapadon, a once-daily Parkinson&#39;s treatment, showing significant symptom improvement and safety.", "symbols": ["ABBV"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/24/12/42393882/abbvies-early-parkinsons-candidate-hits-primary-goal-in-pivotal-late-stage-study", "tags": ["fda"]}
{"id": 42393893, "time": "2024-12-09 11:17:00", "headline": "JMP Securities Reiterates Market Outperform on Vertex, Maintains $61 Price Target", "summary": "", "symbols": ["VERX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393893/jmp-securities-reiterates-market-outperform-on-vertex-maintains-61-price-target", "tags": ["analyst_other"]}
{"id": 42393900, "time": "2024-12-09 11:17:11", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Ally Financial, Raises Price Target to $56", "summary": "", "symbols": ["ALLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393900/keefe-bruyette-woods-maintains-outperform-on-ally-financial-raises-price-target-to-56", "tags": ["analyst_other", "price_target_up"]}
{"id": 42393949, "time": "2024-12-09 11:18:11", "headline": "D. Boral Capital Maintains Buy on CARISMA Therapeutics, Lowers Price Target to $12", "summary": "", "symbols": ["CARM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393949/d-boral-capital-maintains-buy-on-carisma-therapeutics-lowers-price-target-to-12", "tags": ["analyst_other", "price_target_down"]}
{"id": 42393963, "time": "2024-12-09 11:19:11", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on AvidXchange Holdings, Raises Price Target to $12", "summary": "", "symbols": ["AVDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42393963/keefe-bruyette-woods-maintains-market-perform-on-avidxchange-holdings-raises-price-target-to-12", "tags": ["analyst_other", "price_target_up"]}
{"id": 42394030, "time": "2024-12-09 11:21:23", "headline": "Keefe, Bruyette & Woods Maintains Outperform on American Express, Raises Price Target to $350", "summary": "", "symbols": ["AXP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394030/keefe-bruyette-woods-maintains-outperform-on-american-express-raises-price-target-to-350", "tags": ["analyst_other", "price_target_up"]}
{"id": 42394033, "time": "2024-12-09 11:21:35", "headline": "Sexual Health: Psychedelics Found To Enhance Function In Imperial College Study", "summary": "A new study shows psilocybin may improve sexual function for months, offering potential benefits for sexual health and depression.", "symbols": [], "source": "benzinga", "author": "Juan Sp\u00ednelli", "url": "https://www.benzinga.com/24/12/42394033/first-study-to-explore-psychedelics-and-sexual-health-shows-promising-results", "tags": ["offering"]}
{"id": 42394045, "time": "2024-12-09 11:22:17", "headline": "Nasdaq Down Over 100 Points; US Wholesale Inventories Rise By 0.2%", "summary": " ", "symbols": ["ASST", "BIOA", "DUO", "LDTC", "RADX", "UPC"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42394045/nasdaq-down-over-100-points-us-wholesale-inventories-rise-by-0-2", "tags": []}
{"id": 42394117, "time": "2024-12-09 11:24:37", "headline": "RBC Capital Reiterates Outperform on Enghouse Systems, Maintains C$43 Price Target", "summary": "", "symbols": ["TSX:ENGH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394117/rbc-capital-reiterates-outperform-on-enghouse-systems-maintains-c-43-price-target", "tags": ["analyst_other"]}
{"id": 42394144, "time": "2024-12-09 11:27:53", "headline": "RBC Capital Reiterates Outperform on BRP, Maintains C$99 Price Target", "summary": "", "symbols": ["TSX:DOO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394144/rbc-capital-reiterates-outperform-on-brp-maintains-c-99-price-target", "tags": ["analyst_other"]}
{"id": 42394186, "time": "2024-12-09 11:30:29", "headline": "War On Drugs 'Has Failed, Completely And Utterly': UN High Commissioner Urges Evidence-Based Solutions", "summary": "UN calls for evidence-based, human rights-focused approach to drug policies, declaring the failed war on drugs needs to be abandoned. Urges transformative change and adoption of International Guidelines on Human Rights and Drug Policy.", "symbols": ["EBS"], "source": "benzinga", "author": "Maureen Meehan", "url": "https://www.benzinga.com/news/global/24/12/42394186/war-on-drugs-has-failed-completely-and-utterly-un-high-commissioner-urges-evidence-based-solutions", "tags": []}
{"id": 42394187, "time": "2024-12-09 11:30:33", "headline": "Why Trip.com (TCOM) Stock Is Trading Higher", "summary": "Trip.com shares are trading higher by 9.3% during Monday&#39;s session. Several Chinese stocks are trading higher following reports suggesting Chinese officials would embrace a &#39;moderately loose&#39; monetary policy.", "symbols": ["TCOM"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/12/42394187/why-tripcom-tcom-stock-is-trading-higher", "tags": ["why_moving"]}
{"id": 42394303, "time": "2024-12-09 11:31:10", "headline": "$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["COR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42394303/100-invested-in-cencora-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 42394306, "time": "2024-12-09 11:31:15", "headline": "$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["ORCL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42394306/1000-invested-in-this-stock-20-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 42394325, "time": "2024-12-09 11:31:27", "headline": "Spotlight on Asana: Analyzing the Surge in Options Activity", "summary": " ", "symbols": ["ASAN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42394325/spotlight-on-asana-analyzing-the-surge-in-options-activity", "tags": []}
{"id": 42394331, "time": "2024-12-09 11:31:45", "headline": "RBC Capital Maintains Sector Perform on Bank of Montreal, Raises Price Target to C$133", "summary": "", "symbols": ["TSX:BMO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394331/rbc-capital-maintains-sector-perform-on-bank-of-montreal-raises-price-target-to-c-133", "tags": ["analyst_other", "price_target_up"]}
{"id": 42394376, "time": "2024-12-09 11:33:04", "headline": "What's Going On With Riot Platforms Shares Monday?", "summary": "Riot Platforms, Inc. (NASDAQ:RIOT) stock is trading lower on Monday after the company announced a $500 million convertible senior notes offering. Here\u2019s what you need to know.", "symbols": ["BTCUSD", "RIOT"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42394376/whats-going-on-with-riot-platforms-shares-monday", "tags": ["why_moving", "offering"]}
{"id": 42394402, "time": "2024-12-09 11:34:52", "headline": "Why Bilibili Shares Are Exploding Higher", "summary": "Bilibili shares are trading higher by 19.4% during Monday&#39;s session. Several Chinese stocks are trading higher following reports suggesting Chinese officials would embrace a &#39;moderately loose&#39; monetary policy.", "symbols": ["BILI"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/12/42394402/why-bilibili-shares-are-exploding-higher", "tags": ["why_moving"]}
{"id": 42394417, "time": "2024-12-09 11:36:00", "headline": "'Jeep Maker Stellantis Shakes Up North American Executive Ranks; Moves Come After Recent Departure Of The CEO;  Changes Include The Return Of Company Veteran Timothy Kuniskis, Who Retired Under Tavares' Tenure In June, To Run Stellantis's Ram Truck Brand' - WSJ", "summary": "", "symbols": ["STLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394417/jeep-maker-stellantis-shakes-up-north-american-executive-ranks-moves-come-after-recent-departure-of", "tags": ["management"]}
{"id": 42394418, "time": "2024-12-09 11:36:11", "headline": "RBC Capital Maintains Sector Perform on Canadian Imperial Bank, Raises Price Target to C$97", "summary": "", "symbols": ["TSX:CM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394418/rbc-capital-maintains-sector-perform-on-canadian-imperial-bank-raises-price-target-to-c-97", "tags": ["analyst_other", "price_target_up"]}
{"id": 42394421, "time": "2024-12-09 11:37:16", "headline": "Canaccord Genuity Initiates Coverage On Western Copper & Gold with Speculative Buy Rating", "summary": "", "symbols": ["TSX:WRN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394421/canaccord-genuity-initiates-coverage-on-western-copper-gold-with-speculative-buy-rating", "tags": ["analyst_init"]}
{"id": 42394425, "time": "2024-12-09 11:37:47", "headline": "Why Shell Stock Is Rising", "summary": "Shell stock is trading higher by 3.6% during Monday&#39;s session. The stock is higher due to optimism surrounding China&#39;s economic stimulus plans.", "symbols": ["SHEL", "XLE"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/12/42394425/why-shell-stock-is-rising", "tags": []}
{"id": 42394441, "time": "2024-12-09 11:38:06", "headline": "Mullen Automotive's Bollinger Motors Expands Midwest Reach With Broadway Ford Truck Center Dealership", "summary": "Bollinger Motors, a subsidiary of Mullen Automotive, appoints Broadway Ford Truck Center as official dealer for B4 Chassis Cab in Midwest.", "symbols": ["MULN"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/small-cap/24/12/42394441/mullen-automotives-bollinger-motors-expands-midwest-reach-with-broadway-ford-truck-center-dealership", "tags": ["management"]}
{"id": 42394470, "time": "2024-12-09 11:39:18", "headline": "What's Going On With Quantum Computing Shares Monday?", "summary": "Quantum Computing shares are trading lower following new comments on the stock from Iceberg Research.", "symbols": ["QUBT"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42394470/whats-going-on-with-quantum-computing-shares-monday", "tags": ["why_moving"]}
{"id": 42394489, "time": "2024-12-09 11:40:17", "headline": "Canaccord Genuity Maintains Buy on AtriCure, Raises Price Target to $61", "summary": "", "symbols": ["ATRC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394489/canaccord-genuity-maintains-buy-on-atricure-raises-price-target-to-61", "tags": ["analyst_other", "price_target_up"]}
{"id": 42394493, "time": "2024-12-09 11:40:39", "headline": "Watching Unusual Machines; Shares Move Higher Amid Traders Circulating China Is Cutting Off Drone Supplies Critical To Ukraine War", "summary": "", "symbols": ["UMAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394493/watching-unusual-machines-shares-move-higher-amid-traders-circulating-china-is-cutting-off-drone-sup", "tags": []}
{"id": 42394506, "time": "2024-12-09 11:41:03", "headline": "SoundHound AI Shares Are Falling: What's Going On?", "summary": "SoundHound AI stock is trading lower by 6.8% during Monday&#39;s session. The stock is lower potentially due to profit-taking and cooling off after an extraordinary year-to-date rally of over 500%.", "symbols": ["SOUN"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/12/42394506/soundhound-ai-shares-are-falling-whats-going-on", "tags": ["why_moving"]}
{"id": 42394508, "time": "2024-12-09 11:41:09", "headline": "BLM Issues Decision For Coastal Plain Oil And Gas Leasing Program In Arctic National Wildlife Refuge, Announcing January 2025 Sale Of 400,000 Acres With Protections For Wildlife Habitats; Fulfills 2017 Tax Act Requirements While Balancing Conservation Goals", "summary": "", "symbols": ["SPY", "UNG", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394508/blm-issues-decision-for-coastal-plain-oil-and-gas-leasing-program-in-arctic-national-wildlife-refuge", "tags": []}
{"id": 42394518, "time": "2024-12-09 11:41:41", "headline": "'China Is Cutting Off Drone Supplies Critical To Ukraine War Effort; Equipment Squeeze Follows Sanctions On Us Military Contractors; Beijing Expected To Set Tighter Drone Curbs As Soon As January' - Bloomberg", "summary": "", "symbols": ["FXI", "SPY", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42394518/china-is-cutting-off-drone-supplies-critical-to-ukraine-war-effort-equipment-sque", "tags": []}
{"id": 42394519, "time": "2024-12-09 11:42:13", "headline": "RBC Capital Maintains Outperform on George Weston, Raises Price Target to C$266", "summary": "", "symbols": ["TSX:WN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394519/rbc-capital-maintains-outperform-on-george-weston-raises-price-target-to-c-266", "tags": ["analyst_other", "price_target_up"]}
{"id": 42394593, "time": "2024-12-09 11:45:06", "headline": "Canaccord Genuity Maintains Buy on Boston Scientific, Raises Price Target to $101", "summary": "", "symbols": ["BSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394593/canaccord-genuity-maintains-buy-on-boston-scientific-raises-price-target-to-101", "tags": ["analyst_other", "price_target_up"]}
{"id": 42394595, "time": "2024-12-09 11:45:11", "headline": "P/E Ratio Insights for Gartner", "summary": " ", "symbols": ["IT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42394595/pe-ratio-insights-for-gartner", "tags": []}
{"id": 42394620, "time": "2024-12-09 11:45:29", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Bread Finl Hldgs, Raises Price Target to $88", "summary": "", "symbols": ["BFH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394620/keefe-bruyette-woods-maintains-outperform-on-bread-finl-hldgs-raises-price-target-to-88", "tags": ["analyst_other", "price_target_up"]}
{"id": 42394651, "time": "2024-12-09 11:46:12", "headline": "RBC Capital Reiterates Outperform on Loblaw Cos, Raises Price Target to C$217", "summary": "", "symbols": ["TSX:L"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394651/rbc-capital-reiterates-outperform-on-loblaw-cos-raises-price-target-to-c-217", "tags": ["analyst_other", "price_target_up"]}
{"id": 42394680, "time": "2024-12-09 11:47:43", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on BILL Holdings, Raises Price Target to $100", "summary": "", "symbols": ["BILL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394680/keefe-bruyette-woods-maintains-market-perform-on-bill-holdings-raises-price-target-to-100", "tags": ["analyst_other", "price_target_up"]}
{"id": 42394681, "time": "2024-12-09 11:47:46", "headline": "Canaccord Genuity Maintains Buy on CeriBell, Raises Price Target to $33", "summary": "", "symbols": ["CBLL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394681/canaccord-genuity-maintains-buy-on-ceribell-raises-price-target-to-33", "tags": ["analyst_other", "price_target_up"]}
{"id": 42394749, "time": "2024-12-09 11:51:11", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Capital One Finl, Raises Price Target to $232", "summary": "", "symbols": ["COF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394749/keefe-bruyette-woods-maintains-outperform-on-capital-one-finl-raises-price-target-to-232", "tags": ["analyst_other", "price_target_up"]}
{"id": 42394839, "time": "2024-12-09 11:53:09", "headline": "RBC Capital Reiterates Outperform on Spin Master, Maintains C$43 Price Target", "summary": "", "symbols": ["TSX:TOY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394839/rbc-capital-reiterates-outperform-on-spin-master-maintains-c-43-price-target", "tags": ["analyst_other"]}
{"id": 42394844, "time": "2024-12-09 11:53:33", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Corpay, Raises Price Target to $425", "summary": "", "symbols": ["CPAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394844/keefe-bruyette-woods-maintains-outperform-on-corpay-raises-price-target-to-425", "tags": ["analyst_other", "price_target_up"]}
{"id": 42394872, "time": "2024-12-09 11:54:47", "headline": "Jack Ma Makes Rare Appearance At Alibaba Fintech Event Stresses On AI Revolution", "summary": "Jack Ma Returns to Ant Group&#39;s 20th Anniversary Celebration After Three Years\nJack Ma made his first public appearance at Ant Group&#39;s 20th anniversary event, marking his return after the 2020 IPO setback. He expressed optimism about the future of Ant Group, which is pushing forward with AI innovations and strong global growth. Ant&#39;s mobile payment platform, Alipay+, now links 90 million merchants in 66 markets, with a threefold increase in cross-border transactions in 2024.", "symbols": ["BABA"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/24/12/42394872/jack-ma-makes-rare-appearance-at-alibaba-fintech-event-stresses-on-ai-revolution", "tags": []}
{"id": 42394907, "time": "2024-12-09 11:56:29", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Discover Finl, Raises Price Target to $232", "summary": "", "symbols": ["DFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394907/keefe-bruyette-woods-maintains-outperform-on-discover-finl-raises-price-target-to-232", "tags": ["analyst_other", "price_target_up"]}
{"id": 42394913, "time": "2024-12-09 11:57:01", "headline": "Bitcoin Saw 'Historic Rally' In November Thanks To Trump Win, Says JPMorgan", "summary": "November delivered record-breaking performance across the cryptocurrency market, fueled by political developments and surging investor sentiment, according to a JPMorgan research report released Monday.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42394913/bitcoin-saw-historic-rally-in-november-thanks-to-trump-win-says-jpmorgan", "tags": []}
{"id": 42394944, "time": "2024-12-09 11:58:00", "headline": "Roadzen Announces A Leading LNG Supplier In India Will Outfit Its Entire Truck Fleet With Roadzen's DrivebuddyAI; 5-Years Contract For More Than 500 Vehicles, Is Expected To Deliver Over Seven Figures In Revenue Over The Term", "summary": "", "symbols": ["RDZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394944/roadzen-announces-a-leading-lng-supplier-in-india-will-outfit-its-entire-truck-fleet-with-roadzens-d", "tags": ["earnings", "contract"]}
{"id": 42394963, "time": "2024-12-09 11:58:39", "headline": "Alliance Global Partners Initiates Coverage On vTv Therapeutics with Buy Rating, Announces Price Target of $35", "summary": "", "symbols": ["VTVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394963/alliance-global-partners-initiates-coverage-on-vtv-therapeutics-with-buy-rating-announces-price-targ", "tags": ["analyst_init"]}
{"id": 42394965, "time": "2024-12-09 11:58:49", "headline": "Zentek Regains Nasdaq Minimum Bid Price Compliance", "summary": "", "symbols": ["TSXV:ZEN", "ZTEK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394965/zentek-regains-nasdaq-minimum-bid-price-compliance", "tags": []}
{"id": 42394969, "time": "2024-12-09 11:59:14", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Fiserv, Raises Price Target to $238", "summary": "", "symbols": ["FI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42394969/keefe-bruyette-woods-maintains-outperform-on-fiserv-raises-price-target-to-238", "tags": ["analyst_other", "price_target_up"]}
{"id": 42394997, "time": "2024-12-09 12:00:06", "headline": "Trading Halt: Halt status updated at 12:00:00 PM ET: Quotation Resumption: New Issue Available", "summary": "", "symbols": ["NEHC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/12/42394997/trading-halt-halt-status-updated-at-12-00-00-pm-et-quotation-resumption-new-issue-available", "tags": []}
{"id": 42395025, "time": "2024-12-09 12:00:19", "headline": "Decoding 23 Analyst Evaluations For HubSpot", "summary": " ", "symbols": ["HUBS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42395025/decoding-23-analyst-evaluations-for-hubspot", "tags": []}
{"id": 42395032, "time": "2024-12-09 12:00:31", "headline": "The Latest Analyst Ratings For Fiserv", "summary": " ", "symbols": ["FI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42395032/the-latest-analyst-ratings-for-fiserv", "tags": []}
{"id": 42395034, "time": "2024-12-09 12:00:37", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Global Payments, Raises Price Target to $140", "summary": "", "symbols": ["GPN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395034/keefe-bruyette-woods-maintains-outperform-on-global-payments-raises-price-target-to-140", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395041, "time": "2024-12-09 12:00:46", "headline": "Where RLJ Lodging Stands With Analysts", "summary": " ", "symbols": ["RLJ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42395041/where-rlj-lodging-stands-with-analysts", "tags": []}
{"id": 42395049, "time": "2024-12-09 12:00:56", "headline": "In-Depth Examination Of 14 Analyst Recommendations For Arcellx", "summary": " ", "symbols": ["ACLX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42395049/in-depth-examination-of-14-analyst-recommendations-for-arcellx", "tags": []}
{"id": 42395050, "time": "2024-12-09 12:00:57", "headline": "MARA Holdings's Options Frenzy: What You Need to Know", "summary": " ", "symbols": ["MARA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42395050/mara-holdingss-options-frenzy-what-you-need-to-know", "tags": []}
{"id": 42395056, "time": "2024-12-09 12:01:03", "headline": "A Closer Look at 8 Analyst Recommendations For Timken", "summary": " ", "symbols": ["TKR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42395056/a-closer-look-at-8-analyst-recommendations-for-timken", "tags": []}
{"id": 42395060, "time": "2024-12-09 12:01:07", "headline": "Check Out What Whales Are Doing With ABBV", "summary": " ", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42395060/check-out-what-whales-are-doing-with-abbv", "tags": []}
{"id": 42395064, "time": "2024-12-09 12:01:12", "headline": "Alliance Global Partners Initiates Coverage On Hallador Energy with Buy Rating, Announces Price Target of $17", "summary": "", "symbols": ["HNRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395064/alliance-global-partners-initiates-coverage-on-hallador-energy-with-buy-rating-announces-price-targe", "tags": ["analyst_init"]}
{"id": 42395066, "time": "2024-12-09 12:01:13", "headline": "Disc Medicine Highlights Clinical And Preclinical Data From BEACON And AURORA Trials Of Bitopertin And Phase 1 DISC-3405 Trial At ASH 2024, Showcasing Potential For Existing And New Indications While Advancing Pipeline Of Hematologic Disease Therapies", "summary": "", "symbols": ["IRON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42395066/disc-medicine-highlights-clinical-and-preclinical-data-from-beacon-and-aurora-trials-of-bitoperti", "tags": ["fda"]}
{"id": 42395067, "time": "2024-12-09 12:01:14", "headline": "What 16 Analyst Ratings Have To Say About Murphy Oil", "summary": " ", "symbols": ["MUR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42395067/what-16-analyst-ratings-have-to-say-about-murphy-oil", "tags": []}
{"id": 42395119, "time": "2024-12-09 12:03:03", "headline": "Aptose Presents Data At ASH 2024 Supporting Tuspetinib Triple Therapy With Venetoclax And Azacitidine In Newly Diagnosed AML, Highlighting Broad Efficacy In FLT3 Wildtype And Prior-VEN Failure Populations, Favorable Safety, And Potential To Establish Mutation-Agnostic Standard Of Care For Chemotherapy-Ineligible Patients", "summary": "", "symbols": ["APTO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42395119/aptose-presents-data-at-ash-2024-supporting-tuspetinib-triple-therapy-with-venetoclax-and-azaciti", "tags": []}
{"id": 42395174, "time": "2024-12-09 12:03:41", "headline": "CRISPR Therapeutics Highlights CTX112 Data At ASH 2024, Showcasing Potential Clinical Benefits In R/R CD19-Positive B-Cell Malignancies; Receives FDA RMAT Designation For Follicular And Marginal Zone Lymphomas, With Phase 1 Trial Expanding Into Autoimmune Indications And Broader Updates Expected In Mid-2025", "summary": "", "symbols": ["CRSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42395174/crispr-therapeutics-highlights-ctx112-data-at-ash-2024-showcasing-potential-clinical-benefits-in-", "tags": ["fda"]}
{"id": 42388365, "time": "2024-12-09 08:12:06", "headline": "Cogent Biosciences shares are trading lower. The company presented data on Bezuclastinib for Mastocytosis at ASH 2024.", "summary": "", "symbols": ["COGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/12/42388365/cogent-biosciences-shares-are-trading-lower-the-company-presented-data-on-bezuclastinib-for-mastocyt", "tags": ["why_moving"]}
{"id": 42395178, "time": "2024-12-09 12:03:53", "headline": "Golden Globes 2025 Nominations: Netflix Scores Nods For 'Emilia P\u00e9rez' And 'Squid Game'; Comcast Lands 4 'Wicked' Noms", "summary": "Netflix scores Golden Globe nominations for multiple movies and shows, including the second season of &#34;Squid Game.&#34;", "symbols": ["CMCSA", "DIS", "NFLX", "PARA", "PARAA", "WBD"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/entertainment/24/12/42395178/golden-globes-2025-nominations-netflix-scores-nods-for-emilia-perez-and-squid-game-comcast-lands-4-wicked-noms", "tags": []}
{"id": 42395179, "time": "2024-12-09 12:03:57", "headline": "AbbVie And Genmab A/S Present Two Data Analyses From Clinical Trials Show Epcoritamab Induces Durable Complete Reponses As Monotherapy And Combination Treatment In Patients With Diffuse Large B-Cell Lymphoma; Results From Arm 1 Of The EPCORE NHL-2 Trial Show Treatment With Epcoritamab Combination Led To An Overall Response Rate Of 100% And A Complete Response Rate Of 87% In High-Risk Patients With Previously Untreated Diffuse Large B-Cell Lymphoma", "summary": "", "symbols": ["ABBV", "GMAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42395179/abbvie-and-genmab-as-present-two-data-analyses-from-clinical-trials-show-epcoritamab-induces-dura", "tags": ["fda"]}
{"id": 42388800, "time": "2024-12-09 08:21:44", "headline": "Kanzhun shares are trading lower after Bernstein downgraded the stock from Outperform to Market Perform and cut its price target from $19 to $15.", "summary": "", "symbols": ["BZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/12/42388800/kanzhun-shares-are-trading-lower-after-bernstein-downgraded-the-stock-from-outperform-to-market-perf", "tags": ["analyst_down", "why_moving"]}
{"id": 42386856, "time": "2024-12-09 07:25:53", "headline": "Apollo Global Management shares are trading higher after the company was announced to join the S&P 500.", "summary": "", "symbols": ["APO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/12/42386856/apollo-global-management-shares-are-trading-higher-after-the-company-was-announced-to-join-the-s-p-5", "tags": ["why_moving"]}
{"id": 42395199, "time": "2024-12-09 12:04:41", "headline": "Editas Medicine Presents Data From RUBY Trial At ASH 2024, Showing Reni-Cel Achieves 96% VOE-Free Rate, Sustained Increases In Hemoglobin And Fetal Hemoglobin, And Clinically Meaningful Pain And Function Improvements In Severe Sickle Cell Patients; Safety Profile Consistent With Myeloablative Conditioning", "summary": "", "symbols": ["EDIT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42395199/editas-medicine-presents-data-from-ruby-trial-at-ash-2024-showing-reni-cel-achieves-96-voe-free-r", "tags": ["fda"]}
{"id": 42395222, "time": "2024-12-09 12:05:46", "headline": "Poseida Therapeutics Highlights Interim Phase 1 Results For P-BCMA-ALLO1 And Preclinical Data For Dual CAR-T P-CD19CD20-ALLO1 At The 66th ASH Annual Meeting; Additional New Profiling Of Patient Responses From The Optimized Lymphodepletion Arm Show Consistent P-BCMA-ALLO1 Cellular Expansion And Persistence Across Subgroups", "summary": "", "symbols": ["PSTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42395222/poseida-therapeutics-highlights-interim-phase-1-results-for-p-bcma-allo1-and-preclinical-data-for", "tags": ["fda"]}
{"id": 42395224, "time": "2024-12-09 12:05:51", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Mastercard, Raises Price Target to $618", "summary": "", "symbols": ["MA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395224/keefe-bruyette-woods-maintains-outperform-on-mastercard-raises-price-target-to-618", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395280, "time": "2024-12-09 12:07:26", "headline": "Rigel Pharmaceuticals Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 In LR-MDS At The 66th ASH Annual Meeting; R289 Was Generally Well Tolerated And Demonstrated Signs Of Preliminary Clinical Activity In Elderly Heavily Pretreated LR-MDS Patients", "summary": "", "symbols": ["RIGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42395280/rigel-pharmaceuticals-highlights-initial-data-from-ongoing-phase-1b-study-evaluating-r289-in-lr-m", "tags": ["fda"]}
{"id": 42395290, "time": "2024-12-09 12:08:05", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on Nayax, Raises Price Target to $30", "summary": "", "symbols": ["NYAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395290/keefe-bruyette-woods-maintains-market-perform-on-nayax-raises-price-target-to-30", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395322, "time": "2024-12-09 12:08:27", "headline": "Warner Bros Discovery Stock Soars After Multi-Year Deal with Comcast; Comcast Shares Slide On Subscriber Loss Estimates", "summary": "Warner Bros Discovery and Comcast Corp signed a multi-year deal, allowing Xfinity and Sky UK customers to access extensive content portfolio across linear TV, apps, and streaming services. WBD stock up, CMCSA down.", "symbols": ["CMCSA", "WBD"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42395322/warner-bros-discovery-stock-soars-after-multi-year-deal-with-comcast-comcast-shares-slide-on-subscriber-loss-estimates", "tags": ["contract"]}
{"id": 42395385, "time": "2024-12-09 12:11:22", "headline": "Keefe, Bruyette & Woods Maintains Outperform on PayPal Holdings, Raises Price Target to $104", "summary": "", "symbols": ["PYPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395385/keefe-bruyette-woods-maintains-outperform-on-paypal-holdings-raises-price-target-to-104", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395414, "time": "2024-12-09 12:13:03", "headline": "Live On CNBC, Steve Weiss Announces Trimmed Taiwan Semiconductor Manufacturing Position", "summary": "", "symbols": ["TSM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395414/live-on-cnbc-steve-weiss-announces-trimmed-taiwan-semiconductor-manufacturing-position", "tags": []}
{"id": 42395440, "time": "2024-12-09 12:13:16", "headline": "First Citizens Bancshares Among 'Biggest Potential Winners' Of US Elections, Says Bullish Analyst", "summary": "First Citizens Bancshares will benefit from a pro-business environment and deregulation efforts. Analyst initiates coverage with a Buy rating.", "symbols": ["FCNCA"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42395440/first-citizens-bancshares-among-biggest-potential-winners-of-us-elections-says-bullish-analyst", "tags": ["analyst_init"]}
{"id": 42395480, "time": "2024-12-09 12:15:19", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on Block, Raises Price Target to $105", "summary": "", "symbols": ["SQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395480/keefe-bruyette-woods-maintains-market-perform-on-block-raises-price-target-to-105", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395482, "time": "2024-12-09 12:15:36", "headline": "Unpacking the Latest Options Trading Trends in Lam Research", "summary": " ", "symbols": ["LRCX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42395482/unpacking-the-latest-options-trading-trends-in-lam-research", "tags": []}
{"id": 42395483, "time": "2024-12-09 12:15:42", "headline": "Decoding Walt Disney's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["DIS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42395483/decoding-walt-disneys-options-activity-whats-the-big-picture", "tags": []}
{"id": 42395505, "time": "2024-12-09 12:16:40", "headline": "Canaccord Genuity Maintains Buy on CVRx, Raises Price Target to $22", "summary": "", "symbols": ["CVRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395505/canaccord-genuity-maintains-buy-on-cvrx-raises-price-target-to-22", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395534, "time": "2024-12-09 12:17:29", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Synchrony Finl, Raises Price Target to $82", "summary": "", "symbols": ["SYF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395534/keefe-bruyette-woods-maintains-outperform-on-synchrony-finl-raises-price-target-to-82", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395563, "time": "2024-12-09 12:18:01", "headline": "Canaccord Genuity Maintains Buy on DexCom, Raises Price Target to $99", "summary": "", "symbols": ["DXCM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395563/canaccord-genuity-maintains-buy-on-dexcom-raises-price-target-to-99", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395595, "time": "2024-12-09 12:19:05", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on Toast, Raises Price Target to $40", "summary": "", "symbols": ["TOST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395595/keefe-bruyette-woods-maintains-market-perform-on-toast-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395613, "time": "2024-12-09 12:19:58", "headline": "Benchmark Maintains Buy on Bitdeer Technologies, Raises Price Target to $29", "summary": "", "symbols": ["BTDR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395613/benchmark-maintains-buy-on-bitdeer-technologies-raises-price-target-to-29", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395617, "time": "2024-12-09 12:20:32", "headline": "Canaccord Genuity Maintains Buy on iRhythm Technologies, Raises Price Target to $152", "summary": "", "symbols": ["IRTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395617/canaccord-genuity-maintains-buy-on-irhythm-technologies-raises-price-target-to-152", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395627, "time": "2024-12-09 12:20:51", "headline": "Keefe, Bruyette & Woods Maintains Outperform on Visa, Raises Price Target to $360", "summary": "", "symbols": ["V"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395627/keefe-bruyette-woods-maintains-outperform-on-visa-raises-price-target-to-360", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395685, "time": "2024-12-09 12:22:13", "headline": "Keefe, Bruyette & Woods Maintains Market Perform on Western Union, Lowers Price Target to $12", "summary": "", "symbols": ["WU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395685/keefe-bruyette-woods-maintains-market-perform-on-western-union-lowers-price-target-to-12", "tags": ["analyst_other", "price_target_down"]}
{"id": 42395691, "time": "2024-12-09 12:22:49", "headline": "Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $127", "summary": "", "symbols": ["MMSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395691/canaccord-genuity-maintains-buy-on-merit-medical-systems-raises-price-target-to-127", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395694, "time": "2024-12-09 12:23:03", "headline": "'Meloni, Stellantis' Elkann End Dispute To Save Italy Auto Jobs; Two Sides Are Looking To Repair Ties After CEO Was Ousted; Announcement On New Direction Could Come As Soon As Next Week' - Bloomberg News", "summary": "", "symbols": ["EWI", "STLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395694/meloni-stellantis-elkann-end-dispute-to-save-italy-auto-jobs-two-sides-are-looking-to-repair-ties-af", "tags": ["management"]}
{"id": 42395695, "time": "2024-12-09 12:23:03", "headline": "C3.ai Stock Rides Bullish Wave: Will Q2 Earnings Bring Reality Check?", "summary": "C3.ai stock is showing strong bullish momentum ahead of its second-quarter earnings, trading well above its moving averages.", "symbols": ["AI"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/technicals/24/12/42395695/c3-ai-stock-rides-bullish-wave-will-q2-earnings-bring-reality-check", "tags": ["earnings"]}
{"id": 42395731, "time": "2024-12-09 12:24:20", "headline": "TD Cowen Maintains Buy on Paylocity Holding, Raises Price Target to $235", "summary": "", "symbols": ["PCTY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395731/td-cowen-maintains-buy-on-paylocity-holding-raises-price-target-to-235", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395738, "time": "2024-12-09 12:24:57", "headline": "Juan Soto's $765 Million Mets Contract Could Be Bad News For Warren Buffett", "summary": "Juan Soto is set to make more than the combined salaries of Tom Brady, Michael Jordan and Kobe Bryant with his new $765 million deal.", "symbols": ["BATRA", "BRK", "DKNG"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/sports/24/12/42395738/juan-sotos-765-million-mets-contract-could-be-bad-news-for-warren-buffett", "tags": ["contract"]}
{"id": 42395739, "time": "2024-12-09 12:24:57", "headline": "Canaccord Genuity Maintains Hold on Nevro, Lowers Price Target to $4", "summary": "", "symbols": ["NVRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395739/canaccord-genuity-maintains-hold-on-nevro-lowers-price-target-to-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 42395740, "time": "2024-12-09 12:24:57", "headline": "What's Going On With Nikola Shares Today?", "summary": "Nikola shares are trading lower by 2.2% during Monday&#39;s session. The company earlier announced it entered into an Equity Distribution Agreement with BTIG to sell up to $100 million of its common stock.", "symbols": ["NKLA"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/12/42395740/whats-going-on-with-nikola-shares-today", "tags": ["why_moving", "contract"]}
{"id": 42395758, "time": "2024-12-09 12:25:56", "headline": "TD Cowen Maintains Hold on Paycom Software, Raises Price Target to $248", "summary": "", "symbols": ["PAYC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395758/td-cowen-maintains-hold-on-paycom-software-raises-price-target-to-248", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395771, "time": "2024-12-09 12:28:08", "headline": "Canaccord Genuity Maintains Buy on Penumbra, Raises Price Target to $323", "summary": "", "symbols": ["PEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395771/canaccord-genuity-maintains-buy-on-penumbra-raises-price-target-to-323", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395788, "time": "2024-12-09 12:29:10", "headline": "TD Cowen Maintains Buy on CeriBell, Raises Price Target to $36", "summary": "", "symbols": ["CBLL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395788/td-cowen-maintains-buy-on-ceribell-raises-price-target-to-36", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395794, "time": "2024-12-09 12:29:55", "headline": "Faster, Cheaper, Smarter: Prometheum CEO Highlights Why Tokenized Securities Are Gaining Ground", "summary": "Blockchain is transforming financial markets through tokenized securities, streamlining processes and unlocking opportunities.", "symbols": [], "source": "benzinga", "author": "Abbey Higginbotham", "url": "https://www.benzinga.com/news/events/24/12/42395794/faster-cheaper-smarter-prometheum-ceo-highlights-why-tokenized-securities-are-gaining-ground", "tags": ["management"]}
{"id": 42395872, "time": "2024-12-09 12:30:29", "headline": "TD Cowen Maintains Buy on Apollo Global Management, Raises Price Target to $230", "summary": "", "symbols": ["APO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395872/td-cowen-maintains-buy-on-apollo-global-management-raises-price-target-to-230", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395878, "time": "2024-12-09 12:30:43", "headline": "Fangdd Prices $7M Registered Direct Offering At $0.70 Per Share, With Closing Expected December 10, 2024, To Support Strategic Initiatives", "summary": "", "symbols": ["DUO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395878/fangdd-prices-7m-registered-direct-offering-at-0-70-per-share-with-closing-expected-december-10-2024", "tags": ["offering"]}
{"id": 42395879, "time": "2024-12-09 12:30:44", "headline": "Canaccord Genuity Maintains Buy on Insulet, Raises Price Target to $304", "summary": "", "symbols": ["PODD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395879/canaccord-genuity-maintains-buy-on-insulet-raises-price-target-to-304", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395880, "time": "2024-12-09 12:31:02", "headline": "Trump's Policies Could Benefit These 3 Stocks", "summary": "Trump&#39;s second term could bring protectionist trade policies, potential benefits for domestic banks and steel producers, and a friendly stance towards mineral projects.", "symbols": ["LAC", "RNST", "STLD"], "source": "benzinga", "author": "Stjepan Kalinic", "url": "https://www.benzinga.com/government/regulations/24/12/42395880/trumps-policies-could-benefit-these-3-stocks", "tags": []}
{"id": 42395881, "time": "2024-12-09 12:31:03", "headline": "Netflix Unusual Options Activity For December 09", "summary": " ", "symbols": ["NFLX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42395881/netflix-unusual-options-activity-for-december-09", "tags": []}
{"id": 42395884, "time": "2024-12-09 12:31:13", "headline": "Unpacking the Latest Options Trading Trends in JD.com", "summary": " ", "symbols": ["JD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42395884/unpacking-the-latest-options-trading-trends-in-jd-com", "tags": []}
{"id": 42395898, "time": "2024-12-09 12:31:48", "headline": "Canaccord Genuity Maintains Hold on Staar Surgical, Lowers Price Target to $28", "summary": "", "symbols": ["STAA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395898/canaccord-genuity-maintains-hold-on-staar-surgical-lowers-price-target-to-28", "tags": ["analyst_other", "price_target_down"]}
{"id": 42395909, "time": "2024-12-09 12:32:16", "headline": "TD Cowen Maintains Hold on Victoria's Secret, Raises Price Target to $45", "summary": "", "symbols": ["VSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395909/td-cowen-maintains-hold-on-victorias-secret-raises-price-target-to-45", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395922, "time": "2024-12-09 12:32:46", "headline": "What's Going On With D-Wave Quantum Shares Monday?", "summary": "D-Wave entered entered a sales agreement with Needham, Roth Capital, B. Riley and Craig-Hallum.", "symbols": ["QBTS"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42395922/whats-going-on-with-d-wave-quantum-shares-monday", "tags": ["why_moving", "contract"]}
{"id": 42395925, "time": "2024-12-09 12:32:52", "headline": "Canaccord Genuity Maintains Buy on Globus Medical, Raises Price Target to $92", "summary": "", "symbols": ["GMED"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395925/canaccord-genuity-maintains-buy-on-globus-medical-raises-price-target-to-92", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395933, "time": "2024-12-09 12:33:02", "headline": "Fangdd Network Group Shares Halted On Circuit Breaker To The Downside, Stock Now Up 95.4%", "summary": "", "symbols": ["DUO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42395933/fangdd-network-group-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-95-4", "tags": ["halt"]}
{"id": 42395960, "time": "2024-12-09 12:33:39", "headline": "Eye-Disease Focused Kodiak Sciences Is A Promising 'Turnaround Story For 2025': Analyst Upgrades Stock", "summary": "Jefferies upgrades Kodiak Sciences, citing undervaluation and growth potential as Phase 3 trials advance for tarcocimab in retinal diseases.", "symbols": ["KOD"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/12/42395960/eye-disease-focused-kodiak-sciences-is-a-promising-turnaround-story-for-2025-analyst-upgrades-stock", "tags": ["analyst_up", "fda"]}
{"id": 42395975, "time": "2024-12-09 12:34:16", "headline": "TD Cowen Maintains Buy on Amer Sports, Raises Price Target to $29", "summary": "", "symbols": ["AS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42395975/td-cowen-maintains-buy-on-amer-sports-raises-price-target-to-29", "tags": ["analyst_other", "price_target_up"]}
{"id": 42395976, "time": "2024-12-09 12:34:22", "headline": "Pactiv Evergreen, RealReal, Kodiak Sciences And Other Big Stocks Moving Higher On Monday", "summary": " ", "symbols": ["AHG", "BABA", "BILI", "EL", "HSY", "IPG", "KOD", "LCID", "NIO", "NVTS", "PTVE", "REAL", "SATL", "TIGR", "TWI"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42395976/pactiv-evergreen-realreal-kodiak-sciences-and-other-big-stocks-moving-higher-on-monday", "tags": ["why_moving"]}
{"id": 42395995, "time": "2024-12-09 12:35:12", "headline": "10 Information Technology Stocks Whale Activity In Today's Session", "summary": " ", "symbols": ["AAPL", "BTBT", "FRSH", "FSLY", "INTC", "MSFT", "NVDA", "ORCL", "QBTS", "RGTI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42395995/10-information-technology-stocks-whale-activity-in-todays-session", "tags": []}
{"id": 42395997, "time": "2024-12-09 12:35:17", "headline": "10 Consumer Discretionary Stocks Whale Activity In Today's Session", "summary": " ", "symbols": ["AMZN", "DKNG", "JD", "M", "NKE", "PDD", "QS", "RIVN", "TSLA", "ZK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42395997/10-consumer-discretionary-stocks-whale-activity-in-todays-session", "tags": []}
{"id": 42395998, "time": "2024-12-09 12:35:22", "headline": "10 Communication Services Stocks Whale Activity In Today's Session", "summary": " ", "symbols": ["ASTS", "BIDU", "CHTR", "GOOG", "GOOGL", "META", "RBLX", "RDDT", "ROKU", "TMUS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42395998/10-communication-services-stocks-whale-activity-in-todays-session", "tags": []}
{"id": 42396003, "time": "2024-12-09 12:35:44", "headline": "Fangdd Network Group Shares Resume Trade", "summary": "", "symbols": ["DUO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42396003/fangdd-network-group-shares-resume-trade", "tags": []}
{"id": 42396013, "time": "2024-12-09 12:35:47", "headline": "Melius Research Initiates Coverage On Qualcomm with Hold Rating, Announces Price Target of $180", "summary": "", "symbols": ["QCOM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396013/melius-research-initiates-coverage-on-qualcomm-with-hold-rating-announces-price-target-of-180", "tags": ["analyst_init"]}
{"id": 42396086, "time": "2024-12-09 12:39:40", "headline": "HC Wainwright & Co. Reiterates Buy on Beam Therapeutics, Maintains $80 Price Target", "summary": "", "symbols": ["BEAM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396086/hc-wainwright-co-reiterates-buy-on-beam-therapeutics-maintains-80-price-target", "tags": ["analyst_other"]}
{"id": 42396087, "time": "2024-12-09 12:39:49", "headline": "Roth MKM Maintains Buy on Amazon.com, Raises Price Target to $250", "summary": "", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396087/roth-mkm-maintains-buy-on-amazon-com-raises-price-target-to-250", "tags": ["analyst_other", "price_target_up"]}
{"id": 42396101, "time": "2024-12-09 12:41:43", "headline": "Needham Reiterates Buy on Artivion, Maintains $34 Price Target", "summary": "", "symbols": ["AORT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396101/needham-reiterates-buy-on-artivion-maintains-34-price-target", "tags": ["analyst_other"]}
{"id": 42396127, "time": "2024-12-09 12:43:39", "headline": "Canaccord Genuity Maintains Speculative Buy on OrganiGram Holdings, Lowers Price Target to C$3.15", "summary": "", "symbols": ["TSX:OGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396127/canaccord-genuity-maintains-speculative-buy-on-organigram-holdings-lowers-price-target-to-c-3-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 42396141, "time": "2024-12-09 12:45:13", "headline": "Price Over Earnings Overview: Acuity Brands", "summary": " ", "symbols": ["AYI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42396141/price-over-earnings-overview-acuity-brands", "tags": ["earnings"]}
{"id": 42396158, "time": "2024-12-09 12:45:53", "headline": "B of A Securities Downgrades MGIC Investment to Underperform, Lowers Price Target to $25", "summary": "", "symbols": ["MTG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396158/b-of-a-securities-downgrades-mgic-investment-to-underperform-lowers-price-target-to-25", "tags": ["analyst_down", "price_target_down"]}
{"id": 42396165, "time": "2024-12-09 12:46:41", "headline": "Six Flags-Cedar Fair Merger Unlocks $200 Million In Synergies, Analyst Sees Big Growth Potential", "summary": "Jefferies initiates coverage on Six Flags (FUN) with Buy rating and $59.00 price target. Merger with Cedar Fair offers long-term opportunity.", "symbols": ["FUN", "PSCD"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/general/entertainment/24/12/42396165/six-flags-cedar-fair-merger-unlocks-200-million-in-synergies-analyst-sees-big-growth-potential", "tags": ["analyst_init", "merger"]}
{"id": 42396181, "time": "2024-12-09 12:47:27", "headline": "Oil Prices Move Higher As Syrian Rebels Take Control Of Damascus", "summary": "The situation remains fluid and the United Nations Security Council is set to discuss the developments and implications for regional stability on Monday afternoon. Financial markets are reacting to the increased uncertainty in the region, as well.", "symbols": ["IAUM", "QQQ", "SPY", "USO"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/24/12/42396181/whats-going-on-in-syria-how-financial-markets-are-faring", "tags": []}
{"id": 42396331, "time": "2024-12-09 12:51:37", "headline": "T-Mobile CEO Says Q4 Is \"Back End Loaded\" And Investor Should Be Cautious As \"There Is A Lot Of Risk In The Back Half\"", "summary": "", "symbols": ["TMUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396331/t-mobile-ceo-says-q4-is-back-end-loaded-and-investor-should-be-cautious-as-there-is-a-lot-of-risk-in", "tags": ["management"]}
{"id": 42396337, "time": "2024-12-09 12:52:46", "headline": "Why Is Cogent Biosciences Stock Trading Higher On Monday?", "summary": "Cogent Biosciences&#39; SUMMIT trial shows bezuclastinib improves symptoms and quality of life in systemic mastocytosis, with favorable safety data.", "symbols": ["COGT"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/24/12/42396337/why-is-cogent-biosciences-stock-trading-higher-on-monday", "tags": ["why_moving", "fda"]}
{"id": 42396338, "time": "2024-12-09 12:52:53", "headline": "Victoria's Secret Gains From Key Promotion Turning Point, Says Analyst", "summary": "Victoria&#39;s Secret (VSCO) gets upgrade from analyst Matthew Boss of JPMorgan on continued same-store sales growth.", "symbols": ["VSCO"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42396338/victorias-secret-gains-from-key-promotion-turning-point-says-analyst", "tags": ["analyst_up"]}
{"id": 42396339, "time": "2024-12-09 12:52:58", "headline": "Jefferies Initiates Coverage On Avista with Hold Rating, Announces Price Target of $40", "summary": "", "symbols": ["AVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396339/jefferies-initiates-coverage-on-avista-with-hold-rating-announces-price-target-of-40", "tags": ["analyst_init"]}
{"id": 42396405, "time": "2024-12-09 12:54:09", "headline": "T-Mobile CEO Says Device Upgrade Rate Is \"Pretty Low\"", "summary": "", "symbols": ["TMUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396405/t-mobile-ceo-says-device-upgrade-rate-is-pretty-low", "tags": ["analyst_up", "management"]}
{"id": 42396412, "time": "2024-12-09 12:54:40", "headline": "Jefferies Maintains Buy on Paylocity Holding, Raises Price Target to $240", "summary": "", "symbols": ["PCTY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396412/jefferies-maintains-buy-on-paylocity-holding-raises-price-target-to-240", "tags": ["analyst_other", "price_target_up"]}
{"id": 42396420, "time": "2024-12-09 12:56:27", "headline": "Jefferies Maintains Buy on Mastercard, Raises Price Target to $610", "summary": "", "symbols": ["MA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396420/jefferies-maintains-buy-on-mastercard-raises-price-target-to-610", "tags": ["analyst_other", "price_target_up"]}
{"id": 42396421, "time": "2024-12-09 12:56:33", "headline": "Power Vacuum In Syria Increases Geopolitical Instability, China Investigating Nvidia", "summary": "", "symbols": ["AAPL", "AMZN", "BTCUSD", "GLD", "GOOG", "META", "MSFT", "NVDA", "QQQ", "SLV", "SPY", "TSLA", "TUR"], "source": "benzinga", "author": "The Arora Report", "url": "https://www.benzinga.com/markets/emerging-markets/24/12/42396421/power-vacuum-in-syria-increases-geopolitical-instability-china-investigating-nvidia", "tags": []}
{"id": 42396440, "time": "2024-12-09 12:57:44", "headline": "Jefferies Maintains Buy on Charles Schwab, Raises Price Target to $94", "summary": "", "symbols": ["SCHW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396440/jefferies-maintains-buy-on-charles-schwab-raises-price-target-to-94", "tags": ["analyst_other", "price_target_up"]}
{"id": 42396441, "time": "2024-12-09 12:58:02", "headline": "Longtime Nvidia Observer Expects A Crash--How To Protect Against It", "summary": " ", "symbols": ["HOOD", "NVDA"], "source": "benzinga", "author": "David Pinsen", "url": "https://www.benzinga.com/markets/options/24/12/42396441/longtime-nvidia-observer-expects-a-crash-how-to-protect-against-it", "tags": []}
{"id": 42396509, "time": "2024-12-09 13:00:13", "headline": "P/E Ratio Insights for Bank of America", "summary": " ", "symbols": ["BAC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42396509/pe-ratio-insights-for-bank-of-america", "tags": []}
{"id": 42396511, "time": "2024-12-09 13:00:19", "headline": "The Latest Analyst Ratings For CME Gr", "summary": " ", "symbols": ["CME"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42396511/the-latest-analyst-ratings-for-cme-gr", "tags": []}
{"id": 42396518, "time": "2024-12-09 13:00:32", "headline": "Analyst Scoreboard: 18 Ratings For KKR", "summary": " ", "symbols": ["KKR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42396518/analyst-scoreboard-18-ratings-for-kkr", "tags": []}
{"id": 42396521, "time": "2024-12-09 13:00:36", "headline": "CNBC Halftime Report Final Trades: AbbVie, Vertiv, iShares Expanded Tech-Software Sector ETF", "summary": "", "symbols": ["ABBV", "IGV", "VRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396521/cnbc-halftime-report-final-trades-abbvie-vertiv-ishares-expanded-tech-software-sector-etf", "tags": []}
{"id": 42396534, "time": "2024-12-09 13:00:40", "headline": "Decoding 9 Analyst Evaluations For Vertex", "summary": " ", "symbols": ["VERX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42396534/decoding-9-analyst-evaluations-for-vertex", "tags": []}
{"id": 42396539, "time": "2024-12-09 13:00:49", "headline": "Beyond The Numbers: 7 Analysts Discuss JD.com Stock", "summary": " ", "symbols": ["JD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42396539/beyond-the-numbers-7-analysts-discuss-jd-com-stock", "tags": []}
{"id": 42396540, "time": "2024-12-09 13:00:58", "headline": "Evaluating CVRx: Insights From 6 Financial Analysts", "summary": " ", "symbols": ["CVRX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42396540/evaluating-cvrx-insights-from-6-financial-analysts", "tags": []}
{"id": 42396541, "time": "2024-12-09 13:01:05", "headline": "A Closer Look at 4 Analyst Recommendations For Bentley Systems", "summary": " ", "symbols": ["BSY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42396541/a-closer-look-at-4-analyst-recommendations-for-bentley-systems", "tags": []}
{"id": 42396548, "time": "2024-12-09 13:01:29", "headline": "From $100K to $250K? Analyzing Bitcoin's Bull Market Signals", "summary": " ", "symbols": [], "source": "benzinga", "author": "Mike Ermolaev", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42396548/from-100k-to-250k-analyzing-bitcoins-bull-market-signals", "tags": []}
{"id": 42396557, "time": "2024-12-09 13:02:06", "headline": "CoreWeave Signs Strategic Agreement With Dell To Support Next Generation AI Innovation, Coreweave Will Receive Liquid-Cooled, Fully-Integrated Dell IR7000 Racks With Dell PowerEdge XE9712 Servers, Supported By Dell's AI Professional Services To Optimize CoreWeave's Data Center Design", "summary": "", "symbols": ["DELL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396557/coreweave-signs-strategic-agreement-with-dell-to-support-next-generation-ai-innovation-coreweave-wil", "tags": ["contract"]}
{"id": 42396605, "time": "2024-12-09 13:04:04", "headline": "Man Questioned In UnitedHealthcare CEO Murder: McDonald's Customer Tip Leads To Detainment In Pennsylvania", "summary": "A person has been detained in Pennsylvania that could be a suspect in the murder of UnitedHealthcare CEO Brian Thompson.", "symbols": ["UNH"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/health-care/24/12/42396605/man-questioned-in-unitedhealthcare-ceo-murder-mcdonalds-customer-tip-leads-to-detainment-in-pennsylvania", "tags": ["management"]}
{"id": 42396611, "time": "2024-12-09 13:04:25", "headline": "JP Morgan Maintains Neutral on American Express, Raises Price Target to $301", "summary": "", "symbols": ["AXP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396611/jp-morgan-maintains-neutral-on-american-express-raises-price-target-to-301", "tags": ["analyst_other", "price_target_up"]}
{"id": 42396649, "time": "2024-12-09 13:05:56", "headline": "Huize Shares Halted On Circuit Breaker To The Upside, Stock Now Up 110.7%", "summary": "", "symbols": ["HUIZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42396649/huize-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-110-7", "tags": ["halt"]}
{"id": 42396651, "time": "2024-12-09 13:06:01", "headline": "JP Morgan Maintains Neutral on Capital One Finl, Raises Price Target to $186", "summary": "", "symbols": ["COF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396651/jp-morgan-maintains-neutral-on-capital-one-finl-raises-price-target-to-186", "tags": ["analyst_other", "price_target_up"]}
{"id": 42396663, "time": "2024-12-09 13:07:22", "headline": "Only 3% Of Cannabis Consumed In Canada Came From Illicit Sources, National Survey Shows", "summary": "Discover key insights from the Canadian Cannabis Survey 2024: legal access soars, smoking declines, and youth usage remains stable. Learn more about evolving cannabis trends in Canada.", "symbols": [], "source": "benzinga", "author": "Rolando Garc\u00eda", "url": "https://www.benzinga.com/24/12/42396663/only-3-of-cannabis-consumed-in-canada-during-2024-came-from-ilegal-sources-main-national-survey-shows", "tags": []}
{"id": 42396683, "time": "2024-12-09 13:07:51", "headline": "JP Morgan Maintains Neutral on Discover Finl, Raises Price Target to $150", "summary": "", "symbols": ["DFS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396683/jp-morgan-maintains-neutral-on-discover-finl-raises-price-target-to-150", "tags": ["analyst_other", "price_target_up"]}
{"id": 42396690, "time": "2024-12-09 13:08:22", "headline": "Ethereum's 'Important Week:' $4,000 Tapped But Why Is ETH Going Down?", "summary": "Ethereum&#39;s (CRYPTO: ETH) to $4,000 has come to a sudden end on Monday, but traders on social media continue to see bullish catalysts driving ETH higher in the future.", "symbols": ["BTCUSD", "ETHUSD", "XRPUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42396690/ethereums-important-week-4000-tapped-but-why-is-eth-going-down", "tags": []}
{"id": 42396746, "time": "2024-12-09 13:11:21", "headline": "Oracle's Q2 Earnings: Strong Chart Signals, But Watch That RSI", "summary": "Oracle (ORCL) is to report Q2 earnings with expected EPS of $1.48 and revenues of $14.12 billion. Stock up 66.50% in past year, bullish signals ahead.", "symbols": ["ORCL"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/technicals/24/12/42396746/oracles-q2-earnings-strong-chart-signals-but-watch-that-rsi", "tags": ["earnings"]}
{"id": 42396757, "time": "2024-12-09 13:11:59", "headline": "JP Morgan Maintains Overweight on OneMain Holdings, Raises Price Target to $59", "summary": "", "symbols": ["OMF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396757/jp-morgan-maintains-overweight-on-onemain-holdings-raises-price-target-to-59", "tags": ["analyst_other", "price_target_up"]}
{"id": 42396774, "time": "2024-12-09 13:13:30", "headline": "JP Morgan Maintains Overweight on Ally Financial, Raises Price Target to $42", "summary": "", "symbols": ["ALLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396774/jp-morgan-maintains-overweight-on-ally-financial-raises-price-target-to-42", "tags": ["analyst_other", "price_target_up"]}
{"id": 42396788, "time": "2024-12-09 13:13:58", "headline": "Lockheed Martin's Newest Technology Demo For Space Connectivity Is Ready for Launch", "summary": "", "symbols": ["LMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396788/lockheed-martins-newest-technology-demo-for-space-connectivity-is-ready-for-launch", "tags": []}
{"id": 42396803, "time": "2024-12-09 13:15:14", "headline": "Price Over Earnings Overview: Aramark", "summary": " ", "symbols": ["ARMK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42396803/price-over-earnings-overview-aramark", "tags": ["earnings"]}
{"id": 42396831, "time": "2024-12-09 13:16:00", "headline": "JP Morgan Maintains Neutral on SLM, Raises Price Target to $27", "summary": "", "symbols": ["SLM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396831/jp-morgan-maintains-neutral-on-slm-raises-price-target-to-27", "tags": ["analyst_other", "price_target_up"]}
{"id": 42396833, "time": "2024-12-09 13:16:31", "headline": "Huize Shares Resume Trade", "summary": "", "symbols": ["HUIZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42396833/huize-shares-resume-trade", "tags": []}
{"id": 42396834, "time": "2024-12-09 13:17:17", "headline": "JP Morgan Maintains Neutral on Navient, Lowers Price Target to $15", "summary": "", "symbols": ["NAVI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396834/jp-morgan-maintains-neutral-on-navient-lowers-price-target-to-15", "tags": ["analyst_other", "price_target_down"]}
{"id": 42396882, "time": "2024-12-09 13:19:27", "headline": "JP Morgan Maintains Underweight on Rocket Companies, Lowers Price Target to $14", "summary": "", "symbols": ["RKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396882/jp-morgan-maintains-underweight-on-rocket-companies-lowers-price-target-to-14", "tags": ["analyst_other", "price_target_down"]}
{"id": 42396900, "time": "2024-12-09 13:20:33", "headline": "JP Morgan Maintains Underweight on Guild Holdings, Lowers Price Target to $13", "summary": "", "symbols": ["GHLD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396900/jp-morgan-maintains-underweight-on-guild-holdings-lowers-price-target-to-13", "tags": ["analyst_other", "price_target_down"]}
{"id": 42396938, "time": "2024-12-09 13:21:43", "headline": "Huize Shares Halted On Circuit Breaker To The Upside, Stock Now Up 249.9%", "summary": "", "symbols": ["HUIZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42396938/huize-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-249-9", "tags": ["halt"]}
{"id": 42396939, "time": "2024-12-09 13:21:45", "headline": "JP Morgan Maintains Neutral on Essent Group, Lowers Price Target to $60", "summary": "", "symbols": ["ESNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396939/jp-morgan-maintains-neutral-on-essent-group-lowers-price-target-to-60", "tags": ["analyst_other", "price_target_down"]}
{"id": 42396940, "time": "2024-12-09 13:21:59", "headline": "Novo Nordisk To Invest Additional 500M Reais To Expand Factory In Brazil", "summary": "", "symbols": ["NVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396940/novo-nordisk-to-invest-additional-500m-reais-to-expand-factory-in-brazil", "tags": []}
{"id": 42396941, "time": "2024-12-09 13:22:01", "headline": "Broadcom Likely For Upside Backed By AI Pipeline, Market Recovery, VMWare Synergy: Analyst", "summary": "JP Morgan analyst maintains Overweight rating on Broadcom Inc with price target of $210. Expects better than expected earnings and growth in AI products, with strong demand and revenue opportunities.", "symbols": ["AVGO"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/24/12/42396941/broadcom-likely-for-upside-backed-by-ai-pipeline-market-recovery-vmware-synergy-as-key-ai-semiconductor-and-custom-chip-supplier", "tags": ["analyst_other", "earnings"]}
{"id": 42396955, "time": "2024-12-09 13:22:50", "headline": "JP Morgan Maintains Neutral on Enact Holdings, Lowers Price Target to $36", "summary": "", "symbols": ["ACT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42396955/jp-morgan-maintains-neutral-on-enact-holdings-lowers-price-target-to-36", "tags": ["analyst_other", "price_target_down"]}
{"id": 42396973, "time": "2024-12-09 13:23:26", "headline": "Crude Oil Gains 2%; BioAge Labs Shares Plunge", "summary": " ", "symbols": ["BIOA", "DUO", "LDTC", "PTVE", "RIOT", "UPC"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/12/42396973/crude-oil-gains-2-bioage-labs-shares-plunge", "tags": []}
{"id": 42396975, "time": "2024-12-09 13:23:36", "headline": "Vertex Has $5 Billion-Plus Opportunity In Pain And Kidney Disease Programs, Analyst Upgrades Stock", "summary": "Jefferies upgrades Vertex Pharmaceuticals to Buy, highlighting a promising pipeline and $5 billion-$7 billion growth potential from pain and kidney treatments.", "symbols": ["VRTX"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/12/42396975/vertex-has-5-billion-plus-opportunity-in-pain-and-kidney-disease-programs-analyst-upgrades-stock", "tags": ["analyst_up"]}
{"id": 42397000, "time": "2024-12-09 13:25:25", "headline": "JP Morgan Maintains Overweight on NMI Holdings, Lowers Price Target to $41", "summary": "", "symbols": ["NMIH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397000/jp-morgan-maintains-overweight-on-nmi-holdings-lowers-price-target-to-41", "tags": ["analyst_other", "price_target_down"]}
{"id": 42397019, "time": "2024-12-09 13:26:23", "headline": "Huize Shares Resume Trading", "summary": "", "symbols": ["HUIZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42397019/huize-shares-resume-trading", "tags": []}
{"id": 42397024, "time": "2024-12-09 13:26:46", "headline": "JP Morgan Maintains Overweight on KKR Real Estate Finance, Lowers Price Target to $11.5", "summary": "", "symbols": ["KREF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397024/jp-morgan-maintains-overweight-on-kkr-real-estate-finance-lowers-price-target-to-11-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 42397029, "time": "2024-12-09 13:27:33", "headline": "Taiwan Semiconductor Extends Lead As Top Chipmaker", "summary": "Taiwan Semiconductor Manufacturing Co (NYSE:TSM) maintained its global wafer foundry business turf in the third quarter of 2024.", "symbols": ["AAPL", "EMC", "GFS", "SMH", "SSNLF", "TSM", "UMC"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/media/24/12/42397029/taiwan-semiconductor-extends-lead-as-top-chipmaker", "tags": []}
{"id": 42397043, "time": "2024-12-09 13:28:02", "headline": "JP Morgan Maintains Overweight on AGNC Investment, Lowers Price Target to $9.5", "summary": "", "symbols": ["AGNC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397043/jp-morgan-maintains-overweight-on-agnc-investment-lowers-price-target-to-9-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 42397045, "time": "2024-12-09 13:28:03", "headline": "Sam Altman Posts On X \"we are launching sora today, and we made a new product to go with it. if you have an openai plus or pro account, you can generate videos. anyone can view them. it will take some time to roll out, but by the end of the day it should be available at http://sora.com\"", "summary": "", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397045/sam-altman-posts-on-x-we-are-launching-sora-today-and-we-made-a-new-product-to-go-with-it-if-you-hav", "tags": []}
{"id": 42397067, "time": "2024-12-09 13:29:08", "headline": "JP Morgan Maintains Overweight on Annaly Capital Management, Lowers Price Target to $20", "summary": "", "symbols": ["NLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397067/jp-morgan-maintains-overweight-on-annaly-capital-management-lowers-price-target-to-20", "tags": ["analyst_other", "price_target_down"]}
{"id": 42397072, "time": "2024-12-09 13:30:01", "headline": "Novo Nordisk Says Investment Aimed At Expanding Enzymes Output Used For The Production Of Insulin, GLP-1 Medicines", "summary": "", "symbols": ["NVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42397072/novo-nordisk-says-investment-aimed-at-expanding-enzymes-output-used-for-the-production-of-insulin", "tags": []}
{"id": 42397082, "time": "2024-12-09 13:30:14", "headline": "Looking Into Clearwater Analytics Hldg's Recent Short Interest", "summary": " ", "symbols": ["CWAN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42397082/looking-into-clearwater-analytics-hldgs-recent-short-interest", "tags": []}
{"id": 42397083, "time": "2024-12-09 13:30:19", "headline": "(WELL) - Analyzing Welltower's Short Interest", "summary": " ", "symbols": ["WELL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42397083/well-analyzing-welltowers-short-interest", "tags": []}
{"id": 42397084, "time": "2024-12-09 13:30:27", "headline": "Looking Into Ensign Group's Recent Short Interest", "summary": " ", "symbols": ["ENSG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42397084/looking-into-ensign-groups-recent-short-interest", "tags": []}
{"id": 42397116, "time": "2024-12-09 13:31:02", "headline": "El Salvador Relaxes Bitcoin Rules To Seal $1.3 Billion Loan", "summary": "El Salvador close to $1.3B loan deal with IMF, contingent on changes to Bitcoin policy and fiscal deficit reduction. President Bukele focuses on economic revival and foreign investment.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42397116/el-salvador-relaxes-bitcoin-rules-to-seal-13-billion-loan", "tags": ["contract"]}
{"id": 42397129, "time": "2024-12-09 13:31:53", "headline": "Affimed Reports Phase 1 Efficacy And Safety Data For AFM28 In Relapsed/Refractory Acute Myeloid Leukemia; AFM28, A Bispecific, Tetravalent Innate Cell Engager Targeting CD123 And CD16A, Achieved A 40% Composite Complete Remission Rate At The Highest Dose Level In Heavily Pretreated R/R AML Patients", "summary": "", "symbols": ["AFMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42397129/affimed-reports-phase-1-efficacy-and-safety-data-for-afm28-in-relapsedrefractory-acute-myeloid-le", "tags": ["fda"]}
{"id": 42397130, "time": "2024-12-09 13:32:00", "headline": "GSK's Blenrep Combination Secures Priority Review In China For Relapsed/Refractory Multiple Myeloma, Supported By DREAMM-7 Trial Showing Significant PFS And OS Benefits Over Standard Of Care", "summary": "", "symbols": ["GSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42397130/gsks-blenrep-combination-secures-priority-review-in-china-for-relapsedrefractory-multiple-myeloma", "tags": ["fda"]}
{"id": 42397157, "time": "2024-12-09 13:33:58", "headline": "JP Morgan Maintains Overweight on Procore Technologies, Raises Price Target to $92", "summary": "", "symbols": ["PCOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397157/jp-morgan-maintains-overweight-on-procore-technologies-raises-price-target-to-92", "tags": ["analyst_other", "price_target_up"]}
{"id": 42397164, "time": "2024-12-09 13:35:09", "headline": "JP Morgan Maintains Overweight on CCC Intelligent Solutions, Raises Price Target to $14", "summary": "", "symbols": ["CCCS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397164/jp-morgan-maintains-overweight-on-ccc-intelligent-solutions-raises-price-target-to-14", "tags": ["analyst_other", "price_target_up"]}
{"id": 42397176, "time": "2024-12-09 13:36:12", "headline": "JP Morgan Maintains Overweight on Alkami Technology, Raises Price Target to $45", "summary": "", "symbols": ["ALKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397176/jp-morgan-maintains-overweight-on-alkami-technology-raises-price-target-to-45", "tags": ["analyst_other", "price_target_up"]}
{"id": 42397182, "time": "2024-12-09 13:37:23", "headline": "JP Morgan Maintains Overweight on Intapp, Raises Price Target to $75", "summary": "", "symbols": ["INTA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397182/jp-morgan-maintains-overweight-on-intapp-raises-price-target-to-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 42397205, "time": "2024-12-09 13:38:59", "headline": "'Newmont Cuts Management Jobs In Major Corporate Restructuring; Quarterly Results Showed Higher Costs, Weaker Free Cash Flow; Top Gold Miner's Shares Have Lagged This Year's Gold Rally' - Bloomberg News", "summary": "", "symbols": ["NEM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397205/newmont-cuts-management-jobs-in-major-corporate-restructuring-quarterly-results-showed-higher-costs", "tags": []}
{"id": 42397233, "time": "2024-12-09 13:41:52", "headline": "EXCLUSIVE: Drug Expert Dr. Carl Hart Slams Cannabis Prohibition Amid Hemp-THC Surge", "summary": "Dr. Carl Hart discusses hemp THC, unregulated markets, and the need for federal cannabis legalization to reduce risks and protect consumers.", "symbols": ["CGC", "CURLF", "TLRY"], "source": "benzinga", "author": "Patricio Liddle", "url": "https://www.benzinga.com/government/regulations/24/12/42397233/exclusive-drug-expert-dr-carl-hart-slams-cannabis-prohibition-amid-hemp-thc-surge", "tags": []}
{"id": 42397244, "time": "2024-12-09 13:42:09", "headline": "GSK's DREAMM-7 Trial Shows Sustained Overall Survival Benefit For Belantamab Mafodotin Combination Versus Daratumumab Combination; Benefit Seen Early And Maintained Through Follow-up, Reducing The Risk Of Death By 42% In Multiple Myeloma At Or After First Relapse", "summary": "", "symbols": ["GSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397244/gsks-dreamm-7-trial-shows-sustained-overall-survival-benefit-for-belantamab-mafodotin-combination-ve", "tags": ["fda"]}
{"id": 42397286, "time": "2024-12-09 13:44:13", "headline": "Biogen Downgraded On Pipeline Setbacks And Leqembi Sales Slowdown", "summary": "Jefferies downgrades Biogen with a reduced price target, citing pipeline setbacks, slow Leqembi sales, and challenges from declining Ocrevus royalties.", "symbols": ["BIIB", "LLY"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/24/12/42397286/biogen-downgraded-on-pipeline-setbacks-and-leqembi-sales-slowdown", "tags": ["analyst_down"]}
{"id": 42397301, "time": "2024-12-09 13:44:44", "headline": "Barclays Maintains Equal-Weight on MarketAxess Holdings, Lowers Price Target to $260", "summary": "", "symbols": ["MKTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397301/barclays-maintains-equal-weight-on-marketaxess-holdings-lowers-price-target-to-260", "tags": ["analyst_other", "price_target_down"]}
{"id": 42397305, "time": "2024-12-09 13:45:06", "headline": "Disney CFO Says Parks Are Attempting To Keep Prices At 'Accessible' Level; Says Co Has 'Built Some Negative' Into Its Parks Forecast, Reflecting The Opening Of Universal's Epic Universe", "summary": "", "symbols": ["DIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397305/disney-cfo-says-parks-are-attempting-to-keep-prices-at-accessible-level-says-co-has-built-some-negat", "tags": ["guidance", "management"]}
{"id": 42397316, "time": "2024-12-09 13:45:46", "headline": "United Parcel Service Unusual Options Activity For December 09", "summary": " ", "symbols": ["UPS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42397316/united-parcel-service-unusual-options-activity-for-december-09", "tags": []}
{"id": 42397317, "time": "2024-12-09 13:45:51", "headline": "Unpacking the Latest Options Trading Trends in JPMorgan Chase", "summary": " ", "symbols": ["JPM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42397317/unpacking-the-latest-options-trading-trends-in-jpmorgan-chase", "tags": []}
{"id": 42397333, "time": "2024-12-09 13:46:26", "headline": "Google Quantum AI's New Willow Chip Can Do in Minutes That Supercomputers Would Take 10 Septillion Years", "summary": "Google Quantum AI announced its latest quantum chip Willow that can reduce errors exponentially, a significant milestone in its decade-long journey.", "symbols": ["GOOG", "GOOGL", "NVDA"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/24/12/42397333/google-quantum-ais-willow-chip-outsmarts-supercomputers-completing-tasks-in-minutes-that-would-take-10-septillion-years", "tags": []}
{"id": 42397343, "time": "2024-12-09 13:46:50", "headline": "Barclays Maintains Overweight on Nasdaq, Raises Price Target to $97", "summary": "", "symbols": ["NDAQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397343/barclays-maintains-overweight-on-nasdaq-raises-price-target-to-97", "tags": ["analyst_other", "price_target_up"]}
{"id": 42397344, "time": "2024-12-09 13:46:51", "headline": "Disney CFO Forecasts Pricing Increase For Streaming Service In The Future", "summary": "", "symbols": ["DIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397344/disney-cfo-forecasts-pricing-increase-for-streaming-service-in-the-future", "tags": ["management"]}
{"id": 42397350, "time": "2024-12-09 13:47:09", "headline": "Reddit Stock Gets Boost From Morgan Stanley: Analyst Sees 'Best In Class Growth'", "summary": "Morgan Stanley upgrades Reddit stock to Overweight with $200 price target, citing potential for explosive growth and $300 bull case.", "symbols": ["AMZN", "GOOG", "GOOGL", "META", "RDDT"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/general/social-media/24/12/42397350/reddit-stock-gets-boost-from-morgan-stanley-analyst-sees-best-in-class-growth", "tags": ["analyst_up"]}
{"id": 42397400, "time": "2024-12-09 13:48:00", "headline": "Barclays Maintains Overweight on P10, Raises Price Target to $15", "summary": "", "symbols": ["PX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397400/barclays-maintains-overweight-on-p10-raises-price-target-to-15", "tags": ["analyst_other", "price_target_up"]}
{"id": 42397420, "time": "2024-12-09 13:48:46", "headline": "Disney CFO Says Crackdown On Password Sharing For Disney+ Will Have 'Incremental' Benefits Every Quarter", "summary": "", "symbols": ["DIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397420/disney-cfo-says-crackdown-on-password-sharing-for-disney-will-have-incremental-benefits-every-quarte", "tags": ["management"]}
{"id": 42397426, "time": "2024-12-09 13:49:58", "headline": "New York Mayor Adams Says We Have A Strong Person Of Interest In UnitedHealth Executive Shooting; He Matches The Description Of Identification; Also In Possession Of Items That Connect Him To Incident; This Morning In Pennsylvania, Luigi Mangione Was Arrested On Fire Arms Charges", "summary": "", "symbols": ["SPY", "UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42397426/new-york-mayor-adams-says-we-have-a-strong-person-of-interest-in-unitedhealth-exe", "tags": []}
{"id": 42397425, "time": "2024-12-09 13:49:59", "headline": "Microsoft Shareholders To Vote On Bitcoin Investment Proposal", "summary": "Microsoft (NASDAQ:MSFT) shareholders will cast their votes on whether the company should publicly assess adding Bitcoin to its balance sheet on Dec. 10.", "symbols": ["BTCUSD", "MSFT", "MSTR", "TSLA"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42397425/microsoft-shareholders-to-vote-on-bitcoin-investment-proposal", "tags": []}
{"id": 42397454, "time": "2024-12-09 13:50:23", "headline": "Barclays Maintains Equal-Weight on StepStone Group, Lowers Price Target to $66", "summary": "", "symbols": ["STEP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397454/barclays-maintains-equal-weight-on-stepstone-group-lowers-price-target-to-66", "tags": ["analyst_other", "price_target_down"]}
{"id": 42397466, "time": "2024-12-09 13:51:34", "headline": "Barclays Maintains Underweight on T. Rowe Price Gr, Raises Price Target to $115", "summary": "", "symbols": ["TROW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397466/barclays-maintains-underweight-on-t-rowe-price-gr-raises-price-target-to-115", "tags": ["analyst_other", "price_target_up"]}
{"id": 42397509, "time": "2024-12-09 13:53:17", "headline": "CBD Drug For Tuberous Sclerosis: Caregivers Continue Epidiolex Treatment Citing Seizure Reduction And Cognitive Improvements", "summary": "The majority of caregivers of patients with tuberous sclerosis complex (TSC) planned to continue Epidiolex treatment, citing benefits like reduced seizure frequency and improvements in cognition and communication. That&#39;s according to data from the BECOME-TSC (BEhavior, COgnition, and More with Epidiolex) caregiver survey, revealed by Jazz Pharmaceuticals plc (NASDAQ: JAZZ). New data on Epidiolex is being presented at the American Epilepsy Society (AES) 2024 Annual Meeting, being held Decembe", "symbols": ["JAZZ"], "source": "benzinga", "author": "Jelena Martinovic", "url": "https://www.benzinga.com/24/12/42397509/cbd-drug-for-tuberous-sclerosis-patients-caregivers-plan-to-continue-epidiolex-treatment-citing-seizure-reduction-and-cognitive-improvements", "tags": ["fda", "merger"]}
{"id": 42397553, "time": "2024-12-09 13:54:01", "headline": "Barclays Maintains Overweight on Carlyle Group, Raises Price Target to $59", "summary": "", "symbols": ["CG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397553/barclays-maintains-overweight-on-carlyle-group-raises-price-target-to-59", "tags": ["analyst_other", "price_target_up"]}
{"id": 42397564, "time": "2024-12-09 13:55:51", "headline": "Barclays Maintains Overweight on Tradeweb Markets, Raises Price Target to $153", "summary": "", "symbols": ["TW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397564/barclays-maintains-overweight-on-tradeweb-markets-raises-price-target-to-153", "tags": ["analyst_other", "price_target_up"]}
{"id": 42397567, "time": "2024-12-09 13:56:16", "headline": "Freeport-McMoRan's Death Cross: Copper Giant's Pivotal Moment", "summary": "FCX stock hits bearish milestone with Death Cross, 50-day moving average dropping below 200-day. Stock down 12.06% in 6 months, facing obstacles in Indonesia. Caution advised for traders.", "symbols": ["FCX"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/technicals/24/12/42397567/freeport-mcmorans-death-cross-copper-giants-pivotal-moment", "tags": []}
{"id": 42397585, "time": "2024-12-09 13:57:42", "headline": "Barclays Maintains Underweight on Virtus Inv, Raises Price Target to $239", "summary": "", "symbols": ["VRTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397585/barclays-maintains-underweight-on-virtus-inv-raises-price-target-to-239", "tags": ["analyst_other", "price_target_up"]}
{"id": 42397625, "time": "2024-12-09 13:59:12", "headline": "Barclays Maintains Overweight on PVH, Raises Price Target to $144", "summary": "", "symbols": ["PVH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397625/barclays-maintains-overweight-on-pvh-raises-price-target-to-144", "tags": ["analyst_other", "price_target_up"]}
{"id": 42397626, "time": "2024-12-09 13:59:33", "headline": "'Dogecoin Killer' Shiba Inu Burn Rate Surges 876%: Is SHIB Price Really 'Insanely Strong'?", "summary": "Shiba Inu (CRYPTO: SHIB) is seeing increasing burn rates even though prices remain stagnant.", "symbols": ["SHIBUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42397626/dogecoin-killer-shiba-inu-burn-rate-surges-876-is-shib-price-really-insanely-strong", "tags": []}
{"id": 42397643, "time": "2024-12-09 14:00:14", "headline": "Peering Into Color Star Tech's Recent Short Interest", "summary": " ", "symbols": ["ADD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42397643/peering-into-color-star-techs-recent-short-interest", "tags": []}
{"id": 42397645, "time": "2024-12-09 14:00:20", "headline": "How Is The Market Feeling About CoStar Gr?", "summary": " ", "symbols": ["CSGP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42397645/how-is-the-market-feeling-about-costar-gr", "tags": []}
{"id": 42397646, "time": "2024-12-09 14:00:20", "headline": "Beyond The Numbers: 13 Analysts Discuss LPL Finl Hldgs Stock", "summary": " ", "symbols": ["LPLA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42397646/beyond-the-numbers-13-analysts-discuss-lpl-finl-hldgs-stock", "tags": []}
{"id": 42397647, "time": "2024-12-09 14:00:26", "headline": "Peering Into Ventas's Recent Short Interest", "summary": " ", "symbols": ["VTR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42397647/peering-into-ventass-recent-short-interest", "tags": []}
{"id": 42397653, "time": "2024-12-09 14:00:33", "headline": "Key Takeaways From CCC Intelligent Solutions Analyst Ratings", "summary": " ", "symbols": ["CCCS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42397653/key-takeaways-from-ccc-intelligent-solutions-analyst-ratings", "tags": []}
{"id": 42397658, "time": "2024-12-09 14:00:37", "headline": "Barclays Maintains Equal-Weight on Tractor Supply, Raises Price Target to $262", "summary": "", "symbols": ["TSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397658/barclays-maintains-equal-weight-on-tractor-supply-raises-price-target-to-262", "tags": ["analyst_other", "price_target_up"]}
{"id": 42397666, "time": "2024-12-09 14:00:48", "headline": "Decoding 10 Analyst Evaluations For Paycom Software", "summary": " ", "symbols": ["PAYC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42397666/decoding-10-analyst-evaluations-for-paycom-software", "tags": []}
{"id": 42397669, "time": "2024-12-09 14:00:56", "headline": "Alkami Technology Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)", "summary": " ", "symbols": ["ALKT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42397669/alkami-technology-stock-a-deep-dive-into-analyst-perspectives-7-ratings", "tags": []}
{"id": 42397681, "time": "2024-12-09 14:01:03", "headline": "Key Takeaways From DexCom Analyst Ratings", "summary": " ", "symbols": ["DXCM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42397681/key-takeaways-from-dexcom-analyst-ratings", "tags": []}
{"id": 42397682, "time": "2024-12-09 14:01:11", "headline": "Analyst Scoreboard: 13 Ratings For OneMain Holdings", "summary": " ", "symbols": ["OMF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42397682/analyst-scoreboard-13-ratings-for-onemain-holdings", "tags": []}
{"id": 42397697, "time": "2024-12-09 14:01:51", "headline": "Disney CFO Says 'It'll Be A Shame' If Sports Joint Venture Service Venu Fails To Launch", "summary": "", "symbols": ["DIS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397697/disney-cfo-says-itll-be-a-shame-if-sports-joint-venture-service-venu-fails-to-launch", "tags": ["management"]}
{"id": 42397802, "time": "2024-12-09 14:06:50", "headline": "Citigroup Downgrades Fortive to Neutral, Lowers Price Target to $86", "summary": "", "symbols": ["FTV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397802/citigroup-downgrades-fortive-to-neutral-lowers-price-target-to-86", "tags": ["analyst_down", "price_target_down"]}
{"id": 42397827, "time": "2024-12-09 14:08:50", "headline": "Citigroup Upgrades Xylem to Buy, Raises Price Target to $148", "summary": "", "symbols": ["XYL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397827/citigroup-upgrades-xylem-to-buy-raises-price-target-to-148", "tags": ["analyst_up", "price_target_up"]}
{"id": 42397858, "time": "2024-12-09 14:10:54", "headline": "Marvel Rivals Stuns With 10 Million Players In First Weekend", "summary": "Marvel Rivals brings in 10 million players during its opening weekend, sparking debates over gameplay similarities to Overwatch.", "symbols": ["MSFT", "NTES"], "source": "benzinga", "author": "Franca Quarneti", "url": "https://www.benzinga.com/general/gaming/24/12/42397858/marvel-rivals-stuns-with-10-million-players-in-first-weekend", "tags": []}
{"id": 42397864, "time": "2024-12-09 14:11:12", "headline": "Citigroup Maintains Neutral on AGCO, Raises Price Target to $100", "summary": "", "symbols": ["AGCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397864/citigroup-maintains-neutral-on-agco-raises-price-target-to-100", "tags": ["analyst_other", "price_target_up"]}
{"id": 42397872, "time": "2024-12-09 14:11:47", "headline": "Biden Considers Blanket Pardons Amid Trump Retribution Threats: Will Cannabis Prisoners Benefit?", "summary": "Pressure mounts for President Joe Biden to fulfill promise to pardon cannabis prisoners.", "symbols": [], "source": "benzinga", "author": "Maureen Meehan", "url": "https://www.benzinga.com/news/legal/24/12/42397872/biden-considers-blanket-pardons-amid-trump-retribution-threats-will-cannabis-prisoners-benefit", "tags": []}
{"id": 42397884, "time": "2024-12-09 14:12:36", "headline": "Citigroup Maintains Neutral on Allison Transmission, Raises Price Target to $130", "summary": "", "symbols": ["ALSN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397884/citigroup-maintains-neutral-on-allison-transmission-raises-price-target-to-130", "tags": ["analyst_other", "price_target_up"]}
{"id": 42397916, "time": "2024-12-09 14:14:31", "headline": "Citigroup Maintains Buy on Caterpillar, Raises Price Target to $460", "summary": "", "symbols": ["CAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397916/citigroup-maintains-buy-on-caterpillar-raises-price-target-to-460", "tags": ["analyst_other", "price_target_up"]}
{"id": 42397928, "time": "2024-12-09 14:14:48", "headline": "GameStop Q3 Earnings Preview: Investors Want Bitcoin On Balance Sheet, Analyst Wants 'Hint Of Any Strategy'", "summary": "GameStop Corp. (NYSE:GME) could provide a peek at holiday shopping demand when it reports third-quarter earnings after market close Tuesday.", "symbols": ["BTCUSD", "GME"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/gaming/24/12/42397928/gamestop-q3-earnings-preview-investors-want-bitcoin-on-balance-sheet-analyst-wants-hint-of-any-strategy", "tags": ["earnings"]}
{"id": 42397932, "time": "2024-12-09 14:15:12", "headline": "P/E Ratio Insights for Blue Bird", "summary": " ", "symbols": ["BLBD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42397932/pe-ratio-insights-for-blue-bird", "tags": []}
{"id": 42397964, "time": "2024-12-09 14:16:33", "headline": "Citigroup Maintains Buy on CNH Industrial, Raises Price Target to $14", "summary": "", "symbols": ["CNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397964/citigroup-maintains-buy-on-cnh-industrial-raises-price-target-to-14", "tags": ["analyst_other", "price_target_up"]}
{"id": 42397986, "time": "2024-12-09 14:17:59", "headline": "Citigroup Maintains Buy on Cummins, Raises Price Target to $435", "summary": "", "symbols": ["CMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42397986/citigroup-maintains-buy-on-cummins-raises-price-target-to-435", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398003, "time": "2024-12-09 14:19:10", "headline": "Citigroup Maintains Neutral on Deere, Raises Price Target to $470", "summary": "", "symbols": ["DE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398003/citigroup-maintains-neutral-on-deere-raises-price-target-to-470", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398037, "time": "2024-12-09 14:20:54", "headline": "Citigroup Maintains Neutral on PACCAR, Raises Price Target to $125", "summary": "", "symbols": ["PCAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398037/citigroup-maintains-neutral-on-paccar-raises-price-target-to-125", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398069, "time": "2024-12-09 14:22:32", "headline": "Citigroup Maintains Buy on United Rentals, Raises Price Target to $985", "summary": "", "symbols": ["URI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398069/citigroup-maintains-buy-on-united-rentals-raises-price-target-to-985", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398097, "time": "2024-12-09 14:25:19", "headline": "Citigroup Maintains Neutral on A.O. Smith, Lowers Price Target to $78", "summary": "", "symbols": ["AOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398097/citigroup-maintains-neutral-on-a-o-smith-lowers-price-target-to-78", "tags": ["analyst_other", "price_target_down"]}
{"id": 42398115, "time": "2024-12-09 14:27:03", "headline": "Citigroup Maintains Buy on APi Gr, Raises Price Target to $45", "summary": "", "symbols": ["APG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398115/citigroup-maintains-buy-on-api-gr-raises-price-target-to-45", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398134, "time": "2024-12-09 14:28:46", "headline": "Coinbase Seeing 'Landmark Month' In December, Notes Optimistic Analyst Report", "summary": "Needham &amp; Company has raised Coinbase\u2018s (NASDAQ:COIN) price target to $420 from $375, citing record-breaking December trading volumes and heightened altcoin activity.", "symbols": ["BTCUSD", "COIN", "DOGEUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42398134/coinbase-seeing-landmark-month-in-december-notes-optimistic-analyst-report", "tags": []}
{"id": 42398156, "time": "2024-12-09 14:30:12", "headline": "Citigroup Maintains Buy on Dover, Raises Price Target to $236", "summary": "", "symbols": ["DOV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398156/citigroup-maintains-buy-on-dover-raises-price-target-to-236", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398157, "time": "2024-12-09 14:30:14", "headline": "(IDXX) - Analyzing IDEXX Laboratories's Short Interest", "summary": " ", "symbols": ["IDXX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42398157/idxx-analyzing-idexx-laboratoriess-short-interest", "tags": []}
{"id": 42398158, "time": "2024-12-09 14:30:19", "headline": "How Is The Market Feeling About Simpson Manufacturing Co?", "summary": " ", "symbols": ["SSD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42398158/how-is-the-market-feeling-about-simpson-manufacturing-co", "tags": []}
{"id": 42398159, "time": "2024-12-09 14:30:22", "headline": "What's Going On With Hershey Stock Monday?", "summary": "Hershey stock is moving higher on Monday following a report suggesting that Mondelez  is exploring a potential acquisition of the company.", "symbols": ["HSY", "MDLZ"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/24/12/42398159/whats-going-on-with-hershey-stock-monday", "tags": ["why_moving"]}
{"id": 42398161, "time": "2024-12-09 14:30:25", "headline": "Peering Into Teledyne Technologies's Recent Short Interest", "summary": " ", "symbols": ["TDY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42398161/peering-into-teledyne-technologiess-recent-short-interest", "tags": []}
{"id": 42398194, "time": "2024-12-09 14:31:41", "headline": "Still No GTA 6 News? Fans Take Matters Into Their Own Hands", "summary": "A year after the GTA 6 trailer, fans are recreating scenes using GTA 5 tools and speculating about the game&#39;s size and features.", "symbols": ["TTWO"], "source": "benzinga", "author": "Franca Quarneti", "url": "https://www.benzinga.com/general/gaming/24/12/42398194/still-no-gta-6-news-fans-take-matters-into-their-own-hands", "tags": []}
{"id": 42398200, "time": "2024-12-09 14:31:59", "headline": "Citigroup Maintains Buy on Eaton Corp, Raises Price Target to $440", "summary": "", "symbols": ["ETN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398200/citigroup-maintains-buy-on-eaton-corp-raises-price-target-to-440", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398234, "time": "2024-12-09 14:33:58", "headline": "Citigroup Maintains Buy on Flowserve, Raises Price Target to $73", "summary": "", "symbols": ["FLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398234/citigroup-maintains-buy-on-flowserve-raises-price-target-to-73", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398236, "time": "2024-12-09 14:34:21", "headline": "Three Fintech Winners That Rocked In Q3", "summary": " ", "symbols": ["BRK", "FIS", "NU", "RKT"], "source": "benzinga", "author": "jacob@valuewalk.com", "url": "https://www.benzinga.com/fintech/24/12/42398236/three-fintech-winners-that-rocked-in-q3", "tags": []}
{"id": 42398251, "time": "2024-12-09 14:35:29", "headline": "Citigroup Maintains Buy on Gates Industrial Corp, Raises Price Target to $27", "summary": "", "symbols": ["GTES"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398251/citigroup-maintains-buy-on-gates-industrial-corp-raises-price-target-to-27", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398272, "time": "2024-12-09 14:38:16", "headline": "Citigroup Maintains Neutral on GE Vernova, Raises Price Target to $361", "summary": "", "symbols": ["GEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398272/citigroup-maintains-neutral-on-ge-vernova-raises-price-target-to-361", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398312, "time": "2024-12-09 14:41:43", "headline": "Citigroup Maintains Buy on Honeywell Intl, Raises Price Target to $268", "summary": "", "symbols": ["HON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398312/citigroup-maintains-buy-on-honeywell-intl-raises-price-target-to-268", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398314, "time": "2024-12-09 14:41:59", "headline": "Fortis Inc. Announces Renewal Of At-The-Market Equity Program To Issue Up To C$500M In Common Shares Through TSX, NYSE, And Other Marketplaces At Prevailing Market Prices", "summary": "", "symbols": ["FTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398314/fortis-inc-announces-renewal-of-at-the-market-equity-program-to-issue-up-to-c-500m-in-common-shares", "tags": []}
{"id": 42398335, "time": "2024-12-09 14:43:37", "headline": "Citigroup Maintains Buy on IDEX, Raises Price Target to $269", "summary": "", "symbols": ["IEX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398335/citigroup-maintains-buy-on-idex-raises-price-target-to-269", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398359, "time": "2024-12-09 14:45:32", "headline": "Smart Money Is Betting Big In Home Depot Options", "summary": " ", "symbols": ["HD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42398359/smart-money-is-betting-big-in-home-depot-options", "tags": []}
{"id": 42398360, "time": "2024-12-09 14:45:36", "headline": "Citigroup Maintains Neutral on Illinois Tool Works, Raises Price Target to $279", "summary": "", "symbols": ["ITW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398360/citigroup-maintains-neutral-on-illinois-tool-works-raises-price-target-to-279", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398383, "time": "2024-12-09 14:46:43", "headline": "Citigroup Maintains Buy on Ingersoll Rand, Raises Price Target to $119", "summary": "", "symbols": ["IR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398383/citigroup-maintains-buy-on-ingersoll-rand-raises-price-target-to-119", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398384, "time": "2024-12-09 14:46:43", "headline": "Surprise Cyberpunk 2077 Update Announced: 'The Team Still Has Some Gas In The Tank'", "summary": "Cyberpunk 2077 Update 2.2 arrives Dec. 10, 2024, with new content, but no PS5 Pro support or New Game Plus.", "symbols": ["OTGLY"], "source": "benzinga", "author": "Franca Quarneti", "url": "https://www.benzinga.com/general/gaming/24/12/42398384/surprise-cyberpunk-2077-update-announced-the-team-still-has-some-gas-in-the-tank", "tags": []}
{"id": 42398432, "time": "2024-12-09 14:49:27", "headline": "Citigroup Maintains Buy on ITT, Raises Price Target to $183", "summary": "", "symbols": ["ITT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398432/citigroup-maintains-buy-on-itt-raises-price-target-to-183", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398455, "time": "2024-12-09 14:51:03", "headline": "Citigroup Maintains Buy on nVent Electric, Raises Price Target to $91", "summary": "", "symbols": ["NVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398455/citigroup-maintains-buy-on-nvent-electric-raises-price-target-to-91", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398479, "time": "2024-12-09 14:52:26", "headline": "Citigroup Maintains Buy on Pentair, Raises Price Target to $126", "summary": "", "symbols": ["PNR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398479/citigroup-maintains-buy-on-pentair-raises-price-target-to-126", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398510, "time": "2024-12-09 14:54:36", "headline": "Citigroup Maintains Buy on Quanta Services, Raises Price Target to $394", "summary": "", "symbols": ["PWR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398510/citigroup-maintains-buy-on-quanta-services-raises-price-target-to-394", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398524, "time": "2024-12-09 14:56:24", "headline": "Person of Interest Named In UnitedHealthcare CEO's Murder: Ghost Gun Found", "summary": "A man in custody in Pennsylvania is connected to the murder of UnitedHealthcare CEO Brian Thompson. Here are the early details on suspect Luigi Mangione.", "symbols": ["UNH"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/health-care/24/12/42398524/person-of-interest-named-in-unitedhealthcare-ceos-murder-ghost-gun-found", "tags": ["management"]}
{"id": 42398525, "time": "2024-12-09 14:56:37", "headline": "Citigroup Maintains Buy on Rockwell Automation, Raises Price Target to $345", "summary": "", "symbols": ["ROK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398525/citigroup-maintains-buy-on-rockwell-automation-raises-price-target-to-345", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398542, "time": "2024-12-09 14:58:27", "headline": "Citigroup Maintains Buy on Trane Technologies, Raises Price Target to $478", "summary": "", "symbols": ["TT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398542/citigroup-maintains-buy-on-trane-technologies-raises-price-target-to-478", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398553, "time": "2024-12-09 14:59:42", "headline": "Citigroup Maintains Buy on Vertiv Hldgs, Raises Price Target to $155", "summary": "", "symbols": ["VRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398553/citigroup-maintains-buy-on-vertiv-hldgs-raises-price-target-to-155", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398566, "time": "2024-12-09 15:00:15", "headline": "Peering Into Avery Dennison's Recent Short Interest", "summary": " ", "symbols": ["AVY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42398566/peering-into-avery-dennisons-recent-short-interest", "tags": []}
{"id": 42398567, "time": "2024-12-09 15:00:17", "headline": "Demystifying Fortive: Insights From 11 Analyst Reviews", "summary": " ", "symbols": ["FTV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42398567/demystifying-fortive-insights-from-11-analyst-reviews", "tags": []}
{"id": 42398572, "time": "2024-12-09 15:00:21", "headline": "Looking Into SPS Commerce's Recent Short Interest", "summary": " ", "symbols": ["SPSC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42398572/looking-into-sps-commerces-recent-short-interest", "tags": []}
{"id": 42398573, "time": "2024-12-09 15:00:26", "headline": "$1000 Invested In Marvell Tech 20 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["MRVL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42398573/1000-invested-in-marvell-tech-20-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 42398574, "time": "2024-12-09 15:00:26", "headline": "OpenAI CEO Sam Altman Post On X, \"\u2026we want to offer our products in europe, and believe a strong europe is important to the world\u2026\"", "summary": "", "symbols": ["MSFT", "VGK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398574/openai-ceo-sam-altman-post-on-x-we-want-to-offer-our-products-in-europe-and-believe-a-strong-europe", "tags": ["management"]}
{"id": 42398575, "time": "2024-12-09 15:00:26", "headline": "How Is The Market Feeling About Paycom Software?", "summary": " ", "symbols": ["PAYC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42398575/how-is-the-market-feeling-about-paycom-software", "tags": []}
{"id": 42398582, "time": "2024-12-09 15:00:31", "headline": "$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["JCI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42398582/1000-invested-in-this-stock-15-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 42398584, "time": "2024-12-09 15:00:32", "headline": "Assessing T. Rowe Price Gr: Insights From 14 Financial Analysts", "summary": " ", "symbols": ["TROW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42398584/assessing-t-rowe-price-gr-insights-from-14-financial-analysts", "tags": []}
{"id": 42398591, "time": "2024-12-09 15:00:44", "headline": "Expert Ratings For Advanced Micro Devices", "summary": " ", "symbols": ["AMD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42398591/expert-ratings-for-advanced-micro-devices", "tags": []}
{"id": 42398601, "time": "2024-12-09 15:00:54", "headline": "Where United Rentals Stands With Analysts", "summary": " ", "symbols": ["URI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42398601/where-united-rentals-stands-with-analysts", "tags": []}
{"id": 42398602, "time": "2024-12-09 15:00:56", "headline": "Tilly's Shares Halted To The Upside; Stock Now Up 2.13%", "summary": "", "symbols": ["TLYS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/12/42398602/tillys-shares-halted-to-the-upside-stock-now-up-2-13", "tags": ["halt"]}
{"id": 42398603, "time": "2024-12-09 15:01:02", "headline": "Navigating 12 Analyst Ratings For Corpay", "summary": " ", "symbols": ["CPAY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42398603/navigating-12-analyst-ratings-for-corpay", "tags": []}
{"id": 42398607, "time": "2024-12-09 15:01:11", "headline": "22 Analysts Assess Visa: What You Need To Know", "summary": " ", "symbols": ["V"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42398607/22-analysts-assess-visa-what-you-need-to-know", "tags": []}
{"id": 42398618, "time": "2024-12-09 15:01:28", "headline": "Citigroup Maintains Buy on Vontier, Raises Price Target to $46", "summary": "", "symbols": ["VNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398618/citigroup-maintains-buy-on-vontier-raises-price-target-to-46", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398644, "time": "2024-12-09 15:02:46", "headline": "Citigroup Maintains Neutral on Adobe, Lowers Price Target to $590", "summary": "", "symbols": ["ADBE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398644/citigroup-maintains-neutral-on-adobe-lowers-price-target-to-590", "tags": ["analyst_other", "price_target_down"]}
{"id": 42398697, "time": "2024-12-09 15:04:24", "headline": "Citigroup Maintains Buy on Veeva Systems, Raises Price Target to $307", "summary": "", "symbols": ["VEEV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398697/citigroup-maintains-buy-on-veeva-systems-raises-price-target-to-307", "tags": ["analyst_other", "price_target_up"]}
{"id": 42398755, "time": "2024-12-09 15:08:56", "headline": "Breaking Taboos: Rabbi Leads Research On Psychedelics And Jewish Identity", "summary": "A new study explores Jewish Americans&#39; relationship with psychedelics, aiming to understand their spiritual and cultural significance within the community.", "symbols": [], "source": "benzinga", "author": "Juan Sp\u00ednelli", "url": "https://www.benzinga.com/24/12/42398755/breaking-taboos-rabbi-leads-groundbreaking-research-on-psychedelics-and-jewish-identity", "tags": []}
{"id": 42398825, "time": "2024-12-09 15:12:21", "headline": "Sam Altman Calls OpenAI's New Video Generator 'So Compelling'", "summary": "OpenAI unveils AI video tech, co-creation tool, sparking excitement among early adopters. Altman emphasizes collaboration, teases 12 Days of OpenAI.", "symbols": [], "source": "benzinga", "author": "Michael Cohen", "url": "https://www.benzinga.com/24/12/42398825/sam-altman-calls-openais-new-video-generator-so-compelling", "tags": []}
{"id": 42398839, "time": "2024-12-09 15:13:06", "headline": "'Apollo Targets $25 Billion for Flagship Private Equity Fund' - Bloomberg", "summary": "", "symbols": ["APO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42398839/apollo-targets-25-billion-for-flagship-private-equity-fund-bloomberg", "tags": []}
{"id": 42398894, "time": "2024-12-09 15:15:13", "headline": "How Is The Market Feeling About Marriott Intl?", "summary": " ", "symbols": ["MAR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42398894/how-is-the-market-feeling-about-marriott-intl", "tags": []}
{"id": 42398895, "time": "2024-12-09 15:15:18", "headline": "Peering Into Permian Basin Royalty's Recent Short Interest", "summary": " ", "symbols": ["PBT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42398895/peering-into-permian-basin-royaltys-recent-short-interest", "tags": []}
{"id": 42398896, "time": "2024-12-09 15:15:23", "headline": "Peering Into Bitdeer Technologies's Recent Short Interest", "summary": " ", "symbols": ["BTDR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42398896/peering-into-bitdeer-technologiess-recent-short-interest", "tags": []}
{"id": 42399029, "time": "2024-12-09 15:22:30", "headline": "UnitedHealth Group Shares Are On The Rise Today: What's Going On?", "summary": "UnitedHealth Group Inc.&#39;s stock (NYSE: UNH) is trading higher Monday following the detainment of a person of interest in the murder of Brian Thompson, the CEO of UnitedHealthcare. Here&#39;s what you need to know.", "symbols": ["UNH"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/24/12/42399029/unitedhealth-group-shares-are-on-the-rise-today-whats-going-on", "tags": ["why_moving", "management"]}
{"id": 42399077, "time": "2024-12-09 15:23:57", "headline": "Gorilla Technology Group Shares Are On The Rise Today: What's Going On?", "summary": "Gorilla Technology Group Inc. (NASDAQ: GRRR) shares are on the rise Monday. The company announced some strategic advancements in the AI infrastructure space. Here&#39;s what you need to know.", "symbols": ["GRRR"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/24/12/42399077/gorilla-technology-group-shares-are-on-the-rise-today-whats-going-on", "tags": ["why_moving"]}
{"id": 42399139, "time": "2024-12-09 15:30:47", "headline": "If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["DE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42399139/if-you-invested-1000-in-this-stock-5-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 42399150, "time": "2024-12-09 15:30:57", "headline": "VivoPower's Caret Digital Secures Asset-Backed Financing For Up To 1,000 Antminer L9s To Boost DOGE Mining Revenues And Cashflows; Fleet Expected To Deliver 17,000 GH/s Hash Power, Generating Up To $25M Annual Revenue At Current DOGE Prices", "summary": "", "symbols": ["VVPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42399150/vivopowers-caret-digital-secures-asset-backed-financing-for-up-to-1-000-antminer-l9s-to-bo", "tags": ["earnings"]}
{"id": 42399161, "time": "2024-12-09 15:31:08", "headline": "Workday's Options Frenzy: What You Need to Know", "summary": " ", "symbols": ["WDAY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42399161/workdays-options-frenzy-what-you-need-to-know", "tags": []}
{"id": 42399164, "time": "2024-12-09 15:31:13", "headline": "This Is What Whales Are Betting On Snowflake", "summary": " ", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42399164/this-is-what-whales-are-betting-on-snowflake", "tags": []}
{"id": 42399166, "time": "2024-12-09 15:31:19", "headline": "This Is What Whales Are Betting On Constellation Energy", "summary": " ", "symbols": ["CEG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/12/42399166/this-is-what-whales-are-betting-on-constellation-energy", "tags": []}
{"id": 42399202, "time": "2024-12-09 15:32:40", "headline": "'Costco's Popular Kirkland Baby Diapers Are Shifting Suppliers' - Bloomberg", "summary": "", "symbols": ["COST", "KMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399202/costcos-popular-kirkland-baby-diapers-are-shifting-suppliers-bloomberg", "tags": []}
{"id": 42399235, "time": "2024-12-09 15:34:27", "headline": "Bitcoin, Ethereum, Dogecoin Turn Red: 'Timeline Got Bearish,' Trader Notes", "summary": "Cryptocurrency markets are trading lower despite U.S. Bitcoin ETF inflows nearing $10 billion.", "symbols": ["BTCUSD", "DOGEUSD", "ETHUSD", "POPCATUSD", "SHIBUSD", "SOLUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42399235/bitcoin-ethereum-dogecoin-turn-red-timeline-got-bearish-trader-notes", "tags": []}
{"id": 42399295, "time": "2024-12-09 15:43:02", "headline": "Sonnet BioTherapeutics Announces $3.9M Registered Direct Offering And Concurrent Private Placement, Selling 1.76M Shares And Warrants Priced At-The-Market Under Nasdaq Rules With $2.23 Combined Price And $2.10 Warrant Exercise Price", "summary": "", "symbols": ["SONN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399295/sonnet-biotherapeutics-announces-3-9m-registered-direct-offering-and-concurrent-private-placement-se", "tags": ["offering"]}
{"id": 42399338, "time": "2024-12-09 15:45:13", "headline": "Looking Into AT&T's Recent Short Interest", "summary": " ", "symbols": ["T"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42399338/looking-into-at-ts-recent-short-interest", "tags": []}
{"id": 42399339, "time": "2024-12-09 15:45:18", "headline": "How Is The Market Feeling About Western Union?", "summary": " ", "symbols": ["WU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42399339/how-is-the-market-feeling-about-western-union", "tags": []}
{"id": 42399340, "time": "2024-12-09 15:45:23", "headline": "How Is The Market Feeling About United Rentals?", "summary": " ", "symbols": ["URI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/12/42399340/how-is-the-market-feeling-about-united-rentals", "tags": []}
{"id": 42399368, "time": "2024-12-09 15:46:12", "headline": "LendingTree CEO And Chairman Douglas Lebda Purchases 13,000 Shares At An Average Price Of $39.72", "summary": "", "symbols": ["TREE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399368/lendingtree-ceo-and-chairman-douglas-lebda-purchases-13-000-shares-at-an-average-price-of-39-72", "tags": ["management"]}
{"id": 42399447, "time": "2024-12-09 15:52:40", "headline": "Benzinga Market Summary: Person Of Interest Identified In UnitedHealthcare CEO Shooting, Metals And Materials Stocks Rise On Potential China Policy Easing, Nvidia Falls On China Probe", "summary": "", "symbols": ["FCX", "NVDA", "SCCO", "SPY", "UNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/12/42399447/benzinga-market-summary-person-of-interest-identified-in-unitedhealthcare-ceo-sho", "tags": ["management"]}
{"id": 42399499, "time": "2024-12-09 15:58:23", "headline": "DatChat Will Be Issued U.S. Patent Number 12,166,889 Tomorrow Titled \"BLOCKCHAIN-BASED COMMUNICATION SYSTEMS AND METHODS\"", "summary": "", "symbols": ["DATS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399499/datchat-will-be-issued-u-s-patent-number-12-166-889-tomorrow-titled-blockchain-based-communication-s", "tags": []}
{"id": 42399529, "time": "2024-12-09 16:00:30", "headline": "Cracking The Code: Understanding Analyst Reviews For AtriCure", "summary": " ", "symbols": ["ATRC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42399529/cracking-the-code-understanding-analyst-reviews-for-atricure", "tags": []}
{"id": 42399532, "time": "2024-12-09 16:00:38", "headline": "Intuit And Amazon Expand Strategic Partnership; Intuit QuickBooks Will Become Amazon's Preferred Partner For Financial Management Solutions Integrated Directly Into Amazon Seller Central To Fuel The Success Of Amazon Sellers", "summary": "", "symbols": ["AMZN", "INTU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399532/intuit-and-amazon-expand-strategic-partnership-intuit-quickbooks-will-become-amazons-preferred-partn", "tags": ["contract"]}
{"id": 42399548, "time": "2024-12-09 16:00:43", "headline": "The Latest Analyst Ratings For Quanta Services", "summary": " ", "symbols": ["PWR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42399548/the-latest-analyst-ratings-for-quanta-services", "tags": []}
{"id": 42399554, "time": "2024-12-09 16:00:55", "headline": "Key Takeaways From BlackRock Analyst Ratings", "summary": " ", "symbols": ["BLK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42399554/key-takeaways-from-blackrock-analyst-ratings", "tags": []}
{"id": 42399555, "time": "2024-12-09 16:00:56", "headline": "Skillsoft's Earnings Outlook", "summary": " ", "symbols": ["SKIL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42399555/skillsofts-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 42399563, "time": "2024-12-09 16:01:05", "headline": "Examining the Future: Vince Holding's Earnings Outlook", "summary": " ", "symbols": ["VNCE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42399563/examining-the-future-vince-holdings-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 42399565, "time": "2024-12-09 16:01:06", "headline": "The Analyst Landscape: 9 Takes On Bread Finl Hldgs", "summary": " ", "symbols": ["BFH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42399565/the-analyst-landscape-9-takes-on-bread-finl-hldgs", "tags": []}
{"id": 42399577, "time": "2024-12-09 16:01:12", "headline": "Earnings Preview: MIND Technology", "summary": " ", "symbols": ["MIND"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42399577/earnings-preview-mind-technology", "tags": ["earnings"]}
{"id": 42399581, "time": "2024-12-09 16:01:14", "headline": "Breaking Down Host Hotels & Resorts: 6 Analysts Share Their Views", "summary": " ", "symbols": ["HST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42399581/breaking-down-host-hotels-resorts-6-analysts-share-their-views", "tags": []}
{"id": 42399584, "time": "2024-12-09 16:01:20", "headline": "Insights into Mama's Creations's Upcoming Earnings", "summary": " ", "symbols": ["MAMA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42399584/insights-into-mamas-creationss-upcoming-earnings", "tags": ["earnings"]}
{"id": 42399587, "time": "2024-12-09 16:01:26", "headline": "The Analyst Verdict: ITT In The Eyes Of 6 Experts", "summary": " ", "symbols": ["ITT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/12/42399587/the-analyst-verdict-itt-in-the-eyes-of-6-experts", "tags": []}
{"id": 42399589, "time": "2024-12-09 16:01:29", "headline": "Sportsman's Warehouse's Earnings Outlook", "summary": " ", "symbols": ["SPWH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42399589/sportsmans-warehouses-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 42399600, "time": "2024-12-09 16:01:53", "headline": "Protara Therapeutics Announces Proposed Public Offering Of Common Stock, With Proceeds To Support Clinical Development Of TARA-002 And Other Programs, Along With General Corporate Purposes", "summary": "", "symbols": ["TARA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399600/protara-therapeutics-announces-proposed-public-offering-of-common-stock-with-proceeds-to-support-cli", "tags": ["offering", "fda"]}
{"id": 42399602, "time": "2024-12-09 16:01:57", "headline": "Chimerix To Submit Dordaviprone For Accelerated Approval To U.S. FDA For Patients With Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End", "summary": "", "symbols": ["CMRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42399602/chimerix-to-submit-dordaviprone-for-accelerated-approval-to-u-s-fda-for-patients-with-recurrent-h", "tags": ["fda"]}
{"id": 42399616, "time": "2024-12-09 16:02:27", "headline": "Fate Therapeutics Unveils Phase 1 Data For FT819 CAR T-Cell Therapy In Systemic Lupus Erythematosus; First Three Patients Show Rapid And Sustained B-Cell Depletion With No Dose-Limiting Toxicities, One Patient Achieves Six-Month Clinical Remission Free Of Immunosuppressive Therapies; Company To Expand Dose Cohort At 360M Cells Level", "summary": "", "symbols": ["FATE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42399616/fate-therapeutics-unveils-phase-1-data-for-ft819-car-t-cell-therapy-in-systemic-lupus-erythematos", "tags": ["fda"]}
{"id": 42399630, "time": "2024-12-09 16:02:52", "headline": "Biomea Fusion Announces Preliminary Data From Ongoing COVALENT-103 Study Of Investigational Covalent FLT3 Inhibitor BMF-500 In Relapsed Or Refractory Acute Leukemia", "summary": "", "symbols": ["BMEA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42399630/biomea-fusion-announces-preliminary-data-from-ongoing-covalent-103-study-of-investigational-coval", "tags": []}
{"id": 42399632, "time": "2024-12-09 16:02:58", "headline": "HealthEquity Q3 2025 Adj. EPS $0.78 Beats $0.74 Estimate, Sales $300.400M Miss $305.343M Estimate", "summary": "", "symbols": ["HQY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42399632/healthequity-q3-2025-adj-eps-0-78-beats-0-74-estimate-sales-300-400m-miss-305-343m-estimate", "tags": ["earnings"]}
{"id": 42399651, "time": "2024-12-09 16:03:36", "headline": "Phreesia Q3 2025 GAAP EPS $(0.25) Beats $(0.27) Estimate, Sales $106.80M Beat $106.33M Estimate", "summary": "", "symbols": ["PHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42399651/phreesia-q3-2025-gaap-eps-0-25-beats-0-27-estimate-sales-106-80m-beat-106-33m-estimate", "tags": ["earnings"]}
{"id": 42399656, "time": "2024-12-09 16:03:46", "headline": "Fluence Energy Announces $300M Convertible Senior Notes Offering With Option For Additional $45M And Plans For Capped Call Transactions To Mitigate Dilution; Proceeds To Support Battery Cell Line Upgrade, Working Capital, And General Corporate Purposes", "summary": "", "symbols": ["FLNC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399656/fluence-energy-announces-300m-convertible-senior-notes-offering-with-option-for-additional-45m-and-p", "tags": ["analyst_up", "offering"]}
{"id": 42399667, "time": "2024-12-09 16:04:07", "headline": "$100 Invested In Vistra 5 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["VST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42399667/100-invested-in-vistra-5-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 42399682, "time": "2024-12-09 16:04:12", "headline": "If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["PANW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42399682/if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 42399707, "time": "2024-12-09 16:04:48", "headline": "HealthEquity Sees FY25 Adj. EPS $3.08-$3.16 vs $3.11 Est; Revenue $1.185B-$1.195B Vs $1.184B Est.", "summary": "", "symbols": ["HQY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399707/healthequity-sees-fy25-adj-eps-3-08-3-16-vs-3-11-est-revenue-1-185b-1-195b-vs-1-184b-est", "tags": ["earnings"]}
{"id": 42399708, "time": "2024-12-09 16:04:50", "headline": "Solaris Energy Infrastructure Announces Commencement Of Underwritten Public Offering Of 6.5M Shares Of Class A Common Stock", "summary": "", "symbols": ["SEI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399708/solaris-energy-infrastructure-announces-commencement-of-underwritten-public-offering-of-6-5m-shares", "tags": ["offering"]}
{"id": 42399723, "time": "2024-12-09 16:05:06", "headline": "HealthEquity Earnings Report: Q3 Overview", "summary": " ", "symbols": ["HQY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42399723/healthequity-earnings-report-q3-overview", "tags": ["earnings"]}
{"id": 42399762, "time": "2024-12-09 16:05:33", "headline": "12 Information Technology Stocks Moving In Monday's Pre-Market Session", "summary": " ", "symbols": ["AISP", "BBAI", "CYN", "FOXX", "GRRR", "LDTC", "LEDS", "NA", "QMCO", "RGTI", "SMX", "VERB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/12/42399762/12-information-technology-stocks-moving-in-mondays-pre-market-session", "tags": ["why_moving"]}
{"id": 42399769, "time": "2024-12-09 16:05:35", "headline": "Phreesia Narrows FY25 Revenue Outlook From $416M - $426M To $418M - $420M, Est $419.213M", "summary": "", "symbols": ["PHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399769/phreesia-narrows-fy25-revenue-outlook-from-416m-426m-to-418m-420m-est-419-213m", "tags": ["earnings", "guidance"]}
{"id": 42399772, "time": "2024-12-09 16:05:39", "headline": "12 Industrials Stocks Moving In Monday's Pre-Market Session", "summary": " ", "symbols": ["AGFY", "AIRJ", "DFLI", "FRGT", "HURC", "KITT", "OPTT", "SATL", "SES", "SOAR", "VIRC", "ZEO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/12/42399772/12-industrials-stocks-moving-in-mondays-pre-market-session", "tags": ["why_moving"]}
{"id": 42399774, "time": "2024-12-09 16:05:43", "headline": "12 Health Care Stocks Moving In Monday's Pre-Market Session", "summary": " ", "symbols": ["BIOA", "CRVO", "IPHA", "IZTC", "KOD", "MGX", "PBM", "RADX", "RVNC", "SONN", "STRM", "UPC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/12/42399774/12-health-care-stocks-moving-in-mondays-pre-market-session", "tags": ["why_moving"]}
{"id": 42399776, "time": "2024-12-09 16:05:43", "headline": "Oracle Q2 2025 Adj. EPS $1.47 Misses $1.48 Estimate, Sales $14.059B Miss $14.113B Estimate", "summary": "", "symbols": ["ORCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42399776/oracle-q2-2025-adj-eps-1-47-misses-1-48-estimate-sales-14-059b-miss-14-113b-estimate", "tags": ["earnings"]}
{"id": 42399781, "time": "2024-12-09 16:05:49", "headline": "12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session", "summary": " ", "symbols": ["ADD", "GGR", "KIRK", "MRM", "REAL", "RIME", "SBET", "TLF", "TRNR", "WKSP", "YQ", "ZCMD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/12/42399781/12-consumer-discretionary-stocks-moving-in-mondays-pre-market-session", "tags": ["why_moving"]}
{"id": 42399791, "time": "2024-12-09 16:05:58", "headline": "C3.ai Q2 EPS $(0.06) Beats $(0.16) Estimate, Sales $94.34M Beat $91.02M Estimate", "summary": "", "symbols": ["AI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42399791/c3-ai-q2-eps-0-06-beats-0-16-estimate-sales-94-34m-beat-91-02m-estimate", "tags": ["earnings"]}
{"id": 42399824, "time": "2024-12-09 16:06:18", "headline": "Health Equity Sees FY26 Revenue $1.275B-$1.295B.", "summary": "", "symbols": ["HQY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399824/health-equity-sees-fy26-revenue-1-275b-1-295b", "tags": ["earnings"]}
{"id": 42399850, "time": "2024-12-09 16:06:34", "headline": "Phreesia Expects FY26 Revenue Of $472M - $482M, Est $480.856M", "summary": "", "symbols": ["PHR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399850/phreesia-expects-fy26-revenue-of-472m-482m-est-480-856m", "tags": ["earnings"]}
{"id": 42399851, "time": "2024-12-09 16:06:35", "headline": "Braze Q3 Adj $0.02 Up From $(0.05) YoY, Sales $152.05M Beat $148.19M Estimate", "summary": "", "symbols": ["BRZE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42399851/braze-q3-adj-0-02-up-from-0-05-yoy-sales-152-05m-beat-148-19m-estimate", "tags": []}
{"id": 42399857, "time": "2024-12-09 16:06:40", "headline": "MongoDB Q3 2025 Adj. EPS $1.16 Beats $0.69 Estimate, Sales $529.400M Beat $497.758M Estimate", "summary": "", "symbols": ["MDB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42399857/mongodb-q3-2025-adj-eps-1-16-beats-0-69-estimate-sales-529-400m-beat-497-758m-estimate", "tags": ["earnings"]}
{"id": 42399877, "time": "2024-12-09 16:06:51", "headline": "Yext Q3 2025 Adj. EPS $0.12, Inline, Sales $114.000M Beat $113.208M Estimate", "summary": "", "symbols": ["YEXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42399877/yext-q3-2025-adj-eps-0-12-inline-sales-114-000m-beat-113-208m-estimate", "tags": ["earnings"]}
{"id": 42399900, "time": "2024-12-09 16:07:23", "headline": "Vail Resorts Q1 EPS $(4.61) Beats $(5.05) Estimate, Sales $260.27M Beat $254.00M Estimate", "summary": "", "symbols": ["MTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42399900/vail-resorts-q1-eps-4-61-beats-5-05-estimate-sales-260-27m-beat-254-00m-estimate", "tags": ["earnings"]}
{"id": 42399918, "time": "2024-12-09 16:07:41", "headline": "Amtech Q4 Revenue $24.1M Vs $26.7M YoY; Adj. EPS $(0.00) Vs $0.08 YoY", "summary": "", "symbols": ["ASYS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42399918/amtech-q4-revenue-24-1m-vs-26-7m-yoy-adj-eps-0-00-vs-0-08-yoy", "tags": ["earnings"]}
{"id": 42399928, "time": "2024-12-09 16:07:54", "headline": "Cumberland Says FDA Approved Supplemental New Drug Application For Its Acetadote (N-acetylcysteine For Injection) Product", "summary": "", "symbols": ["CPIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399928/cumberland-says-fda-approved-supplemental-new-drug-application-for-its-acetadote-n-acetylcysteine-fo", "tags": ["fda"]}
{"id": 42399944, "time": "2024-12-09 16:08:22", "headline": "C3.ai Sees Q3 Revenue $95.5M-$100.5M Vs $97.57M Est.; FY25 Revenue $378M-$398M Vs $382.57M Est.", "summary": "", "symbols": ["AI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399944/c3-ai-sees-q3-revenue-95-5m-100-5m-vs-97-57m-est-fy25-revenue-378m-398m-vs-382-57m-est", "tags": ["earnings"]}
{"id": 42399958, "time": "2024-12-09 16:08:37", "headline": "MongoDB Sees Q4 Revenue $515M-$519M vs $506.13M Est; Sees Q4 Adj. EPS $0.62-$0.65 vs $0.56 Est", "summary": "", "symbols": ["MDB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399958/mongodb-sees-q4-revenue-515m-519m-vs-506-13m-est-sees-q4-adj-eps-0-62-0-65-vs-0-56-est", "tags": ["earnings"]}
{"id": 42399966, "time": "2024-12-09 16:08:48", "headline": "MongoDB Sees FY25 Revenue $1.973B-$1.977B vs $1.93B Est; Sees FY25 Adj. EPS $3.01-$3.03 vs $2.47 Est", "summary": "", "symbols": ["MDB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399966/mongodb-sees-fy25-revenue-1-973b-1-977b-vs-1-93b-est-sees-fy25-adj-eps-3-01-3-03-vs-2-47-est", "tags": ["earnings"]}
{"id": 42399968, "time": "2024-12-09 16:08:59", "headline": "Heidrick & Struggles Appoints Nirupam Sinha As CFO, Effective January 6, 2025", "summary": "", "symbols": ["HSII"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399968/heidrick-struggles-appoints-nirupam-sinha-as-cfo-effective-january-6-2025", "tags": ["management"]}
{"id": 42399972, "time": "2024-12-09 16:09:06", "headline": "Amtech Sees Q1 2025 Revenue $21-$24M", "summary": "", "symbols": ["ASYS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399972/amtech-sees-q1-2025-revenue-21-24m", "tags": ["earnings"]}
{"id": 42399973, "time": "2024-12-09 16:09:12", "headline": "Yext Sees F25 Adj. EBITDA $67M-$67.5M; Revenue $420.3M-$420.8M Vs $420.536M Est.", "summary": "", "symbols": ["YEXT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42399973/yext-sees-f25-adj-ebitda-67m-67-5m-revenue-420-3m-420-8m-vs-420-536m-est", "tags": ["earnings"]}
{"id": 42400021, "time": "2024-12-09 16:10:06", "headline": "MongoDB Q3 Earnings Assessment", "summary": " ", "symbols": ["MDB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42400021/mongodb-q3-earnings-assessment", "tags": ["earnings"]}
{"id": 42400047, "time": "2024-12-09 16:10:41", "headline": "Vail Resorts Raises FY25 Net Income Guidance From $224M-$300M To $240M-$316M", "summary": "", "symbols": ["MTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400047/vail-resorts-raises-fy25-net-income-guidance-from-224m-300m-to-240m-316m", "tags": ["guidance"]}
{"id": 42400066, "time": "2024-12-09 16:10:56", "headline": "Genasys Q4 Revenue $6.7M Vs $10.7M YoY; EPS $(0.26) Vs $(0.27) YoY", "summary": "", "symbols": ["GNSS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42400066/genasys-q4-revenue-6-7m-vs-10-7m-yoy-eps-0-26-vs-0-27-yoy", "tags": ["earnings"]}
{"id": 42400080, "time": "2024-12-09 16:11:42", "headline": "Heritage Insurance Board Authorizes New Share Repurchase Plan Of $10M Commencing Upon  December 31, 2024 Expiration Of Prior Program", "summary": "", "symbols": ["HRTG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400080/heritage-insurance-board-authorizes-new-share-repurchase-plan-of-10m-commencing-upon-december-31-202", "tags": ["buyback"]}
{"id": 42400103, "time": "2024-12-09 16:12:29", "headline": "Oil-Dri Q1 2025 Net Sales $127.945M Vs $111.438M YoY; EPS $2.25 Vs $1.50 YoY", "summary": "", "symbols": ["ODC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42400103/oil-dri-q1-2025-net-sales-127-945m-vs-111-438m-yoy-eps-2-25-vs-1-50-yoy", "tags": ["earnings"]}
{"id": 42400105, "time": "2024-12-09 16:12:33", "headline": "Braze Sees Q4 EPS $0.05-$0.06 Vs $0.04 Est. Revenue $155M-$156M Vs $155.25M Est.; FY25 EPS $0.10-$0.11 Vs $0.07 Est.; Revenue $588M-$589M Vs $584.41M Est.", "summary": "", "symbols": ["BRZE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400105/braze-sees-q4-eps-0-05-0-06-vs-0-04-est-revenue-155m-156m-vs-155-25m-est-fy25-eps-0-10-0-11-vs-0-07", "tags": ["earnings"]}
{"id": 42400141, "time": "2024-12-09 16:13:40", "headline": "MongoDB COO And CFO Michael Gordon To Step Down January 31, 2025; Serge Tanjga Named Interim CFO Starting February 1 If No Successor Is Appointed; Company Initiates Search For New CFO With Internal And External Candidates Under Consideration", "summary": "", "symbols": ["MDB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400141/mongodb-coo-and-cfo-michael-gordon-to-step-down-january-31-2025-serge-tanjga-named-interim-cfo-start", "tags": ["management"]}
{"id": 42400145, "time": "2024-12-09 16:13:46", "headline": "Kinder Morgan Sees FY25 Adj. EPS $1.27 vs $1.27 Est., Adj. EBITDA $8.3B", "summary": "", "symbols": ["KMI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400145/kinder-morgan-sees-fy25-adj-eps-1-27-vs-1-27-est-adj-ebitda-8-3b", "tags": ["earnings"]}
{"id": 42400208, "time": "2024-12-09 16:14:46", "headline": "Essential Properties Realty Trust Increases Quarterly Dividend From $0.29 To $0.295 Per Share", "summary": "", "symbols": ["EPRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400208/essential-properties-realty-trust-increases-quarterly-dividend-from-0-29-to-0-295-per-share", "tags": ["dividend"]}
{"id": 42400209, "time": "2024-12-09 16:14:48", "headline": "Lee Enterprises And ProRata.ai Announce Partnership To Revolutionize Local News And Advertising With AI-Driven Hyper-Personalized Content And Real-Time Advertising Solutions, Introducing Cutting-Edge Attribution Platform For Local Media", "summary": "", "symbols": ["LEE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400209/lee-enterprises-and-prorata-ai-announce-partnership-to-revolutionize-local-news-and-advertising-with", "tags": ["contract"]}
{"id": 42400230, "time": "2024-12-09 16:15:10", "headline": "Phreesia Earnings Review: Q3 Summary", "summary": " ", "symbols": ["PHR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42400230/phreesia-earnings-review-q3-summary", "tags": ["earnings"]}
{"id": 42400234, "time": "2024-12-09 16:15:15", "headline": "Yext Earnings Report: Q3 Overview", "summary": " ", "symbols": ["YEXT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42400234/yext-earnings-report-q3-overview", "tags": ["earnings"]}
{"id": 42400235, "time": "2024-12-09 16:15:17", "headline": "Alexandria Real Estate Equities Boosts Cash Dividend From $1.30 To $1.32 Per Common Share", "summary": "", "symbols": ["ARE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400235/alexandria-real-estate-equities-boosts-cash-dividend-from-1-30-to-1-32-per-common-share", "tags": ["dividend"]}
{"id": 42400236, "time": "2024-12-09 16:15:20", "headline": "Earnings Breakdown: Genasys Q4", "summary": " ", "symbols": ["GNSS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42400236/earnings-breakdown-genasys-q4", "tags": ["earnings"]}
{"id": 42400245, "time": "2024-12-09 16:15:24", "headline": "Earnings Breakdown: Amtech Systems Q4", "summary": " ", "symbols": ["ASYS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42400245/earnings-breakdown-amtech-systems-q4", "tags": ["earnings"]}
{"id": 42400256, "time": "2024-12-09 16:15:35", "headline": "This Cannabis REIT Offers 13%+ Yield, Safer Returns Than Fed-Backed Bonds", "summary": "The company&#39;s loan portfolio offers 18%+ returns, with a 13%+ yield, making it an attractive investment, according to Zuanic &amp; Associates.", "symbols": ["AFCG", "IIPR", "NLCP", "REFI"], "source": "benzinga", "author": "Nicol\u00e1s Jose Rodriguez", "url": "https://www.benzinga.com/real-estate/reit/24/12/42400256/this-cannabis-reit-offers-13-yield-safer-returns-than-fed-backed-bonds", "tags": []}
{"id": 42400265, "time": "2024-12-09 16:15:42", "headline": "Broadridge Launches AI-Powered Algorithm Insights Service For NYFIX", "summary": "", "symbols": ["BR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400265/broadridge-launches-ai-powered-algorithm-insights-service-for-nyfix", "tags": []}
{"id": 42400273, "time": "2024-12-09 16:15:48", "headline": "Zuora Q3 2025 Adj. EPS $0.16 Beats $0.11 Estimate, Sales $116.9M Beat $116.022M Estimate", "summary": "", "symbols": ["ZUO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42400273/zuora-q3-2025-adj-eps-0-16-beats-0-11-estimate-sales-116-9m-beat-116-022m-estimate", "tags": ["earnings"]}
{"id": 42400297, "time": "2024-12-09 16:15:59", "headline": "Genasys Says \"Software Pipeline And Bookings Continue To Grow. The Rate Of Growth In Our Fiscal 2025 Software Revenues Is Expected To Moderate From The Triple Digit Rate Experienced In Fiscal 2024\"", "summary": "", "symbols": ["GNSS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400297/genasys-says-software-pipeline-and-bookings-continue-to-grow-the-rate-of-growth-in-our-fiscal-2025-s", "tags": []}
{"id": 42400335, "time": "2024-12-09 16:16:28", "headline": "Casey's General Stores Q2 2025 GAAP EPS $4.85 Beats $4.26 Estimate, Sales $3.95B Miss $4.02B Estimate", "summary": "", "symbols": ["CASY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42400335/caseys-general-stores-q2-2025-gaap-eps-4-85-beats-4-26-estimate-sales-3-95b-miss-4-02b-estimate", "tags": ["earnings"]}
{"id": 42400362, "time": "2024-12-09 16:17:43", "headline": "Relay Therapeutics To Present Updated Clinical Data On RLY-2608 In HR+/HER2- Breast Cancer At 2024 San Antonio Breast Cancer Symposium", "summary": "", "symbols": ["RLAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42400362/relay-therapeutics-to-present-updated-clinical-data-on-rly-2608-in-hr-her2-breast-cancer-at-2024-", "tags": ["fda"]}
{"id": 42400440, "time": "2024-12-09 16:18:42", "headline": "Oracle Says  This Fiscal Year, Total Oracle Cloud Revenue Should Top $25 Billion", "summary": "", "symbols": ["ORCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400440/oracle-says-this-fiscal-year-total-oracle-cloud-revenue-should-top-25-billion", "tags": ["earnings"]}
{"id": 42400456, "time": "2024-12-09 16:18:54", "headline": "Planet Labs Announces That Its Latest High-Resolution Satellite Pelican-2 And 36 SuperDoves Have Arrived At Vandenberg Space Force Base On December 9, In Preparation For Liftoff In Early 2025 On Board The Transporter-12 Rideshare Mission With SpaceX", "summary": "", "symbols": ["PL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400456/planet-labs-announces-that-its-latest-high-resolution-satellite-pelican-2-and-36-superdoves-have-arr", "tags": []}
{"id": 42400473, "time": "2024-12-09 16:19:25", "headline": "Casey's Still Expects FY25 Inside Same-Store Sales To Increase 3% To 5% And Inside Margin Comparable To FY24", "summary": "", "symbols": ["CASY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400473/caseys-still-expects-fy25-inside-same-store-sales-to-increase-3-to-5-and-inside-margin-comparable-to", "tags": []}
{"id": 42400500, "time": "2024-12-09 16:20:09", "headline": "Earnings Breakdown: Casey's General Stores Q2", "summary": " ", "symbols": ["CASY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42400500/earnings-breakdown-caseys-general-stores-q2", "tags": ["earnings"]}
{"id": 42400503, "time": "2024-12-09 16:20:14", "headline": "Planet Labs Earnings Review: Q3 Summary", "summary": " ", "symbols": ["PL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42400503/planet-labs-earnings-review-q3-summary", "tags": ["earnings"]}
{"id": 42400544, "time": "2024-12-09 16:21:13", "headline": "Zuora Says \"We Will Not Be Holding A Conference Call Or Live Webcast To Discuss Zuora's Q3 Of Fiscal 2025 Financial Results, We Will Not Be Providing Any Forward Looking Guidance, And We Are Withdrawing All Previously Provided Goals, Outlook, And Guidance\"", "summary": "", "symbols": ["ZUO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400544/zuora-says-we-will-not-be-holding-a-conference-call-or-live-webcast-to-discuss-zuoras-q3-of-fiscal-2", "tags": ["guidance"]}
{"id": 42400634, "time": "2024-12-09 16:21:54", "headline": "Planet Labs Q3 2025 Revenue $61.266M Vs 55.380M YoY; Adj. EPS $(0.02) Vs $(0.05) YoY", "summary": "", "symbols": ["PL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42400634/planet-labs-q3-2025-revenue-61-266m-vs-55-380m-yoy-adj-eps-0-02-vs-0-05-yoy", "tags": ["earnings"]}
{"id": 42400641, "time": "2024-12-09 16:22:14", "headline": "Planet Labs Sees Q4 2025 Revenue $61M-$63M", "summary": "", "symbols": ["PL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400641/planet-labs-sees-q4-2025-revenue-61m-63m", "tags": ["earnings"]}
{"id": 42400645, "time": "2024-12-09 16:22:16", "headline": "Krystal Biotech Provides Update On EMA's Ongoing Regulatory Review Of B-VEC For Dystrophic Epidermolysis Bullosa; CHMP Opinion Now Expected In 1Q 2025", "summary": "", "symbols": ["KRYS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42400645/krystal-biotech-provides-update-on-emas-ongoing-regulatory-review-of-b-vec-for-dystrophic-epiderm", "tags": []}
{"id": 42400651, "time": "2024-12-09 16:22:21", "headline": "Celanese Names Scott Richardson, Currently Its COO, As CEO; Lori Ryerkerk Is Stepping Down As Chairman, CEO  And Director At End Of The Year", "summary": "", "symbols": ["CE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400651/celanese-names-scott-richardson-currently-its-coo-as-ceo-lori-ryerkerk-is-stepping-down-as-chairman", "tags": ["management"]}
{"id": 42400659, "time": "2024-12-09 16:23:01", "headline": "NANOBIOTIX Announces Completion Of Phase 1 Study Of NBTXR3 In Pancreatic Cancer; 23 Months Median Overall Survival From Date Of Diagnosis Was Observed In 22 Patients With Locally Advanced Or Borderline Resectable Pancreatic Cancer", "summary": "", "symbols": ["NBTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42400659/nanobiotix-announces-completion-of-phase-1-study-of-nbtxr3-in-pancreatic-cancer-23-months-median-", "tags": ["fda"]}
{"id": 42400661, "time": "2024-12-09 16:23:03", "headline": "Celanese Names Edward Galante, An Independent Director On Board Since 2013, As Chair Of Board", "summary": "", "symbols": ["CE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400661/celanese-names-edward-galante-an-independent-director-on-board-since-2013-as-chair-of-board", "tags": []}
{"id": 42400677, "time": "2024-12-09 16:24:01", "headline": "AMD Appoints Tim Keating As Senior Vice President, Government Relations And Regulatory Affairs", "summary": "", "symbols": ["AMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400677/amd-appoints-tim-keating-as-senior-vice-president-government-relations-and-regulatory-affairs", "tags": ["management"]}
{"id": 42400723, "time": "2024-12-09 16:24:23", "headline": "Oracle Q2 Earnings: Revenue Miss, EPS Miss, AI Growth, Ellison Says 'Opportunity Is Unimaginable'", "summary": "Oracle Corporation reported second-quarter financial results Dec. 9. A look at the key highlights and what&#39;s next for the company.", "symbols": ["ORCL"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/news/earnings/24/12/42400723/oracle-q2-earnings-revenue-miss-eps-miss-ai-growth-ellison-says-opportunity-is-unimaginable", "tags": ["earnings"]}
{"id": 42400543, "time": "2024-12-09 16:21:03", "headline": "Eli Lilly Announced A New $1.5B Share Repurchase Program", "summary": "", "symbols": ["LLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400543/eli-lilly-announced-a-new-1-5b-share-repurchase-program-and-seventh-consecutive-year-it-has-raised-i", "tags": ["buyback"]}
{"id": 42400638, "time": "2024-12-09 16:22:03", "headline": "Eli Lilly Increases Quarterly Dividend From $1.30 To $1.50, Payable March 10, 2025", "summary": "", "symbols": ["LLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400638/eli-lilly-announces-15b-share-repurchase-program-increases-quarterly-dividend-from-1-30-to-1-50-paya", "tags": ["dividend"]}
{"id": 42400744, "time": "2024-12-09 16:24:51", "headline": "C3.ai Stock Rallies After Q2 Results, 'Seventh Consecutive Quarter Of Accelerating Revenue Growth'", "summary": "C3.ai reported its second-quarter results after Monday&#39;s closing bell. Here&#39;s a look at the key figures from the quarter.", "symbols": ["AI"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/24/12/42400744/c3ai-stock-rallies-after-q2-results-seventh-consecutive-quarter-of-accelerating-revenue-growth", "tags": ["earnings"]}
{"id": 42400749, "time": "2024-12-09 16:25:07", "headline": "HealthEquity Q3 Earnings Assessment", "summary": " ", "symbols": ["HQY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42400749/healthequity-q3-earnings-assessment", "tags": ["earnings"]}
{"id": 42400781, "time": "2024-12-09 16:26:18", "headline": "Lesaka Technologies Files Prospectus Relates To Resale Of Up To 14.7M Shares Of Common Stock By Selling Shareholders", "summary": "", "symbols": ["LSAK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400781/lesaka-technologies-files-prospectus-relates-to-resale-of-up-to-14-7m-shares-of-common-stock-by-sell", "tags": []}
{"id": 42400785, "time": "2024-12-09 16:26:58", "headline": "ThredUp Regains Compliance With The Minimum Bid Price Requirement", "summary": "", "symbols": ["TDUP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42400785/thredup-regains-compliance-with-the-minimum-bid-price-requirement", "tags": []}
{"id": 42400808, "time": "2024-12-09 16:28:03", "headline": "TransMedics Says On Dec 5, Co Acquired A Fixed-Wing Aircraft From A-JETS CZ, a.s. For About $13.9M", "summary": "", "symbols": ["TMDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42400808/transmedics-says-on-dec-5-co-acquired-a-fixed-wing-aircraft-from-a-jets-cz-a-s-for-about-13-9m", "tags": ["merger"]}
{"id": 42400886, "time": "2024-12-09 16:30:17", "headline": "Earnings Summary: HealthEquity Q3", "summary": " ", "symbols": ["HQY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42400886/earnings-summary-healthequity-q3", "tags": ["earnings"]}
{"id": 42400902, "time": "2024-12-09 16:30:43", "headline": "$100 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth This Much Today", "summary": " ", "symbols": ["ALNY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42400902/100-invested-in-alnylam-pharmaceuticals-20-years-ago-would-be-worth-this-much-today", "tags": []}
{"id": 42400903, "time": "2024-12-09 16:30:48", "headline": "Here's How Much $100 Invested In Quanta Services 15 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["PWR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42400903/heres-how-much-100-invested-in-quanta-services-15-years-ago-would-be-worth-today", "tags": []}
{"id": 42401014, "time": "2024-12-09 16:31:25", "headline": "Toll Brothers Q4 2024 Adj EPS $4.63 Beats $4.33 Estimate, Sales $3.33B Beat $3.17B Estimate", "summary": "", "symbols": ["TOL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/12/42401014/toll-brothers-q4-2024-adj-eps-4-63-beats-4-33-estimate-sales-3-33b-beat-3-17b-estimate", "tags": ["earnings"]}
{"id": 42401015, "time": "2024-12-09 16:31:25", "headline": "Dover Announces Retirement Of Chief Financial Officer; Christopher Woenker Named Successor, Effective January 31, 2025", "summary": "", "symbols": ["DOV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42401015/dover-announces-retirement-of-chief-financial-officer-christopher-woenker-named-successor-effective", "tags": []}
{"id": 42401018, "time": "2024-12-09 16:31:40", "headline": "Rocket Lab Announces The Launch Of A Suborbital Mission In Nov. To Test Hypersonic Technology For The DoD", "summary": "", "symbols": ["RKLB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42401018/rocket-lab-announces-the-launch-of-a-suborbital-mission-in-nov-to-test-hypersonic-technology-for-the", "tags": []}
{"id": 42401033, "time": "2024-12-09 16:32:56", "headline": "Manulife Has Been Notified Of An Unsolicited Mini-Tender Offer Made By New York Stock And Bond LLC To Purchase Up To 50K Manulife Common Shares At A Price Of $12.50 Per Share; Manulife Cautions Shareholders That The Mini-Tender Offer Has Been Made At A Price Below The Current Market Price For Manulife Shares", "summary": "", "symbols": ["MFC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/12/42401033/manulife-has-been-notified-of-an-unsolicited-mini-tender-offer-made-by-new-york-stock-and-bond-llc-t", "tags": []}
{"id": 42401039, "time": "2024-12-09 16:33:24", "headline": "Toll Brothers Expects Deliveries Of 1,900 - 2,100 Units For Q1, 11,200 - 11,600 Units For FY25", "summary": "", "symbols": ["TOL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42401039/toll-brothers-expects-deliveries-of-1-900-2-100-units-for-q1-11-200-11-600-units-for-fy25", "tags": []}
{"id": 42401043, "time": "2024-12-09 16:34:09", "headline": "Kite, A Gilead Company Presents Longest Follow-Up Data Reported For Tecartus CAR T-Cell Therapy At ASH 2024 Reinforce Durable Efficacy And Survival Benefits; ZUMA-2 Analysis Shows 91% Overall Response Rate, Including 73% Complete Response Rate, In Bruton Tyrosine Kinase Inhibitor-Na\u00efve R/R MCL Patients", "summary": "", "symbols": ["GILD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/12/42401043/kite-a-gilead-company-presents-longest-follow-up-data-reported-for-tecartus-car-t-cell-therapy-at", "tags": []}
{"id": 42401069, "time": "2024-12-09 16:34:45", "headline": "Workhorse Group Announces Grant Thornton Declines Reappointment As Independent Auditor For 2024; No Disagreements Reported On Financial Practices, But Material Weaknesses In Internal Controls Cited, Including Issues With Convertible Note Valuation And Accounting Staff Turnover", "summary": "", "symbols": ["WKHS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42401069/workhorse-group-announces-grant-thornton-declines-reappointment-as-independent-auditor-for-2024-no-d", "tags": []}
{"id": 42401070, "time": "2024-12-09 16:35:06", "headline": "HealthEquity Earnings Analysis: Q3 Recap", "summary": " ", "symbols": ["HQY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42401070/healthequity-earnings-analysis-q3-recap", "tags": ["earnings"]}
{"id": 42401072, "time": "2024-12-09 16:35:18", "headline": "Crane Company Announces Promotion Of Alejandro Alcala To Chief Operating Officer, Effective Immediately", "summary": "", "symbols": ["CR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42401072/crane-company-announces-promotion-of-alejandro-alcala-to-chief-operating-officer-effective-immediate", "tags": []}
{"id": 42401084, "time": "2024-12-09 16:35:29", "headline": "Butterfield Announces $100M Share Repurchase Program Authorizing Buyback Of Up To 2.7M Shares Through December 31, 2025", "summary": "", "symbols": ["NTB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42401084/butterfield-announces-100m-share-repurchase-program-authorizing-buyback-of-up-to-2-7m-shares-through", "tags": ["buyback"]}
{"id": 42401133, "time": "2024-12-09 16:37:06", "headline": "DiamondRock Hospitality Declared A Q4 Dividend Of $0.23 Per Common Share, Which Includes The Company's Regular Quarterly Dividend Of $0.03 Per Common Share, Along With A Stub Dividend Of $0.20 Per Common Share.", "summary": "", "symbols": ["DRH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42401133/diamondrock-hospitality-declared-a-q4-dividend-of-0-23-per-common-share-which-includes-the-companys", "tags": ["dividend"]}
{"id": 42401134, "time": "2024-12-09 16:37:23", "headline": "States Without Legal Cannabis Are Missing Out On Billions In Annual Tax Revenue, New Analysis Shows", "summary": "Cannabis tax revenue is transforming state economies, with over $19 billion raised so far. States like California and Colorado direct cannabis tax revenue to education.", "symbols": [], "source": "benzinga", "author": "Rolando Garc\u00eda", "url": "https://www.benzinga.com/24/12/42401134/unlegalized-states-collectively-miss-out-on-nearly-5-billion-in-cannabis-tax-revenue-each-year-new-analysis-shows", "tags": ["earnings"]}
{"id": 42401140, "time": "2024-12-09 16:37:46", "headline": "Ocean Biomedical Receives Nasdaq Non-Compliance Notice For Minimum Bid Price", "summary": "", "symbols": ["OCEA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42401140/ocean-biomedical-receives-nasdaq-non-compliance-notice-for-minimum-bid-price", "tags": []}
{"id": 42401222, "time": "2024-12-09 16:40:07", "headline": "Insights into Toll Brothers Q4 Earnings", "summary": " ", "symbols": ["TOL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42401222/insights-into-toll-brothers-q4-earnings", "tags": ["earnings"]}
{"id": 42401225, "time": "2024-12-09 16:40:13", "headline": "Earnings Breakdown: HealthEquity Q3", "summary": " ", "symbols": ["HQY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42401225/earnings-breakdown-healthequity-q3", "tags": ["earnings"]}
{"id": 42401269, "time": "2024-12-09 16:42:21", "headline": "MongoDB Shares Climb After Blockbuster Q3 Results, FY25 Guidance Above Estimates", "summary": "MongoDB reported its third-quarter results after Monday&#39;s closing bell. Here&#39;s a look at the key figures from the quarter.", "symbols": ["MDB"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/24/12/42401269/mongodb-shares-climb-after-blockbuster-q3-results-fy25-guidance-above-estimates", "tags": ["earnings", "guidance"]}
{"id": 42401270, "time": "2024-12-09 16:42:29", "headline": "AT&T Says Remains On Track To Meet All Of The Financial And Operational Guidance Shared During Its 2024 Analyst & Investor Day", "summary": "", "symbols": ["T"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42401270/at-t-says-remains-on-track-to-meet-all-of-the-financial-and-operational-guidance-shared-during-its-2", "tags": ["guidance"]}
{"id": 42401293, "time": "2024-12-09 16:43:41", "headline": "AT&T Expects Its Multi-year Strategic Plan To Provide $50B+ Of Financial Capacity Over Next Three Years, Largely Through Organic Growth", "summary": "", "symbols": ["T"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42401293/at-t-expects-its-multi-year-strategic-plan-to-provide-50b-of-financial-capacity-over-next-three-year", "tags": []}
{"id": 42401307, "time": "2024-12-09 16:44:13", "headline": "NYSE To Begin Delisting Proceedings Against The Container Store Group", "summary": "", "symbols": ["TCS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42401307/nyse-to-begin-delisting-proceedings-against-the-container-store-group", "tags": []}
{"id": 42401345, "time": "2024-12-09 16:45:06", "headline": "MongoDB: Q3 Earnings Insights", "summary": " ", "symbols": ["MDB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42401345/mongodb-q3-earnings-insights", "tags": ["earnings"]}
{"id": 42401401, "time": "2024-12-09 16:47:36", "headline": "Murdoch Succession Plan Faces Setback As Commissioner Rejects Eldest Son's Control", "summary": "Rupert Murdoch&#39;s attempt to favor his eldest son Lachlan in a trust fund shuffle hit a roadblock when Commissioner Edmund J. Gorman Jr. ruled against it.", "symbols": ["NWS", "NWSA"], "source": "benzinga", "author": "Anthony Noto", "url": "https://www.benzinga.com/general/entertainment/24/12/42401401/murdoch-succession-plan-faces-setback-as-commissioner-rejects-eldest-sons-control", "tags": []}
{"id": 42401688, "time": "2024-12-09 16:53:32", "headline": "Toll Brothers Reports Better-Than-Expected Q4 Results, Weak Q1 Home Deliveries Guidance: Details", "summary": "Toll Brothers reported its fourth-quarter results after Monday&#39;s closing bell. Here&#39;s a look at the details from the report.", "symbols": ["TOL"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/24/12/42401688/toll-brothers-reports-better-than-expected-q4-results-weak-q1-home-deliveries-guidance-details", "tags": ["earnings", "guidance"]}
{"id": 42401742, "time": "2024-12-09 16:55:10", "headline": "Earnings Breakdown: MongoDB Q3", "summary": " ", "symbols": ["MDB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42401742/earnings-breakdown-mongodb-q3", "tags": ["earnings"]}
{"id": 42401743, "time": "2024-12-09 16:55:15", "headline": "Insights into HealthEquity Q3 Earnings", "summary": " ", "symbols": ["HQY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/12/42401743/insights-into-healthequity-q3-earnings", "tags": ["earnings"]}
{"id": 42401902, "time": "2024-12-09 17:02:08", "headline": "If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today", "summary": " ", "symbols": ["VRSK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42401902/if-you-invested-1000-in-this-stock-15-years-ago-you-would-have-this-much-today", "tags": []}
{"id": 42401904, "time": "2024-12-09 17:02:13", "headline": "Here's How Much $100 Invested In Imperial Oil 5 Years Ago Would Be Worth Today", "summary": " ", "symbols": ["IMO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42401904/heres-how-much-100-invested-in-imperial-oil-5-years-ago-would-be-worth-today", "tags": []}
{"id": 42401581, "time": "2024-12-09 16:51:07", "headline": "TJX Companies CEO And President Ernie Herrman Sells 7,533 Shares At An Average Price Of $126.18", "summary": "", "symbols": ["TJX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42401581/tjx-companies-ceo-president-herrman-ernie-sells-7-533-shares-at-126-1849-each", "tags": ["management"]}
{"id": 42402077, "time": "2024-12-09 17:12:18", "headline": "Planet Labs Stock Drops After Q3 Results: Here's Why", "summary": "Planet Labs reported its third-quarter results after Monday&#39;s closing bell. Here&#39;s a look at the key figures from the quarter.", "symbols": ["PL"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/general/space/24/12/42402077/planet-labs-stock-drops-after-q3-results-heres-why", "tags": ["earnings"]}
{"id": 42402166, "time": "2024-12-09 17:17:01", "headline": "Momentus Effectuates 1-For-14 Reverse Stock Split Of Its Class A Common Stock, Effective December 12, 2024 At 5:00 p.m. Eastern Time", "summary": "", "symbols": ["MNTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42402166/momentus-effectuates-1-for-14-reverse-stock-split-of-its-class-a-common-stock-effective-december-12", "tags": []}
{"id": 42402237, "time": "2024-12-09 17:18:29", "headline": "Oracle Executive Says Revenue Growth Will Accelerate Further In The Coming Quarters", "summary": "", "symbols": ["ORCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42402237/oracle-executive-says-revenue-growth-will-accelerate-further-in-the-coming-quarters", "tags": ["earnings"]}
{"id": 42402247, "time": "2024-12-09 17:19:24", "headline": "Oracle Executive Says FY25 Capex Will Be Double What Is Was In FY24", "summary": "", "symbols": ["ORCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42402247/oracle-executive-says-fy25-capex-will-be-double-what-is-was-in-fy24", "tags": []}
{"id": 42402381, "time": "2024-12-09 17:25:15", "headline": "Oracle Executive Says Company Remains Confident That Full-year Revenue Will Grow In Double Digits", "summary": "", "symbols": ["ORCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42402381/oracle-executive-says-company-remains-confident-that-full-year-revenue-will-grow-in-double-digits", "tags": ["earnings"]}
{"id": 42402410, "time": "2024-12-09 17:27:13", "headline": "Oracle Expects Q3 Revenue To Grow 9% - 11%, Adj. EPS To Be $1.50 - $1.54 (Est $1.57)", "summary": "", "symbols": ["ORCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42402410/oracle-expects-q3-revenue-to-grow-9-11-adj-eps-to-be-1-50-1-54-est-1-57", "tags": ["earnings"]}
{"id": 42402484, "time": "2024-12-09 17:30:20", "headline": "Here's How Much You Would Have Made Owning Pure Storage Stock In The Last 5 Years", "summary": " ", "symbols": ["PSTG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/12/42402484/heres-how-much-you-would-have-made-owning-pure-storage-stock-in-the-last-5-years", "tags": []}
{"id": 42402629, "time": "2024-12-09 17:43:33", "headline": "Trump To Change Dollar Stores For Good? Dollar Tree Exec Says 'Prepared To Act'", "summary": "Dollar Tree could raise prices or get rid of certain items to offset tariff plans from Donald Trump.", "symbols": ["DLTR"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/news/global/24/12/42402629/trump-to-change-dollar-stores-for-good-dollar-tree-exec-says-prepared-to-act", "tags": []}
{"id": 42402733, "time": "2024-12-09 17:48:17", "headline": "Regeneron Presents New And Updated Data For Odronextamab At ASH Annual Meeting", "summary": "", "symbols": ["REGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42402733/regeneron-presents-new-and-updated-data-for-odronextamab-at-ash-annual-meeting", "tags": []}
{"id": 42402763, "time": "2024-12-09 17:50:02", "headline": "Bitfarms Reveals Restatement Of Certain Previously Issued Financial Statements", "summary": "", "symbols": ["BITF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42402763/bitfarms-reveals-restatement-of-certain-previously-issued-financial-statements", "tags": []}
{"id": 42402839, "time": "2024-12-09 17:52:14", "headline": "TScan Therapeutics To Present Updated Results From Ongoing ALLOHA Phase 1 Trial Of TSC-100 And TSC-101 At ASH Meeting", "summary": "", "symbols": ["TCRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42402839/tscan-therapeutics-to-present-updated-results-from-ongoing-alloha-phase-1-trial-of-tsc-100-and-tsc-1", "tags": ["fda"]}
{"id": 42402861, "time": "2024-12-09 17:54:51", "headline": "Eli Lilly Reports Results From Phase 3 BRUIN CLL-321 Trial Evaluating Pirtobrutinib; Study's Primary Endpoint Of Progression-Free Survival Was Met At Primary Analysis", "summary": "", "symbols": ["LLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42402861/eli-lilly-reports-results-from-phase-3-bruin-cll-321-trial-evaluating-pirtobrutinib-studys-primary-e", "tags": ["fda"]}
{"id": 42402873, "time": "2024-12-09 17:56:25", "headline": "What's Going On With NIO Stock Today?", "summary": "Nio shares gained 12.4% Monday. Shares of U.S.-listed Chinese traded higher following reports suggesting Chinese officials would embrace a &#34;moderately loose&#34; monetary policy.", "symbols": ["NIO"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/global/24/12/42402873/whats-going-on-with-nio-stock-today-15", "tags": ["why_moving"]}
{"id": 42402883, "time": "2024-12-09 17:56:51", "headline": "Bristol Myers Squibb Reports Results From 18 Presentations; Data Demonstrate Efficacy, Durability And Safety Of Currently Available Therapies In Blood Cancers", "summary": "", "symbols": ["BMY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42402883/bristol-myers-squibb-reports-results-from-18-presentations-data-demonstrate-efficacy-durability-and", "tags": []}
{"id": 42402890, "time": "2024-12-09 17:58:57", "headline": "Gilead Company Kite Reports Results From Five-year Follow-up Analysis Of ZUMA-5, A Phase 2 Study Of Yescarta", "summary": "", "symbols": ["GILD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42402890/gilead-company-kite-reports-results-from-five-year-follow-up-analysis-of-zuma-5-a-phase-2-study-of-y", "tags": ["fda"]}
{"id": 42402908, "time": "2024-12-09 18:00:58", "headline": "SS&C Enters An Initial Agreement With Insignia Financial To Deliver Superannuation Member Administration Services", "summary": "", "symbols": ["SSNC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42402908/ss-c-enters-an-initial-agreement-with-insignia-financial-to-deliver-superannuation-member-administra", "tags": ["contract"]}
{"id": 42402914, "time": "2024-12-09 18:01:42", "headline": "TradePulse Power Inflow Alert: Applovin (APP) Receives Alert After Dropping Early, Then Rises Over 20 Points", "summary": " ", "symbols": ["APP"], "source": "benzinga", "author": "Finit", "url": "https://www.benzinga.com/trading-ideas/24/12/42402914/tradepulse-power-inflow-alert-applovin-app-receives-alert-after-dropping-early-then-rises-over-20-p", "tags": []}
{"id": 42402918, "time": "2024-12-09 18:01:59", "headline": "MAIA Biotechnology Enters Definitive Agreements For Purchase And Sale Of Aggregate 507,364 Shares Of Common Stock At $1.872 Per Share, In Private Placement", "summary": "", "symbols": ["MAIA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42402918/maia-biotechnology-enters-definitive-agreements-for-purchase-and-sale-of-aggregate-507-364-shares-of", "tags": ["offering"]}
{"id": 42402937, "time": "2024-12-09 18:04:01", "headline": "Nurix Therapeutics Presents New Clinical Data From Patients With Relapsed Or Refractory CLL/SLL Treated In  Phase 1a/1b Clinical Trial Of Its Bruton's Tyrosine Kinase Degrader NX-5948", "summary": "", "symbols": ["NRIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42402937/nurix-therapeutics-presents-new-clinical-data-from-patients-with-relapsed-or-refractory-cllsll-treat", "tags": ["fda"]}
{"id": 42402964, "time": "2024-12-09 18:05:45", "headline": "Recursion ReportsInitial Monotherapy Dose-escalation Data From Phase 1/2 Study Of REC-617 In Advanced Solid Tumors", "summary": "", "symbols": ["RXRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42402964/recursion-reportsinitial-monotherapy-dose-escalation-data-from-phase-12-study-of-rec-617-in-advanced", "tags": ["fda"]}
{"id": 42402976, "time": "2024-12-09 18:06:59", "headline": "Air Transport Services Reports Expiration Of \"Go-Shop\" Period; Stonepeak Transaction To Close in H1 Of 2025", "summary": "", "symbols": ["ATSG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42402976/air-transport-services-reports-expiration-of-go-shop-period-stonepeak-transaction-to-close-in-h1-of", "tags": []}
{"id": 42402983, "time": "2024-12-09 18:07:32", "headline": "Otter Tail Power Plans To Add Two Solar Facilities To Its Energy Generation Fleet To Meet Customers' Future Energy Needs", "summary": "", "symbols": ["OTTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42402983/otter-tail-power-plans-to-add-two-solar-facilities-to-its-energy-generation-fleet-to-meet-customers", "tags": []}
{"id": 42402989, "time": "2024-12-09 18:08:51", "headline": "How To Beat The Market When One Of Your Top Stocks Drops 44%", "summary": " ", "symbols": ["ANF", "CENX", "DELL", "FIX", "MSTR", "POWL", "QFIN", "SMCI", "SMTC", "SPY"], "source": "benzinga", "author": "David Pinsen", "url": "https://www.benzinga.com/markets/options/24/12/42402989/how-to-beat-the-market-when-one-of-your-top-stocks-drops-44", "tags": []}
{"id": 42403003, "time": "2024-12-09 18:10:25", "headline": "JinkoSolar Shares Are On The Rise Today: What's Going On?", "summary": "JinkoSolar shares are trading higher Monday following the company&#39;s announcement of a patent infringement lawsuit filed against VSUN Solar USA, Toyo Co., and their affiliates. Here&#39;s what you need to know.", "symbols": ["JKS"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/news/legal/24/12/42403003/jinkosolar-shares-are-on-the-rise-today-whats-going-on", "tags": ["why_moving", "legal"]}
{"id": 42402768, "time": "2024-12-09 18:21:34", "headline": "MAPS Drops Free Psychedelic Education And Artist-Curated Playlists - Start Your Journey Here", "summary": "MAPS&#39; &#34;Music is the Bridge&#34; combines curated playlists from artists like Melissa Etheridge with free psychedelic education for safe exploration.", "symbols": [], "source": "benzinga", "author": "Franca Quarneti", "url": "https://www.benzinga.com/general/education/24/12/42402768/maps-drops-free-psychedelic-education-and-artist-curated-playlists-start-your-journey-here", "tags": []}
{"id": 42403257, "time": "2024-12-09 18:36:06", "headline": "Activist Investor Urges Macy's To Rethink Strategy, Prioritize Shareholder Returns", "summary": "Retail giant Macy&#39;s faces challenges, activist investor Barington Capital urges focus on real estate to increase value.", "symbols": ["KSS", "M"], "source": "benzinga", "author": "Hayden Buckfire", "url": "https://www.benzinga.com/news/management/24/12/42403257/activist-investor-urges-macys-to-rethink-strategy-prioritize-shareholder-returns", "tags": []}
{"id": 42403470, "time": "2024-12-09 18:58:16", "headline": "Michael Saylor Uses LeBron James, Michael Jordan Sports Analogy To Explain Bitcoin To Dave Portnoy: 'Satoshi Gave Us A Game We Can All Win'", "summary": "Barstool Sports founder Dave Portnoy asked MicroStrategy Inc (NASDAQ:MSTR) Chairman Michael Saylor in a recent interview to explain Bitcoin (CRYPTO: BTC) to him in a way th", "symbols": ["BTCUSD", "MSTR"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/sports/24/12/42403470/michael-saylor-uses-lebron-james-michael-jordan-sports-analogy-to-explain-bitcoin-to-dave-portnoy-satoshi-gave-us-a-game-we-can-all-win", "tags": []}
{"id": 42403536, "time": "2024-12-09 19:04:11", "headline": "Dave & Buster's Q3 Earnings Preview: Data Shows Off-Peak Traffic Up", "summary": "Dave &amp; Buster&#39;s is set to report its third-quarter financial results after Tuesday&#39;s closing bell. Here&#39;s what investors will be looking for in the report.", "symbols": ["PLAY"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/general/restaurants/24/12/42403536/dave-busters-q3-earnings-preview-data-shows-off-peak-traffic-up", "tags": ["earnings"]}
{"id": 42403697, "time": "2024-12-09 19:19:56", "headline": "Donald Trump Tried To Block 'The Apprentice' From Movie Theaters, Film Gets 2 Golden Globe Nominations", "summary": "Sebastian Stan played Donald Trump on film in the movie &#34;The Apprentice.&#34; The movie could score Stan his first Golden Globe win.", "symbols": ["PARA", "PARAA"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/entertainment/24/12/42403697/donald-trump-tried-to-block-the-apprentice-from-movie-theaters-film-gets-2-golden-globe-nominations", "tags": []}
{"id": 42403806, "time": "2024-12-09 19:30:16", "headline": "The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns", "summary": "New Lake Capital Partners (OTC:NLCP), a real estate company focused on cannabis properties, offers an attractive investment with a 9.1% dividend yield, well above the return on 10-year government bonds.", "symbols": ["AAWH", "CRLBF", "CURLF", "GTBIF", "IIPR", "NLCP", "TCNNF"], "source": "benzinga", "author": "Nicol\u00e1s Jose Rodriguez", "url": "https://www.benzinga.com/real-estate/reit/24/12/42403806/the-price-is-right-this-weed-real-estate-stock-proves-conservative-strategies-bring-returns", "tags": ["dividend"]}
{"id": 42403914, "time": "2024-12-09 19:42:46", "headline": "UBS Maintains Buy on Comfort Systems USA, Raises Price Target to $575", "summary": "", "symbols": ["FIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42403914/ubs-maintains-buy-on-comfort-systems-usa-raises-price-target-to-575", "tags": ["analyst_other", "price_target_up"]}
{"id": 42403932, "time": "2024-12-09 19:45:54", "headline": "UBS Upgrades Expand Energy to Buy, Raises Price Target to $123", "summary": "", "symbols": ["EXE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42403932/ubs-upgrades-expand-energy-to-buy-raises-price-target-to-123", "tags": ["analyst_up", "price_target_up"]}
{"id": 42403936, "time": "2024-12-09 19:47:52", "headline": "UBS Upgrades Range Resources to Neutral, Raises Price Target to $35", "summary": "", "symbols": ["RRC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42403936/ubs-upgrades-range-resources-to-neutral-raises-price-target-to-35", "tags": ["analyst_up", "price_target_up"]}
{"id": 42403977, "time": "2024-12-09 19:50:03", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["JL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/12/42403977/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 42403978, "time": "2024-12-09 19:50:08", "headline": "UBS Downgrades Halliburton to Neutral, Lowers Price Target to $34", "summary": "", "symbols": ["HAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42403978/ubs-downgrades-halliburton-to-neutral-lowers-price-target-to-34", "tags": ["analyst_down", "price_target_down"]}
{"id": 42403987, "time": "2024-12-09 19:51:24", "headline": "UBS Maintains Buy on Diamondback Energy, Lowers Price Target to $212", "summary": "", "symbols": ["FANG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42403987/ubs-maintains-buy-on-diamondback-energy-lowers-price-target-to-212", "tags": ["analyst_other", "price_target_down"]}
{"id": 42404021, "time": "2024-12-09 19:52:26", "headline": "UBS Maintains Buy on Ovintiv, Lowers Price Target to $56", "summary": "", "symbols": ["OVV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42404021/ubs-maintains-buy-on-ovintiv-lowers-price-target-to-56", "tags": ["analyst_other", "price_target_down"]}
{"id": 42404022, "time": "2024-12-09 19:53:48", "headline": "UBS Maintains Neutral on APA, Lowers Price Target to $27", "summary": "", "symbols": ["APA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42404022/ubs-maintains-neutral-on-apa-lowers-price-target-to-27", "tags": ["analyst_other", "price_target_down"]}
{"id": 42404044, "time": "2024-12-09 19:56:06", "headline": "UBS Maintains Neutral on Murphy Oil, Lowers Price Target to $34", "summary": "", "symbols": ["MUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42404044/ubs-maintains-neutral-on-murphy-oil-lowers-price-target-to-34", "tags": ["analyst_other", "price_target_down"]}
{"id": 42404045, "time": "2024-12-09 19:58:08", "headline": "UBS Maintains Neutral on Occidental Petroleum, Lowers Price Target to $51", "summary": "", "symbols": ["OXY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42404045/ubs-maintains-neutral-on-occidental-petroleum-lowers-price-target-to-51", "tags": ["analyst_other", "price_target_down"]}
{"id": 42404048, "time": "2024-12-09 19:59:51", "headline": "UBS Maintains Neutral on Antero Resources, Raises Price Target to $35", "summary": "", "symbols": ["AR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42404048/ubs-maintains-neutral-on-antero-resources-raises-price-target-to-35", "tags": ["analyst_other", "price_target_up"]}
{"id": 42404074, "time": "2024-12-09 20:03:16", "headline": "UBS Maintains Buy on Wells Fargo, Raises Price Target to $85", "summary": "", "symbols": ["WFC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42404074/ubs-maintains-buy-on-wells-fargo-raises-price-target-to-85", "tags": ["analyst_other", "price_target_up"]}
{"id": 42404078, "time": "2024-12-09 20:04:23", "headline": "UBS Maintains Buy on Chord Energy, Lowers Price Target to $161", "summary": "", "symbols": ["CHRD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42404078/ubs-maintains-buy-on-chord-energy-lowers-price-target-to-161", "tags": ["analyst_other", "price_target_down"]}
{"id": 42404104, "time": "2024-12-09 20:06:32", "headline": "UBS Initiates Coverage On Zoetis with Neutral Rating, Announces Price Target of $196", "summary": "", "symbols": ["ZTS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42404104/ubs-initiates-coverage-on-zoetis-with-neutral-rating-announces-price-target-of-196", "tags": ["analyst_init"]}
{"id": 42404120, "time": "2024-12-09 20:07:57", "headline": "UBS Maintains Neutral on Nike, Lowers Price Target to $80", "summary": "", "symbols": ["NKE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42404120/ubs-maintains-neutral-on-nike-lowers-price-target-to-80", "tags": ["analyst_other", "price_target_down"]}
{"id": 42404134, "time": "2024-12-09 20:10:46", "headline": "UBS Downgrades TIM to Neutral", "summary": "", "symbols": ["TIMB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42404134/ubs-downgrades-tim-to-neutral", "tags": ["analyst_down"]}
{"id": 42404138, "time": "2024-12-09 20:13:51", "headline": "Citigroup Maintains Neutral on SITE Centers, Lowers Price Target to $16", "summary": "", "symbols": ["SITC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42404138/citigroup-maintains-neutral-on-site-centers-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 42404145, "time": "2024-12-09 20:15:30", "headline": "Citigroup Maintains Buy on Merus, Raises Price Target to $97", "summary": "", "symbols": ["MRUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/12/42404145/citigroup-maintains-buy-on-merus-raises-price-target-to-97", "tags": ["analyst_other", "price_target_up"]}
{"id": 42404312, "time": "2024-12-09 20:47:34", "headline": "Gary Black Boosts Tesla Price Target By 27% To $380 Based On 'Increased Conviction' That Elon Musk-Led Company Will Launch $25K Hatchback", "summary": "Tesla Inc. could see significant growth from a new budget electric vehicle offering, according to prominent investor Gary Black, who raised his price target for the EV maker by 27% to $380 from $300 on Monday, Dec. 9, 2024.", "symbols": ["FFND", "TSLA"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/24/12/42404312/gary-black-boosts-tesla-price-target-by-27-to-380-citing-25k-hatchbacks-market-potential", "tags": ["offering"]}
{"id": 42404352, "time": "2024-12-09 20:51:30", "headline": "Nvidia China Antitrust Probe May 'Remain Unsolved' In Near Term Says Top Analyst; Investors Should Be Prepared For Increased Scrutiny", "summary": "China has launched an antitrust investigation into Nvidia, alleging monopoly practices in AI chips, but analysts predict limited short-term financial impact and suggest the case may remain unresolved amid geopolitical tensions.", "symbols": ["NVDA", "QCOM"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/news/legal/24/12/42404352/nvidia-china-antitrust-probe-may-remain-unsolved-in-near-term-says-top-analyst-investors-should-be-prepared-for-increased-scrutiny", "tags": ["legal"]}
{"id": 42404540, "time": "2024-12-09 21:26:04", "headline": "What's Going On With Dogecoin Rival Shiba Inu (SHIB)?", "summary": "Shiba Inu (CRYPTO: SHIB) faced sharp price swings during Monday trading, falling as much as 22% to the $0.000024-level Monday afternoon, as Bitcoin (CRYPTO: BTC) retreated from its ", "symbols": ["BTCUSD", "DOGEUSD", "SHIBUSD"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/12/42404540/whats-going-on-with-dogecoin-rival-shiba-inu-shib-2", "tags": ["why_moving"]}
{"id": 42404610, "time": "2024-12-09 21:44:56", "headline": "Peter Schiff Advises Biden To Do One 'Good Thing' Before His Term Ends: 'Sell All The Bitcoin' Held By The US", "summary": "Influential economist Peter Schiff suggested on Monday that President Joe Biden sell all of the U.S.-owned Bitcoin (CRYPTO: BTC) before leaving office to help reduce the country\u2019s ballooning budget deficit.", "symbols": ["BTCM", "BTCUSD", "DOGEUSD", "LTCUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42404610/peter-schiff-advises-biden-to-do-one-good-thing-before-his-term-ends-sell-all-the-bitcoin-held-by-the-us", "tags": []}
{"id": 42404450, "time": "2024-12-09 21:12:00", "headline": "Bitcoin, Ethereum, Dogecoin Recover Losses After Flash Crash: Analyst Pinpoints Critical BTC Support Levels", "summary": "Leading cryptocurrency dumped hard on Monday following Bitcoin&#39;s flash crash to $94,000.", "symbols": ["BTCUSD", "DOGEUSD", "ETHUSD", "NVDA"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/trading-ideas/movers/24/12/42404450/bitcoin-ethereum-dogecoin-recover-losses-after-flash-crash-analyst-pinpoints-critical-btc-support-levels", "tags": []}
{"id": 42404763, "time": "2024-12-09 22:19:02", "headline": "Google's Willow Quantum Computing Chip Sparks Stellar Conversation Between Elon Musk And Sundar Pichai: 'Most Obvious Path Is Staring At Our Eyes'", "summary": "Google CEO Sundar Pichai and Elon Musk discussed ambitious technological possibilities, from leveraging quantum computing advancements like Google&#39;s Willow chip to envisioning solar-powered quantum clusters in space, highlighting their shared focus on transformative innovation.", "symbols": ["GOOG", "GOOGL", "NVDA"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/24/12/42404763/pichai-and-musk-dream-big-about-quantum-computing-and-solar-energy-the-most-obvious-path-is-staring-at-our-eyes-literally", "tags": ["management"]}
{"id": 42404869, "time": "2024-12-09 22:50:47", "headline": "Can Solana And Toncoin Print Fresh All-Time Highs Just Like Bitcoin's Recent $100K Move? Here's What This Analyst Says", "summary": "An influential cryptocurrency analyst on Monday identified Solana (CRYPTO: SOL) and Toncoin (CRYPTO: TON) as the next contenders to reach new all-time highs, following the accomplishments of Bitcoin (CRYPTO: ", "symbols": ["BNBUSD", "BTCM", "BTCUSD", "SOL", "SOLUSD", "TONUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/24/12/42404869/can-solana-and-toncoin-print-fresh-all-time-highs-just-like-bitcoins-recent-100k-move-heres-what-this-analyst-says", "tags": []}
{"id": 42404918, "time": "2024-12-09 22:56:14", "headline": "Oracle Positioned To Benefit From Enterprise Revolution, Says Dan Ives: 'The Software Phase Of The AI Revolution Is Now Here'", "summary": "Oracle Corp. is positioned to capitalize on the emerging enterprise software AI revolution, according to Wedbush Securities Managing Director Dan Ives&#39; interview on Monday, Dec. 9, 2024.", "symbols": ["CRM", "ORCL", "PLTR"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/24/12/42404918/oracle-positioned-to-benefit-from-enterprise-revolution-says-dan-ives-the-software-phase-of-the-ai-revolution-is-now-here", "tags": []}
{"id": 42405142, "time": "2024-12-09 23:59:13", "headline": "Nvidia, AMD, C3 ai, Oracle, Tesla: Why These 5 Stocks Are On Investors' Radars Today?", "summary": "On Monday, major U.S. indices closed in the red, with the Dow Jones Industrial Average falling 0.5% to 44,401.93.", "symbols": ["AI", "AMD", "NVDA", "ORCL", "TSLA"], "source": "benzinga", "author": "Shomik Sen Bhattacharjee", "url": "https://www.benzinga.com/24/12/42405142/nvidia-amd-c3-ai-oracle-tesla-why-these-5-stocks-are-on-investors-radars-today", "tags": []}
{"id": 42391597, "time": "2024-12-09 10:00:34", "headline": "Cryptocurrency Pepe Rises More Than 7% In 24 hours", "summary": "Over the past 24 hours, Pepe&#39;s (CRYPTO: PEPE) price rose 7.87% to $0.000027. This continues its positive trend over the past week where it has experienced a 28.0% gain, moving from $0.000020 to its current price.", "symbols": ["PEPEUSD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/cryptocurrency/24/12/42391597/test0-6403884069198504-cryptocurrency-pepe-rises-more-than-7-in-24-hours", "tags": []}
